Bursitis of shoulder

M13_SHOULDERBURSITIS

Hemarthrosis: Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M75.5 Hospital discharge: ICD-9 — 7261B Cause of death: ICD-10 — M75.5 Cause of death: ICD-9 — 7261B 2 out of 7 registries used, show all original rules.	1050
4. Check minimum number of events None	1050
5. Include endpoints None	1050
6. Filter based on genotype QC (FinnGen only)	1014

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M75
Name in latin: Bursitis regionis deltoideae

NAME	M13_SHOULDERBURSITIS
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M755
HD_ICD_9	7261B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M755
COD_ICD_9	7261B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bursitis of shoulder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	6225	3601	2591
Only index persons	5944	3456	2488
Unadjusted period prevalence (%)
Whole population	0.09	0.10	0.07
Only index persons	0.11	0.13	0.09
Median age at first event (years)
Whole population	52.66	53.18	52.04
Only index persons	52.39	52.74	51.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1014	638	376
Unadjusted period prevalence (%)	0.21	0.23	0.17
Median age at first event (years)	53.87	52.94	55.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1050: Matched controls
10500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M75.5

ICD-10 Finland

Bursitis of shoulder

2552.3

307.7

986

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

47.5

307.7

237

M75.1

ICD-10 Finland

Rotator cuff syndrome

12.6

307.7

602

1015

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

63.1

307.7

204

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

13.1

145.3

147

129

M19.0

ICD-10 Finland

Primary arthrosis of other joints

7.3

137.1

232

393

L08

ICPC

Shoulder symptom/complaint

4.9

133.1

429

1300

NBG10

NOMESCO Finland

Acromioplastia

60.3

130.3

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

8.0

122.6

185

275

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

41.2

119.9

N02AX02

ATC

tramadol; systemic, rectal

4.2

114.5

622

2704

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

36.2

112.6

M79.6

ICD-10 Finland

Pain in limb

4.0

107.5

580

2480

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

25.5

107.4

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

20.3

104.1

M79.0

ICD-10 Finland

Rheumatism, unspecified

37.4

96.1

N03AX16

ATC

[U] pregabalin

4.0

91.8

351

1164

WX200

NOMESCO Finland

Interscalenous plexus blockade

17.4

87.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.9

86.2

223

548

N03AX12

ATC

[U] gabapentin; oral

4.5

85.3

253

693

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.4

84.8

594

2880

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

28.1

82.2

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

36.7

78.1

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

38.6

77.6

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

23.6

77.1

G56.0

ICD-10 Finland

Carpal tunnel syndrome

4.4

76.0

227

621

M25.5

ICD-10 Finland

Pain in joint

3.3

75.7

470

2085

7261B

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[BURSITIS CALCAREA HUMEROSCAPULARIS]

+∞

70.6

M79.7

ICD-10 Finland

Fibromyalgia

18.3

66.6

N02AJ06

ATC

codeine and paracetamol; systemic

3.0

64.6

556

2898

M54.4

ICD-10 Finland

Lumbago with sciatica

3.5

63.6

273

952

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.9

62.9

224

690

N06AX21

ATC

duloxetine; oral

4.2

62.8

194

540

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.5

62.0

168

423

M01AH05

ATC

etoricoxib; oral

3.1

59.5

773

4944

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.9

57.7

199

597

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.0

56.5

105

190

M03BX02

ATC

tizanidine; oral

3.0

55.6

765

4957

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

4.9

55.3

134

307

M75.2

ICD-10 Finland

Bicipital tendinitis

10.1

53.5

M54.2

ICD-10 Finland

Cervicalgia

4.6

53.4

138

333

M70.6

ICD-10 Finland

Trochanteric bursitis

3.8

52.5

181

541

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

7.8

51.4

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

50.5

309

1309

M79.1

ICD-10 Finland

Myalgia

3.6

49.7

192

618

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.9

49.5

116

258

M01AH01

ATC

celecoxib; oral

3.1

48.7

244

922

H02AB06

ATC

prednisolone; systemic

2.5

47.9

575

3380

M54.5

ICD-10 Finland

Low back pain

2.6

47.9

450

2358

M01AB05

ATC

diclofenac; systemic, rectal

2.8

47.9

783

5339

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.4

47.6

128

318

M48.0

ICD-10 Finland

Spinal stenosis

3.7

47.1

169

517

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

7.4

46.7

101

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

46.4

439

2300

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

5.2

46.1

100

208

M01AC06

ATC

meloxicam; systemic, rectal

2.5

44.8

445

2377

G44.2

ICD-10 Finland

Tension-type headache

3.3

43.6

193

674

A01

ICPC

Pain general/multiple sites

3.8

43.2

148

438

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.4

42.7

N06AA09

ATC

amitriptyline; systemic

3.9

42.5

138

393

A02BC02

ATC

pantoprazole; systemic

2.7

41.8

791

5594

M77.1

ICD-10 Finland

Lateral epicondylitis

4.4

41.5

111

274

G54.0

ICD-10 Finland

Brachial plexus disorders

7.8

39.8

N02BF01

ATC

gabapentin; oral

3.6

39.4

146

454

R51.80

ICD-10 Finland

Headache

3.0

38.8

205

790

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

38.3

339

1693

M02AA07

ATC

piroxicam; topical

2.4

37.9

410

2237

A02BC03

ATC

lansoprazole; oral

2.4

37.9

350

1781

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

14.6

37.5

R52.9

ICD-10 Finland

Pain, unspecified

3.5

37.2

143

455

L92

ICPC

Shoulder syndrome

8.0

36.4

X58

ICD-10 Finland

Exposure to other specified factors

2.9

36.4

200

786

R06.0

ICD-10 Finland

Dyspnoea

2.4

36.3

328

1647

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

70.9

36.2

M75.8

ICD-10 Finland

Other shoulder lesions

5.8

34.3

119

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.1

34.0

165

603

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

4.8

33.7

175

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.4

32.9

131

425

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

32.7

257

1204

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.8

32.5

168

M67.4

ICD-10 Finland

Ganglion

5.1

32.3

145

N02BE01

ATC

paracetamol; systemic, rectal

4.1

32.2

982

8167

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.4

32.1

127

410

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.3

32.1

133

442

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.8

31.7

106

ZXA05

NOMESCO Finland

Left side

2.4

31.5

277

1363

M01AX17

ATC

nimesulide; oral

2.4

31.4

277

1365

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

5.0

31.3

145

A02BC05

ATC

esomeprazole; systemic

2.1

31.2

462

2812

ACC51

NOMESCO Finland

Release of median nerve

3.8

31.1

102

291

NBM20

NOMESCO Finland

Excision of bursa of shoulder or upper arm

322.1

31.0

L03

ICPC

Low back symptom/complaint

2.3

30.7

338

1827

M65.3

ICD-10 Finland

Trigger finger

5.9

29.7

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

29.4

307

1620

L12

ICPC

Hand/finger symptom/complaint

2.5

29.3

211

944

M01AE02

ATC

naproxen; oral, rectal

2.1

29.2

620

4284

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

32.8

29.2

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

29.2

235

1107

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

45.1

28.8

S18

ICPC

Laceration/cut

2.1

28.7

523

3411

XA402

NOMESCO Finland

ENMG

7.6

28.6

M13.9

ICD-10 Finland

Arthritis, unspecified

3.6

28.6

102

308

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

28.4

219

1010

ZXA00

NOMESCO Finland

Right side

2.3

28.1

288

1503

M01AH02

ATC

rofecoxib; oral

2.8

27.9

152

590

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

6.5

27.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

26.9

110

362

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

6.4

26.8

R03AC02

ATC

salbutamol; inhalant

2.0

26.8

606

4232

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

5.4

26.5

102

M77.0

ICD-10 Finland

Medial epicondylitis

7.3

26.4

Z3226

NOMESCO Finland

Physiotherapist

2.4

26.1

208

971

R02

ICPC

Shortness of breath/dyspnoea

2.6

26.1

169

716

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

25.9

214

1015

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.9

25.7

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

25.5

269

1414

L17

ICPC

Foot/toe symptom/complaint

2.1

25.4

334

1912

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

25.1

217

1049

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

24.5

504

3368

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

24.4

337

1959

L01

ICPC

Neck symptom/complaint

2.4

24.4

196

916

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.6

24.2

160

683

M19.9

ICD-10 Finland

Arthrosis, unspecified

4.2

24.0

161

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

23.8

313

1786

A07EC01

ATC

sulfasalazine; oral, rectal

3.1

23.7

105

362

Z50.1

ICD-10 Finland

Other physical therapy

3.8

23.4

210

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

5.5

23.4

R96

ICPC

Asthma

2.8

23.3

132

521

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

23.1

144

596

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.7

23.0

135

542

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.0

22.9

107

380

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

22.8

501

3397

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

22.8

282

1569

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.9

22.6

N02AA05

ATC

oxycodone; systemic

2.3

22.5

199

967

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

22.5

774

6079

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.4

22.4

256

J01FF01

ATC

clindamycin; systemic

2.0

22.2

300

1722

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

22.1

218

1108

L13

ICPC

Hip symptom/complaint

2.2

21.9

215

1091

P01BA02

ATC

hydroxychloroquine; oral

3.0

21.7

102

363

L11

ICPC

Wrist symptom/complaint

2.8

21.7

117

450

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

21.6

766

6027

SPAT1263

SPAT

Sampling

1.9

21.5

431

2822

J01AA02

ATC

doxycycline; systemic

2.1

21.4

833

6764

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

21.4

385

2433

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

21.3

171

796

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.9

21.2

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

5.1

21.0

J01DB01

ATC

cefalexin; oral

2.2

20.9

874

7251

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

20.9

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.2

20.9

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

20.8

167

777

M01AB55

ATC

diclofenac, combinations; oral

3.3

20.8

258

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.9

20.7

L29

ICPC

Musculoskeletal sympt/complt other

2.8

20.6

108

408

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

4.1

20.5

144

L88

ICPC

Rheumatoid/seropositive arthritis

4.0

20.5

153

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

20.5

195

975

J01MA02

ATC

ciprofloxacin; systemic

1.9

20.5

407

2648

L04AX03

ATC

methotrexate; systemic

2.7

20.3

120

483

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

20.0

592

4344

M54.1

ICD-10 Finland

Radiculopathy

4.3

20.0

125

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.7

20.0

118

475

M01AX05

ATC

glucosamine; oral

2.2

19.9

200

1021

R4120

NOMESCO Finland

Occupational therapy

3.2

19.8

266

R42

ICD-10 Finland

Dizziness and giddiness

2.0

19.6

245

1358

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

7.5

19.6

R52.2

ICD-10 Finland

Other chronic pain

4.3

19.5

123

D06

ICPC

Abdominal pain localized other

2.8

19.4

107

416

R51

ICD-10 Finland

Headache

3.4

19.2

229

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.0

19.1

304

R05

ICPC

Cough

2.0

19.0

279

1635

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.5

19.0

131

568

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

14.5

18.7

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.8

18.6

N02BF02

ATC

pregabalin; oral

3.1

18.5

266

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

18.4

428

2900

L09

ICPC

Arm symptom/complaint

3.4

18.2

211

M02AA10

ATC

ketoprofen; topical

2.2

18.1

168

828

L28

ICPC

Limited function/disability (L)

2.1

18.1

190

985

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

17.9

310

1915

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

17.8

233

1308

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

17.7

285

1717

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

17.7

280

1678

R03DC03

ATC

montelukast; oral

2.1

17.6

188

979

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.6

17.5

166

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.6

17.5

106

431

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.1

17.5

120

G47.3

ICD-10 Finland

Sleep apnoea

1.9

17.1

253

1481

L15

ICPC

Knee symptom/complaint

1.9

17.1

272

1631

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

16.9

325

R4110

NOMESCO Finland

Physiotherapy

1.9

16.9

294

1814

UJF32

NOMESCO Finland

Coloscopy

1.9

16.8

269

1616

NB1BG, ,

SPAT

4.7

16.7

R06AE07

ATC

cetirizine; oral

1.7

16.6

459

3240

L10

ICPC

Elbow symptom/complaint

3.1

16.6

239

R05

ICD-10 Finland

Cough

1.9

16.5

234

1347

A02BC01

ATC

omeprazole; systemic

1.9

16.5

272

1646

N06AX16

ATC

venlafaxine; oral

2.2

16.5

161

809

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

16.4

245

1436

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

16.4

240

1398

A03

ICPC

Fever

2.1

16.4

183

969

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

5.3

16.3

L86

ICPC

Back syndrome with radiating pain

3.0

16.3

258

NB1AA, ,

SPAT

3.3

16.2

190

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

16.2

294

1833

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

16.0

317

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.7

16.0

147

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.5

16.0

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.9

16.0

124

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

16.0

217

1231

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

15.9

119

534

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

15.8

205

1145

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

5.4

15.7

C03CA01

ATC

furosemide; systemic

1.8

15.7

276

1703

R01AD09

ATC

mometasone; nasal

1.7

15.4

472

3409

M19.8

ICD-10 Finland

Other specified arthrosis

3.4

15.4

171

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

15.4

267

J01FA06

ATC

roxithromycin; oral

1.7

15.1

405

2816

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.9

15.1

120

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

15.0

502

3700

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

11.0

15.0

S80.0

ICD-10 Finland

Contusion of knee

2.6

14.9

347

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.6

14.8

342

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.3

14.8

175

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

14.8

337

M01AE01

ATC

ibuprofen; systemic, rectal

2.3

14.7

949

8428

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

14.6

112

508

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

14.6

263

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.0

14.6

M70.2

ICD-10 Finland

Olecranon bursitis

4.5

14.6

WX400

NOMESCO Finland

Inhalation anesthesy

3.4

14.5

167

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.1

14.4

101

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

14.4

114

524

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

14.4

323

N02AC04

ATC

dextropropoxyphene; oral

3.9

14.4

110

ZA1.0

ICD-10 Finland

Shoulder region

4.4

14.4

J01FA10

ATC

azithromycin; systemic

1.7

14.3

583

4502

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

14.3

347

2340

R60.0

ICD-10 Finland

Localized oedema

2.2

14.3

123

586

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

14.3

681

5479

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

14.3

103

455

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

14.2

263

1640

WZA90

NOMESCO Finland

Other medical or dental certificate

1.9

14.2

232

1394

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

14.1

186

1040

WX702

NOMESCO Finland

Supraglottic ventilation device

2.8

14.1

285

M76.6

ICD-10 Finland

Achilles tendinitis

3.5

14.1

150

AA1AD

NOMESCO Finland

CT of head and brain

1.8

14.0

284

1818

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

14.0

377

2612

A02BA02

ATC

ranitidine; systemic

1.9

14.0

188

1059

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.9

14.0

108

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.4

14.0

156

K02.1

ICD-10 Finland

Caries of dentine

1.7

14.0

604

4725

M75

ICD-10 Finland

Shoulder lesions

3.2

13.9

182

N06AA10

ATC

nortriptyline; systemic

5.1

13.9

A11

ICPC

Chest pain NOS

2.4

13.9

416

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.9

13.8

237

P01AB01

ATC

metronidazole; oral, rectal

1.7

13.8

413

2940

NHQ40

NOMESCO Finland

Amputation of toe

6.3

13.8

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

13.7

296

J01DA01

ATC

[U] cefalexin

1.6

13.6

612

4823

B01AB05

ATC

enoxaparin; parenteral

1.7

13.5

311

2062

Z01.2

ICD-10 Finland

Dental examination

1.6

13.5

474

3509

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

13.5

111

519

M77.4

ICD-10 Finland

Metatarsalgia

3.0

13.4

213

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

5.7

13.4

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

26.1

13.4

C10AA05

ATC

atorvastatin; oral

1.6

13.4

424

3057

RF210, ,

NOMESCO Finland

4.2

13.4

SFA20

NOMESCO Finland

Two-surface restoration

1.6

13.3

605

4767

C07AB07

ATC

bisoprolol; oral

1.6

13.2

472

3502

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.9

13.2

226

R09

ICPC

Sinus symptom/complaint

2.4

13.1

407

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

12.3

13.1

M89.0

ICD-10 Finland

Algoneurodystrophy

15.3

13.1

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

13.1

226

1377

Z71.8

ICD-10 Finland

Other specified counselling

1.7

13.0

347

2388

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.4

13.0

138

SFA10

NOMESCO Finland

One-surface restoration

1.6

13.0

561

4355

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

13.0

101

461

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.8

12.9

235

A03FA02

ATC

cisapride; oral, rectal

2.6

12.8

306

M35.7

ICD-10 Finland

Hypermobility syndrome

10.7

12.8

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

12.7

280

1828

L04AA13

ATC

[U] leflunomide

4.4

12.7

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

12.6

135

700

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.2

12.6

156

M01AX01

ATC

nabumetone; oral

3.3

12.6

146

J46

ICD-10 Finland

Status asthmaticus

4.2

12.6

C10AX09

ATC

ezetimibe; oral

1.9

12.5

172

973

NBL50

NOMESCO Finland

Tenolysis or tenosynovectomy of shoulder or upper arm

+∞

12.5

N05CF01

ATC

zopiclone; oral

1.7

12.5

316

2141

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

24.6

12.5

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.4

12.4

132

N06AX11

ATC

mirtazapine; oral

1.7

12.4

342

2369

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.0

12.3

D01

ICPC

Abdominal pain/cramps general

2.1

12.3

129

663

K08.80

ICD-10 Finland

Toothache NOS

2.2

12.3

106

505

SPAT1153

SPAT

Removal of sutures

1.7

12.3

296

1979

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

12.3

224

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.9

12.3

H01

ICPC

Ear pain/earache

2.1

12.2

119

595

L14

ICPC

Leg/thigh symptom/complaint

2.4

12.2

388

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.3

12.2

144

WX002

NOMESCO Finland

Sedation and analgesia

1.8

12.1

190

1121

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

12.1

120

605

NBK92

NOMESCO Finland

Other operation on bone of shoulder or upper arm, clavicle

27.0

12.1

J02AC01

ATC

fluconazole; systemic

1.6

12.1

400

2897

L20

ICPC

Joint symptom/complaint NOS

3.2

12.1

150

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

12.0

158

881

S06.0

ICD-10 Finland

Concussion

2.2

12.0

112

551

J01CA04

ATC

amoxicillin; systemic

1.7

12.0

831

7189

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.9

12.0

199

H02AB04

ATC

methylprednisolone; systemic

2.0

11.9

142

765

R4110, ,

SPAT

2.0

11.9

142

765

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

11.9

518

3997

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

4.2

11.8

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

11.8

349

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

11.8

342

2392

R03AC03

ATC

terbutaline; inhalant

2.0

11.7

141

762

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

4.1

11.7

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.9

11.7

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

11.7

364

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

23.2

11.6

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.3

11.6

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

11.6

136

729

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

11.5

433

3223

7260A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Adhesive capsulitis of shoulder

+∞

11.5

S21

ICPC

Skin texture symptom/complaint

1.9

11.5

156

879

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.7

11.5

L01BA01

ATC

methotrexate; systemic

3.4

11.5

124

L16

ICPC

Ankle symptom/complaint

2.1

11.4

116

590

R03BA05

ATC

fluticasone; inhalant

1.8

11.3

179

1058

D07AC01

ATC

betamethasone; topical

1.6

11.3

359

2565

SFA30

NOMESCO Finland

Three-surface restoration

1.6

11.3

441

3307

KMAK, ,

NOMESCO Finland

1.6

11.2

515

4003

R03BA08

ATC

ciclesonide; inhalant

2.2

11.2

463

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

11.1

142

R21

ICPC

Throat symptom/complaint

1.8

11.1

200

1230

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

4.3

11.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

11.0

134

726

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.4

11.0

354

EB1VA, ,

NOMESCO Finland

1.8

11.0

188

1137

R74

ICPC

Upper respiratory infection acute

1.6

11.0

320

2235

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.7

11.0

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

43.8

10.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

10.9

434

R01AD58

ATC

fluticasone, combinations; nasal

1.7

10.9

257

1700

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.4

10.9

318

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.1

10.9

109

551

R53

ICD-10 Finland

Malaise and fatigue

1.7

10.9

239

1553

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

10.8

133

723

A46

ICD-10 Finland

Erysipelas

1.9

10.8

141

782

M43.1

ICD-10 Finland

Spondylolisthesis

3.0

10.8

160

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.9

10.8

R03BA01

ATC

beclometasone; inhalant

1.9

10.8

139

769

M20.2

ICD-10 Finland

Hallux rigidus

3.3

10.8

124

R52.0

ICD-10 Finland

Acute pain

3.4

10.8

119

A04

ICPC

Weakness/tiredness general

1.9

10.7

148

837

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

10.7

361

2608

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

10.7

445

N06AX05

ATC

trazodone; oral

3.8

10.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

10.6

157

908

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

10.6

237

1545

AN1

Coronary angiography

2.1

10.6

487

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.2

10.5

136

S63.5

ICD-10 Finland

Sprain and strain of wrist

3.2

10.5

136

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.9

10.5

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.9

10.5

R01AD08

ATC

fluticasone; nasal

1.6

10.5

283

1936

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

10.5

239

1566

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

10.5

305

2126

N01

ICPC

Headache

2.1

10.5

105

531

L02

ICPC

Back symptom/complaint

2.1

10.5

106

538

P03

ICPC

Feeling depressed

2.1

10.4

483

NBK02

NOMESCO Finland

Excision of fragment of bone of shoulder or upper arm, clavicle

+∞

10.4

M66.3

ICD-10 Finland

Spontaneous rupture of flexor tendons

+∞

10.4

-1, ,

NOMESCO Finland

1.6

10.4

322

2277

9211

FHL

Exploration or removal of diskusprolapse

4.2

10.4

L91

ICPC

Osteoarthrosis other

4.2

10.4

R23.3

ICD-10 Finland

Spontaneous ecchymoses

4.2

10.4

S16

ICPC

Bruise/contusion

3.4

10.3

107

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

10.3

202

1269

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

10.3

113

590

M19.2

ICD-10 Finland

Other secondary arthrosis

8.9

10.3

N17

ICPC

Vertigo/dizziness

1.9

10.3

128

699

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

10.3

130

714

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

7.6

10.2

RF420, ,

NOMESCO Finland

7.6

10.2

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

10.2

488

3801

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

10.2

315

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

10.2

235

R03BA02

ATC

budesonide; inhalant

1.8

10.2

179

1091

ZXE00

NOMESCO Finland

One hour or less

1.6

10.2

368

2696

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

10.1

178

M54

ICD-10 Finland

Dorsalgia

2.0

10.1

121

653

B01AF01

ATC

rivaroxaban; oral

2.0

10.1

121

653

SPAT1301

SPAT

No procedures

1.6

10.1

281

1936

M54.3

ICD-10 Finland

Sciatica

2.6

10.0

219

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

10.0

484

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

10.0

596

4858

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

9.9

138

782

H02AB07

ATC

prednisone; oral

1.9

9.9

126

693

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

9.9

173

1052

R07.3

ICD-10 Finland

Other chest pain

2.1

9.8

101

515

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.8

9.8

175

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

9.8

238

1583

R07.0

ICD-10 Finland

Pain in throat

2.3

9.8

321

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

9.8

240

R06AX27

ATC

desloratadine; oral

1.6

9.7

286

1992

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

9.7

284

K07.60

ICD-10 Finland

Snapping jaw

2.6

9.7

211

W19

ICD-10 Finland

Unspecified fall

2.1

9.7

490

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

9.7

670

5619

N05BA01

ATC

diazepam; systemic, rectal

1.9

9.7

129

721

WYA10

NOMESCO Finland

Emergency care or similar visit

2.3

9.6

349

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

9.6

177

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

9.6

425

3243

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

9.6

170

1037

ZXD05

NOMESCO Finland

Urgent procedure

1.6

9.6

281

1956

ZXD20

NOMESCO Finland

Day surgery

1.9

9.6

120

657

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

9.6

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

4.1

9.5

P06

ICPC

Sleep disturbance

1.9

9.5

126

702

A02BC04

ATC

rabeprazole; oral

2.1

9.5

466

C01DA14

ATC

isosorbide mononitrate; oral

1.9

9.5

120

659

N04BC05

ATC

pramipexole; oral

2.3

9.5

345

A29

ICPC

General symptom/complaint other

1.9

9.5

133

756

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.7

9.5

196

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

9.4

108

573

SPAT1283

SPAT

Restricted health certificate

1.8

9.4

148

871

M01AE52

ATC

naproxen and esomeprazole; oral

3.2

9.4

114

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

9.4

118

647

R50.9

ICD-10 Finland

Fever, unspecified

1.8

9.4

144

842

WX290

NOMESCO Finland

Other blockage of nerve

1.5

9.3

464

3622

M54.8

ICD-10 Finland

Other dorsalgia

2.8

9.2

164

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

9.2

416

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

9.2

253

K59.0

ICD-10 Finland

Constipation

2.5

9.2

235

SPAT1312

SPAT

General health counselling

1.6

9.1

285

2010

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.6

9.1

M22.4

ICD-10 Finland

Chondromalacia patellae

3.6

9.1

R75

ICPC

Sinusitis acute/chronic

2.6

9.1

200

A07AA02

ATC

nystatin; oral

2.5

9.1

224

J45

ICD-10 Finland

Asthma

2.0

9.0

107

574

1221

FHL

Arthroscopy and meniscus surgery

3.6

9.0

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

9.0

307

R5599

NOMESCO Finland

Other rehabilitation service

3.5

9.0

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

9.0

270

1887

SPAT1254

SPAT

Administration of medicine

1.9

9.0

128

731

K30

ICD-10 Finland

Functional dyspepsia

1.9

9.0

111

605

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

8.9

374

2811

TQW30

NOMESCO Finland

Acupuncture

24.2

8.9

UKC02

NOMESCO Finland

Cystoscopy

1.8

8.9

138

808

J01EA01

ATC

trimethoprim; systemic

1.6

8.9

244

1668

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.1

8.8

409

Z08

ICPC

Social welfare problem

4.7

8.8

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

4.1

8.8

A02BA04

ATC

nizatidine; systemic

2.3

8.8

316

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.3

8.8

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.3

8.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

8.7

120

677

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

8.7

432

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

8.7

301

2168

C10AA07

ATC

rosuvastatin; oral

1.5

8.7

335

2471

G50.1

ICD-10 Finland

Atypical facial pain

4.3

8.7

WZC00, ,

SPAT

1.8

8.7

143

853

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

8.7

222

1492

T74.1

ICD-10 Finland

Physical abuse

4.0

8.6

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.5

8.6

230

I20.09

ICD-10 Finland

Unstable angina

2.5

8.6

218

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

11.7

8.6

N05CD07

ATC

temazepam; oral

1.9

8.6

104

563

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

8.5

178

1134

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

10.1

8.5

K04.08

ICD-10 Finland

Other specified pulpit

2.1

8.5

408

SPAT1216

SPAT

Assessment of functional ability

1.8

8.5

133

781

R25.1

ICD-10 Finland

Tremor, unspecified

3.1

8.5

116

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

8.5

347

2589

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

8.5

283

2021

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

8.5

376

2853

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.9

8.5

138

M24.5

ICD-10 Finland

Contracture of joint

90.8

8.4

A10AE04

ATC

insulin glargine; parenteral

2.0

8.4

480

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

8.4

264

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

8.4

376

D11

ICPC

Diarrhoea

1.9

8.4

111

618

R13

ICD-10 Finland

Dysphagia

2.2

8.4

316

H02BX01

ATC

methylprednisolone, combinations; systemic

2.7

8.4

173

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

8.4

460

WX320

NOMESCO Finland

Spinalanesthesy

1.6

8.4

223

1512

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

8.3

330

SPAT1260

SPAT

Consultation of another employee

1.7

8.3

153

941

NA1BG, ,

SPAT

3.7

8.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

8.3

154

951

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.7

8.3

174

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

8.3

365

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

8.2

129

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

8.2

102

556

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.3

8.2

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

14.6

8.2

ND2AA, ,

SPAT

2.4

8.2

248

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

8.2

408

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

3.6

8.2

A01AB09

ATC

miconazole; local oral

2.1

8.2

415

B01AC04

ATC

clopidogrel; oral

1.8

8.2

139

837

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.3

8.1

R25.2

ICD-10 Finland

Cramp and spasm

3.4

8.1

R29

ICPC

Respiratory symptom/complaint other

2.2

8.1

314

SGA01

NOMESCO Finland

Emergency treatment

1.7

8.1

158

988

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

8.1

114

M24.2

ICD-10 Finland

Disorder of ligament

6.9

8.1

M71.0

ICD-10 Finland

Abscess of bursa

17.3

8.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

8.1

348

2619

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

8.0

107

598

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

8.0

270

M76.0

ICD-10 Finland

Gluteal tendinitis

3.9

8.0

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

8.0

Z3231

NOMESCO Finland

Registered nurse

1.6

8.0

247

1732

M15

ICD-10 Finland

Polyarthrosis

2.4

8.0

220

W10

ICD-10 Finland

Fall on and from stairs and steps

2.3

7.9

258

NB1AE, ,

SPAT

3.1

7.9

110

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.8

7.9

143

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

7.9

370

2827

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

7.9

237

1648

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

7.9

190

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

7.9

265

M02AA15

ATC

diclofenac; topical

2.2

7.9

331

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

7.9

232

1608

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

7.9

456

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

6.2

7.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

7.9

144

885

SFA00

NOMESCO Finland

Small restoration

1.7

7.9

139

846

L99

ICPC

Musculoskeletal disease other

3.5

7.9

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

7.8

312

M65.2

ICD-10 Finland

Calcific tendinitis

10.9

7.8

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

10.9

7.8

N06AX03

ATC

mianserin; oral

2.4

7.8

216

M10.9

ICD-10 Finland

Gout, unspecified

2.2

7.8

293

9502

FHL

Tendon splitting (De Quervain, click finger)

45.3

7.7

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

7.7

112

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.8

7.7

125

742

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.9

7.7

123

L60.0

ICD-10 Finland

Ingrowing nail

2.5

7.7

205

C01CA24

ATC

epinephrine; parenteral

2.2

7.7

315

C05AA08

ATC

fluocortolone; rectal, topical

1.8

7.6

126

752

E883A

ICD-9 Finland

Fall into hole or other opening in surface

2.4

7.6

206

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

7.6

100

556

RF410, ,

NOMESCO Finland

6.8

7.6

M71.5

ICD-10 Finland

Other bursitis, not elsewhere classified

25.2

7.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

7.6

455

N02AJ13

ATC

tramadol and paracetamol; systemic

3.5

7.6

L04AK01

ATC

leflunomide; oral

10.1

7.5

R81

ICPC

Pneumonia

2.7

7.5

153

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

7.5

449

T90

ICPC

Diabetes non-insulin dependent

1.6

7.5

227

1581

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.6

7.5

171

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

4.3

7.5

C10AA04

ATC

fluvastatin; oral

2.1

7.5

352

H29

ICPC

Ear symptom/complaint other

1.8

7.5

118

695

SPAT1058

SPAT

PEF monitoring instruction

2.1

7.5

373

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

7.5

394

S04

ICPC

Lump/swelling localized

1.8

7.4

104

590

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.1

7.4

313

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.8

7.4

116

682

M01AC01

ATC

piroxicam; systemic, rectal

1.8

7.4

116

682

Z00.0

ICD-10 Finland

General medical examination

1.6

7.3

170

1111

M15.8

ICD-10 Finland

Other polyarthrosis

3.7

7.3

C10AC01

ATC

colestyramine; oral

3.1

7.3

N05AH04

ATC

quetiapine; oral

1.6

7.3

162

1047

R11

ICD-10 Finland

Nausea and vomiting

2.0

7.3

418

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

7.3

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.9

7.3

534

R55

ICD-10 Finland

Syncope and collapse

1.9

7.3

534

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.2

7.3

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

3.9

7.3

D02

ICPC

Abdominal pain epigastric

2.2

7.3

288

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

7.3

156

A06AD11

ATC

lactulose; oral

1.7

7.3

124

747

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

4.0

7.2

M23.3

ICD-10 Finland

Other meniscus derangements

4.0

7.2

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

7.2

244

J02.0

ICD-10 Finland

Streptococcal pharyngitis

3.5

7.1

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

7.1

118

704

EBA00

NOMESCO Finland

Extraction of tooth

1.5

7.1

337

2572

L04

ICPC

Chest symptom/complaint

2.1

7.1

311

E66.8

ICD-10 Finland

Other obesity

2.2

7.0

259

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

7.0

191

1297

S22.3

ICD-10 Finland

Fracture of rib

2.0

7.0

361

X57

ICD-10 Finland

Unspecified privation

3.4

7.0

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.4

7.0

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.6

7.0

159

Angiography of the heart and coronary arteries

2.4

7.0

202

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.0

6.9

362

NA3BG, ,

SPAT

2.4

6.9

190

J01DA06

ATC

[U] cefuroxime

1.7

6.9

133

827

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

6.9

222

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

6.9

241

1729

B01AA03

ATC

warfarin; systemic

1.7

6.9

144

916

8404A

ICD-9 Finland

Sprains and strains of shoulder and upper arm, Rotator cuff (capsule)

13.9

6.9

N05BA04

ATC

oxazepam; oral

1.5

6.9

244

1756

1220

FHL

Arthroscopy

2.7

6.9

137

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

6.8

120

A05

ICPC

Feeling ill

2.2

6.8

262

R35

ICD-10 Finland

Polyuria

2.2

6.8

282

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

6.8

309

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

6.8

340

2615

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

4.1

6.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

6.8

501

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

6.8

479

M79.5

ICD-10 Finland

Residual foreign body in soft tissue

3.8

6.8

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.3

6.8

217

SPAT1229

SPAT

Assessment of need for aid

2.1

6.8

296

M25.8

ICD-10 Finland

Other specified joint disorders

11.0

6.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

6.8

111

660

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.7

6.8

132

N06AB04

ATC

citalopram; systemic

1.6

6.8

189

1290

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

6.8

532

ZXA10

NOMESCO Finland

Bilateral

1.6

6.8

159

1042

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

6.8

570

R06.2

ICD-10 Finland

Wheezing

2.5

6.7

168

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

6.7

219

1547

A13

ICPC

Concern/fear medical treatment

3.3

6.7

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

6.7

318

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.3

6.7

R83

ICPC

Respiratory infection other

1.5

6.7

237

1703

N05CF02

ATC

zolpidem; oral

1.6

6.7

166

1102

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

6.7

107

632

A10AA01, ,

ATC

3.0

6.7

SPAT1202

SPAT

Intra-articular injection

3.0

6.7

S70.0

ICD-10 Finland

Contusion of hip

2.6

6.7

139

J01DA09

ATC

[U] cefadroxil

1.5

6.7

243

1758

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

3.8

6.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

6.6

226

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.7

6.6

128

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.1

6.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

6.6

182

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

6.6

101

589

H03AA01

ATC

levothyroxine sodium; systemic

1.5

6.6

222

1580

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

4.2

6.6

NDG76

NOMESCO Finland

Fusion of DIP joint

8.8

6.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

6.5

298

2251

M25.2

ICD-10 Finland

Flail joint

6.9

6.5

WX199

NOMESCO Finland

Other local analgesia

2.6

6.5

135

SPAT1262

SPAT

Handing over of treatment supplies

1.6

6.5

148

962

K29

ICPC

Cardiovascular sympt/complt other

2.5

6.5

165

M19

ICD-10 Finland

Other arthrosis

3.1

6.5

D07AD01

ATC

clobetasol; topical

1.6

6.4

158

1046

J01FA09

ATC

clarithromycin; systemic

1.5

6.4

283

2123

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

6.4

430

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

6.4

117

719

SPAT1211

SPAT

Application of soft bandage

2.0

6.4

381

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

6.4

483

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

6.4

367

L90

ICPC

Osteoarthrosis of knee

2.0

6.4

325

L83

ICPC

Neck syndrome

6.6

6.3

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.1

6.3

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.6

6.3

137

NB1AD

NOMESCO Finland

Shoulder CT examination

3.6

6.3

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

5.6

6.3

U02

ICPC

Urinary frequency/urgency

1.6

6.3

134

856

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

6.3

146

953

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.2

6.3

251

F29

ICPC

Eye symptom/complaint other

1.8

6.3

103

613

S29

ICPC

Skin symptom/complaint other

1.6

6.3

180

1235

R03AC13

ATC

formoterol; inhalant

2.2

6.3

225

C08CA13

ATC

lercanidipine; oral

1.7

6.3

131

833

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

6.3

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

+∞

6.3

SPAT1097

SPAT

Recording of ECG

1.7

6.3

125

786

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.5

6.2

156

L84

ICPC

Back syndrome without radiat pain

2.2

6.2

219

C09CA06

ATC

candesartan; oral

1.5

6.2

233

1691

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

26.8

6.2

NBE25

NOMESCO Finland

Suture or reinsertion of ligament of shoulder, arthroscopic

26.8

6.2

G81.9

ICD-10 Finland

Hemiplegia, unspecified

7.1

6.2

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.3

6.2

200

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.1

6.2

D82

ICPC

Teeth/gum disease

1.4

6.2

343

2679

F01

ICPC

Eye pain

2.8

6.2

104

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.8

6.2

517

N29

ICPC

Neurological sympt/complt other

3.6

6.2

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.6

6.2

N03AE01

ATC

clonazepam; systemic

2.2

6.2

240

H57.1

ICD-10 Finland

Ocular pain

2.5

6.2

151

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.5

6.2

145

K04.09

ICD-10 Finland

Pulpit UNS

2.3

6.2

201

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

7.7

6.1

R03DC01

ATC

zafirlukast; oral

3.8

6.1

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

4.2

6.1

C10AA01

ATC

simvastatin; oral

1.4

6.1

348

2733

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.8

6.1

105

XQ855

NOMESCO Finland

Skin temperature measurement

12.6

6.1

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

6.1

183

OAA81, ,

SPAT

2.5

6.1

152

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

6.1

263

1964

R52.1

ICD-10 Finland

Chronic intractable pain

8.7

6.1

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

6.1

395

H04AA01

ATC

glucagon; nasal, parenteral

3.6

6.1

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

6.0

269

SPAT1310

SPAT

Counselling related to known health issue

1.4

6.0

267

2002

C08CA01

ATC

amlodipine; oral

1.4

6.0

344

2700

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

6.0

276

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

3.5

6.0

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.2

6.0

U07

ICPC

Urine symptom/complaint other

1.9

6.0

418

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.6

6.0

129

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Rotator cuff syndrome
M75.1 [45596678]

2.1e+00

3.5e+00

4.9e+00

—

5.0e+00

4.0e+00

2.1e+00

cases:9.60%

controls:1.33%

cases:16.03%

controls:0.57%

cases:7.29%

controls:0.06%

—

cases:6.53%

controls:0.05%

cases:20.89%

controls:0.47%

cases:16.36%

controls:2.24%

100

138

942

10267

167

875

10346

966

10399

—

973

10369

211

799

10023

149

202

762

8799

Physical Medicine And Rehabilitation
25 [38004468]

1.6e+00

2.5e+00

3.2e+00

—

3.8e+00

2.7e+00

1.8e+00

cases:16.70%

controls:4.04%

cases:13.92%

controls:1.29%

cases:4.80%

controls:0.20%

—

cases:6.92%

controls:0.17%

cases:16.04%

controls:1.25%

cases:20.31%

controls:4.04%

174

420

868

9985

145

134

897

10271

992

10384

—

969

10356

162

126

848

9944

185

364

726

8637

Shoulder symptom/complaint
L08 [2002000632]

1.4e+00

2.5e+00

3.0e+00

1.0e+50

3.7e+00

2.8e+00

1.4e+00

cases:5.95%

controls:1.53%

cases:6.24%

controls:0.56%

cases:2.30%

controls:0.12%

cases:0.58%

controls:0.00%

cases:5.19%

controls:0.13%

cases:8.71%

controls:0.56%

cases:9.77%

controls:2.61%

159

980

10246

977

10347

1018

10393

1036

10405

987

10360

922

10014

235

822

8766

Orthopedic Surgery
20 [38004465]

1.2e+00

2.0e+00

2.5e+00

—

3.2e+00

2.5e+00

1.7e+00

cases:24.66%

controls:8.77%

cases:20.35%

controls:3.20%

cases:6.05%

controls:0.52%

—

cases:8.84%

controls:0.40%

cases:29.01%

controls:3.18%

cases:37.87%

controls:10.09%

257

913

785

9492

212

333

830

10072

979

10351

—

949

10333

293

320

717

9750

345

908

566

8093

Physiotherapist
Z3226 [2001311560]

1.2e+00

1.7e+00

2.6e+00

—

3.3e+00

2.3e+00

1.5e+00

cases:4.51%

controls:1.47%

cases:2.30%

controls:0.42%

cases:0.77%

controls:0.06%

—

cases:2.02%

controls:0.08%

cases:3.86%

controls:0.40%

cases:4.83%

controls:1.11%

153

995

10252

1018

10361

1034

10399

—

1020

10366

971

10030

100

867

8901

tramadol; oral, parenteral, rectal
N02AX02 [21604298]

1.3e+00

2.0e+00

2.4e+00

—

2.7e+00

1.6e+00

cases:15.93%

controls:4.92%

cases:10.56%

controls:1.62%

cases:3.74%

controls:0.34%

—

cases:4.32%

controls:0.31%

cases:7.92%

controls:1.68%

cases:19.21%

controls:4.61%

166

512

876

9893

110

169

932

10236

1003

10370

—

996

10342

169

930

9901

175

415

736

8586

Impingement syndrome of shoulder
M75.4 [45553266]

3.5e+00

4.8e+00

—

1.0e+50

—

3.1e+00

cases:3.84%

controls:0.12%

cases:5.57%

controls:0.05%

—

cases:3.36%

controls:0.00%

cases:1.83%

controls:0.00%

—

cases:4.28%

controls:0.21%

1002

10393

984

10400

—

1007

10405

1022

10374

—

872

8982

Outpatient Visit
OP [9202]

8.2e-01

9.8e-01

1.1e+00

4.8e+00

1.3e+00

1.2e+00

9.4e-01

cases:77.93%

controls:60.80%

cases:64.59%

controls:40.74%

cases:21.69%

controls:8.36%

cases:42.80%

controls:0.59%

cases:25.46%

controls:8.30%

cases:68.71%

controls:40.25%

cases:85.29%

controls:69.34%

812

6326

230

4079

673

4239

369

6166

226

870

816

9535

446

596

10344

265

861

776

9513

694

4053

316

6017

777

6241

134

2760

Pain in limb
M79.6 [45587063]

1.5e+00

1.7e+00

2.8e+00

—

1.5e+00

1.6e+00

1.4e+00

cases:11.13%

controls:2.81%

cases:6.24%

controls:1.21%

cases:1.73%

controls:0.11%

—

cases:1.25%

controls:0.27%

cases:6.14%

controls:1.25%

cases:16.68%

controls:4.79%

116

292

926

10113

126

977

10279

1024

10394

—

1028

10346

126

948

9944

152

431

759

8570

Rheumatology
66 [38004491]

1.1e+00

1.4e+00

1.8e+00

—

2.5e+00

1.9e+00

1.8e+00

cases:6.43%

controls:2.13%

cases:4.89%

controls:1.24%

cases:1.44%

controls:0.23%

—

cases:2.50%

controls:0.21%

cases:7.72%

controls:1.25%

cases:12.18%

controls:2.34%

222

975

10183

129

991

10276

1027

10381

—

1015

10352

126

932

9944

111

211

800

8790

Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]

1.7e+00

3.7e+00

—

2.5e+00

cases:1.34%

controls:0.25%

cases:1.82%

controls:0.05%

—

cases:0.99%

controls:0.08%

cases:2.52%

controls:0.21%

1028

10379

1023

10400

—

1000

10062

888

8982

gabapentin; oral
N02BF01 [955005]

1.3e+00

1.8e+00

1.9e+00

—

2.0e+00

1.7e+00

1.5e+00

cases:4.70%

controls:1.30%

cases:4.22%

controls:0.74%

cases:1.25%

controls:0.19%

—

cases:1.63%

controls:0.22%

cases:4.36%

controls:0.81%

cases:9.11%

controls:2.17%

135

993

10270

998

10328

1029

10385

—

1024

10351

966

9988

195

828

8806

Pain in joint
M25.5 [45586941]

1.2e+00

1.9e+00

2.6e+00

—

1.7e+00

1.6e+00

1.2e+00

cases:7.77%

controls:2.53%

cases:5.76%

controls:0.92%

cases:1.73%

controls:0.13%

—

cases:1.06%

controls:0.19%

cases:4.85%

controls:0.97%

cases:12.29%

controls:3.93%

263

961

10142

982

10309

1024

10391

—

1030

10354

961

9972

112

354

799

8647

Primary arthrosis of other joints
M19.0 [45601353]

1.6e+00

2.7e+00

—

1.0e+50

—

3.5e+00

2.2e+00

cases:2.40%

controls:0.49%

cases:3.65%

controls:0.25%

—

cases:3.93%

controls:0.00%

—

cases:6.14%

controls:0.19%

cases:6.70%

controls:0.77%

1017

10354

1004

10379

—

1001

10405

—

948

10051

850

8932

Shoulder X-ray examination without contrast
NB1AA [2001307225]

1.5e+00

3.4e+00

1.0e+50

—

3.2e+00

1.9e+00

cases:1.34%

controls:0.30%

cases:3.17%

controls:0.11%

cases:1.06%

controls:0.00%

cases:3.26%

controls:0.00%

—

cases:3.07%

controls:0.13%

cases:3.18%

controls:0.49%

1028

10374

1009

10394

1031

10405

1008

10405

—

979

10057

882

8957

amitriptyline; oral, parenteral
N06AA09 [21604696]

1.4e+00

1.7e+00

2.3e+00

—

1.9e+00

1.5e+00

1.3e+00

cases:9.40%

controls:2.49%

cases:5.18%

controls:1.03%

cases:1.63%

controls:0.17%

—

cases:1.54%

controls:0.24%

cases:5.35%

controls:1.27%

cases:10.21%

controls:2.90%

259

944

10146

107

988

10298

1025

10387

—

1025

10349

128

956

9942

261

818

8740

paracetamol; oral, parenteral, rectal
N02BE01 [21604344]

7.2e-01

1.0e+00

1.1e+00

3.5e+00

1.6e+00

1.0e+00

9.2e-01

cases:41.65%

controls:25.77%

cases:29.94%

controls:13.28%

cases:6.14%

controls:2.14%

cases:2.21%

controls:0.07%

cases:9.89%

controls:2.13%

cases:28.91%

controls:13.05%

cases:52.58%

controls:30.74%

434

2681

608

7724

312

1382

730

9023

223

978

10182

1019

10398

103

221

938

10153

292

1314

718

8756

479

2767

432

6234

Cervicobrachial syndrome
M53.1 [45567577]

1.6e+00

2.6e+00

—

1.0e+50

2.0e+00

2.2e+00

1.5e+00

cases:3.17%

controls:0.68%

cases:3.45%

controls:0.26%

—

cases:1.06%

controls:0.00%

cases:0.58%

controls:0.08%

cases:2.18%

controls:0.25%

cases:5.05%

controls:1.21%

1009

10334

1006

10378

—

1031

10405

1035

10366

988

10045

109

865

8892

Hand Surgery
40 [38004480]

1.4e+00

1.9e+00

2.6e+00

1.0e+50

1.5e+00

2.2e+00

1.5e+00

cases:5.57%

controls:1.42%

cases:3.74%

controls:0.59%

cases:1.34%

controls:0.10%

cases:2.02%

controls:0.00%

cases:0.58%

controls:0.13%

cases:3.96%

controls:0.46%

cases:7.14%

controls:1.66%

148

984

10257

1003

10344

1028

10395

1021

10405

1035

10361

970

10024

149

846

8852

codeine and paracetamol
N02AJ06 [1123647]

9.0e-01

1.4e+00

1.9e+00

1.0e+50

2.7e+00

1.5e+00

1.2e+00

cases:22.07%

controls:10.28%

cases:12.96%

controls:3.58%

cases:4.03%

controls:0.63%

cases:2.98%

controls:0.00%

cases:6.53%

controls:0.47%

cases:14.26%

controls:3.50%

cases:28.10%

controls:10.27%

230

1070

812

9335

135

372

907

10033

1000

10339

1011

10405

973

10325

144

352

866

9718

256

924

655

8077

Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]

7.4e-01

1.5e+00

2.6e+00

—

2.1e+00

1.4e+00

1.2e+00

cases:3.26%

controls:1.59%

cases:2.40%

controls:0.56%

cases:1.15%

controls:0.09%

—

cases:0.58%

controls:0.07%

cases:2.87%

controls:0.71%

cases:8.23%

controls:2.58%

165

1008

10240

1017

10347

1030

10396

—

1035

10367

981

9999

232

836

8769

Cervical disc disorder with radiculopathy
M50.1 [45596588]

1.9e+00

3.1e+00

—

1.0e+50

—

2.2e+00

2.4e+00

cases:1.73%

controls:0.25%

cases:1.06%

controls:0.05%

—

cases:0.48%

controls:0.00%

—

cases:0.59%

controls:0.07%

cases:2.41%

controls:0.23%

1024

10379

1031

10400

—

1037

10405

—

1004

10063

889

8980

Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]

7.1e-01

1.6e+00

2.2e+00

—

2.5e+00

1.4e+00

1.2e+00

cases:3.84%

controls:1.92%

cases:2.88%

controls:0.62%

cases:0.86%

controls:0.10%

—

cases:0.67%

controls:0.06%

cases:3.07%

controls:0.76%

cases:8.67%

controls:2.79%

200

1002

10205

1012

10341

1033

10395

—

1034

10368

979

9993

251

832

8750

General Surgery
2 [38004447]

1.0e+00

1.3e+00

2.2e+00

—

2.5e+00

1.5e+00

9.7e-01

cases:31.29%

controls:14.33%

cases:14.01%

controls:4.07%

cases:4.32%

controls:0.48%

—

cases:5.38%

controls:0.48%

cases:14.75%

controls:3.67%

cases:26.34%

controls:11.89%

326

1491

716

8914

146

424

896

9981

997

10355

—

985

10324

149

370

861

9700

240

1070

671

7931

Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]

1.8e+00

1.9e+00

—

3.3e+00

2.5e+00

cases:2.50%

controls:0.43%

cases:1.25%

controls:0.18%

—

cases:2.67%

controls:0.10%

cases:3.51%

controls:0.31%

1016

10360

1029

10386

—

983

10060

879

8973

pregabalin; oral
N02BF02 [955152]

1.2e+00

1.6e+00

1.7e+00

—

1.7e+00

1.5e+00

1.8e+00

cases:6.91%

controls:2.25%

cases:4.61%

controls:0.95%

cases:1.44%

controls:0.27%

—

cases:1.63%

controls:0.30%

cases:3.76%

controls:0.87%

cases:11.64%

controls:2.20%

234

970

10171

994

10306

1027

10377

—

1024

10343

972

9982

106

198

805

8803

etoricoxib; oral
M01AH05 [21603996]

9.4e-01

1.6e+00

1.9e+00

—

2.5e+00

1.5e+00

1.0e+00

cases:22.65%

controls:10.30%

cases:16.70%

controls:3.99%

cases:3.65%

controls:0.54%

—

cases:5.48%

controls:0.47%

cases:15.05%

controls:3.90%

cases:29.20%

controls:13.22%

236

1072

806

9333

174

415

868

9990

1004

10349

—

984

10325

152

393

858

9677

266

1190

645

7811

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
S46.0 [45544769]

1.3e+00

3.8e+00

—

2.7e+00

1.5e+00

cases:1.44%

controls:0.38%

cases:2.21%

controls:0.05%

—

cases:2.18%

controls:0.15%

cases:2.20%

controls:0.50%

1027

10365

1019

10400

—

988

10055

891

8956

oxycodone; oral, parenteral
N02AA05 [21604260]

1.4e+00

1.1e+00

1.6e+00

—

2.5e+00

1.5e+00

1.2e+00

cases:3.07%

controls:0.76%

cases:1.63%

controls:0.53%

cases:0.96%

controls:0.20%

—

cases:1.44%

controls:0.13%

cases:2.18%

controls:0.48%

cases:4.94%

controls:1.58%

1010

10326

1025

10350

1032

10384

—

1026

10361

988

10022

142

866

8859

buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]

1.7e+00

1.9e+00

1.5e+00

—

2.2e+00

1.5e+00

1.9e+00

cases:3.74%

controls:0.72%

cases:2.78%

controls:0.42%

cases:0.86%

controls:0.20%

—

cases:1.25%

controls:0.13%

cases:2.38%

controls:0.52%

cases:6.81%

controls:1.12%

1003

10330

1013

10361

1033

10384

—

1028

10360

986

10018

101

849

8900

Other spondylosis with radiculopathy
M47.2 [45591850]

2.0e+00

2.5e+00

—

2.3e+00

2.2e+00

cases:2.50%

controls:0.36%

cases:1.73%

controls:0.14%

—

cases:1.29%

controls:0.13%

cases:2.96%

controls:0.33%

1016

10368

1024

10390

—

997

10057

884

8971

Carpal tunnel syndrome
G56.0 [45566891]

1.3e+00

1.9e+00

2.5e+00

1.0e+50

—

1.9e+00

1.4e+00

cases:3.84%

controls:1.11%

cases:2.69%

controls:0.40%

cases:0.67%

controls:0.06%

cases:1.44%

controls:0.00%

—

cases:2.38%

controls:0.36%

cases:4.50%

controls:1.12%

115

1002

10290

1014

10363

1035

10399

1027

10405

—

986

10034

101

870

8900

fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]

1.9e+00

2.3e+00

—

3.0e+00

1.6e+00

cases:0.67%

controls:0.10%

cases:0.58%

controls:0.06%

—

cases:0.99%

controls:0.05%

cases:1.10%

controls:0.23%

1035

10395

1036

10399

—

1000

10065

901

8980

Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]

1.8e+00

1.9e+00

—

2.6e+00

2.3e+00

cases:2.40%

controls:0.39%

cases:1.25%

controls:0.18%

—

cases:1.58%

controls:0.12%

cases:3.62%

controls:0.37%

1017

10364

1029

10386

—

994

10058

878

8968

Adhesive capsulitis of shoulder
M75.0 [45533931]

2.8e+00

—

1.0e+50

3.5e+00

2.4e+00

cases:2.69%

controls:0.17%

—

cases:1.25%

controls:0.00%

cases:0.96%

controls:0.00%

cases:0.77%

controls:0.00%

cases:3.07%

controls:0.10%

cases:3.62%

controls:0.36%

1014

10387

—

1029

10405

1032

10405

1033

10374

979

10060

878

8969

Physiotherapy
R4110 [2001310233]

8.5e-01

1.1e+00

1.4e+00

—

3.1e+00

2.0e+00

1.3e+00

cases:6.91%

controls:3.09%

cases:3.65%

controls:1.21%

cases:0.86%

controls:0.22%

—

cases:2.69%

controls:0.13%

cases:6.93%

controls:0.96%

cases:9.88%

controls:2.87%

321

970

10084

126

1004

10279

1033

10382

—

1013

10361

940

9973

258

821

8743

Pharmacy visit
OMOP4822462 [581458]

6.2e-01

1.0e+00

7.5e-01

2.4e+00

1.0e+00

1.1e+00

1.2e+00

cases:93.57%

controls:88.68%

cases:90.88%

controls:78.35%

cases:57.77%

controls:39.35%

cases:16.51%

controls:1.84%

cases:64.55%

controls:38.96%

cases:92.18%

controls:79.05%

cases:97.91%

controls:93.61%

975

9227

1178

947

8152

2253

602

4094

440

6311

172

191

870

10214

672

4042

369

6332

931

7960

2110

892

8426

575

Other seropositive rheumatoid arthritis
M05.8 [45538634]

1.3e+00

1.4e+00

2.3e+00

—

1.6e+00

1.5e+00

cases:2.78%

controls:0.78%

cases:2.11%

controls:0.53%

cases:0.96%

controls:0.10%

—

cases:0.58%

controls:0.12%

cases:2.48%

controls:0.59%

cases:3.84%

controls:0.84%

1013

10324

1020

10350

1032

10395

—

1035

10362

985

10011

876

8925

oxycodone and naloxone; oral
N02AA55 [21604265]

9.0e-01

1.2e+00

—

3.0e+00

1.5e+00

1.3e+00

cases:2.50%

controls:1.03%

cases:1.54%

controls:0.47%

—

cases:1.54%

controls:0.08%

cases:2.28%

controls:0.52%

cases:6.04%

controls:1.74%

107

1016

10298

1026

10356

—

1025

10366

987

10018

157

856

8844

celecoxib
L01XX33 [21603805]

1.3e+00

1.6e+00

1.8e+00

1.0e+50

2.3e+00

1.5e+00

1.2e+00

cases:4.41%

controls:1.25%

cases:2.30%

controls:0.49%

cases:0.48%

controls:0.08%

cases:0.48%

controls:0.00%

cases:0.77%

controls:0.08%

cases:1.88%

controls:0.42%

cases:3.51%

controls:1.09%

130

996

10275

1018

10354

1037

10397

1037

10405

1033

10366

991

10028

879

8903

celecoxib; oral
M01AH01 [21603992]

1.3e+00

1.6e+00

1.8e+00

1.0e+50

2.3e+00

1.5e+00

1.2e+00

cases:4.41%

controls:1.25%

cases:2.30%

controls:0.49%

cases:0.48%

controls:0.08%

cases:0.48%

controls:0.00%

cases:0.77%

controls:0.08%

cases:1.88%

controls:0.42%

cases:3.51%

controls:1.09%

130

996

10275

1018

10354

1037

10397

1037

10405

1033

10366

991

10028

879

8903

Sprain and strain of shoulder joint
S43.4 [45607418]

1.8e+00

2.7e+00

—

2.0e+00

1.3e+00

cases:1.25%

controls:0.20%

cases:0.86%

controls:0.06%

—

cases:0.59%

controls:0.08%

cases:1.32%

controls:0.36%

1029

10384

1033

10399

—

1004

10062

899

8969

General Practice
1 [38004446]

1.0e+00

1.1e+00

1.3e+00

—

2.1e+00

1.3e+00

8.7e-01

cases:19.67%

controls:8.14%

cases:9.40%

controls:3.33%

cases:1.82%

controls:0.49%

—

cases:3.65%

controls:0.47%

cases:11.88%

controls:3.43%

cases:22.39%

controls:10.78%

205

847

837

9558

346

944

10059

1023

10354

—

1003

10325

120

345

890

9725

204

970

707

8031

Acromioplastia, arthroscopic
NBG15 [2001307302]

3.4e+00

1.0e+50

—

1.0e+50

—

1.0e+50

4.1e+00

cases:1.44%

controls:0.05%

cases:2.11%

controls:0.00%

—

cases:4.41%

controls:0.00%

—

cases:4.26%

controls:0.00%

cases:3.40%

controls:0.06%

1027

10400

1020

10405

—

996

10405

—

967

10070

880

8996

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

4.0e-01

4.9e-01

8.1e-01

3.6e+00

1.1e+00

6.5e-01

5.0e-01

cases:28.60%

controls:21.11%

cases:20.25%

controls:13.41%

cases:6.05%

controls:2.78%

cases:5.76%

controls:0.17%

cases:6.92%

controls:2.43%

cases:23.86%

controls:14.00%

cases:43.14%

controls:31.57%

298

2196

744

8209

211

1395

831

9010

289

979

10116

982

10387

252

969

10122

241

1410

769

8660

393

2842

518

6159

diclofenac; oral, parenteral, rectal
M01AB05 [21603945]

8.2e-01

1.3e+00

1.8e+00

—

1.9e+00

8.0e-01

8.4e-01

cases:24.47%

controls:12.51%

cases:13.24%

controls:3.94%

cases:3.07%

controls:0.53%

—

cases:3.46%

controls:0.51%

cases:9.01%

controls:4.24%

cases:24.15%

controls:12.13%

255

1302

787

9103

138

410

904

9995

1010

10350

—

1005

10321

427

919

9643

220

1092

691

7909

Suture or reinsertation of rotator cuff of shoulder
NBL00 [2001307341]

1.8e+00

—

2.7e+00

2.9e+00

cases:0.67%

controls:0.12%

—

cases:0.89%

controls:0.06%

cases:1.43%

controls:0.08%

1035

10393

—

1001

10064

898

8994

Shoulder lesion, unspecified
M75.9 [45557986]

2.2e+00

3.4e+00

—

2.3e+00

1.9e+00

cases:1.34%

controls:0.15%

cases:1.63%

controls:0.06%

—

cases:0.50%

controls:0.05%

cases:1.54%

controls:0.24%

1028

10389

1025

10399

—

1005

10065

897

8979

Scheduled procedure
ZXD10 [2001311387]

8.6e-01

1.3e+00

1.1e+00

—

2.6e+00

1.6e+00

1.0e+00

cases:9.98%

controls:4.50%

cases:4.13%

controls:1.19%

cases:0.48%

controls:0.15%

—

cases:0.86%

controls:0.07%

cases:4.85%

controls:1.01%

cases:8.45%

controls:3.19%

104

468

938

9937

124

999

10281

1037

10389

—

1032

10367

102

961

9968

287

834

8714

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]

1.7e+00

2.1e+00

—

1.8e+00

1.7e+00

cases:2.21%

controls:0.41%

cases:0.86%

controls:0.11%

—

cases:1.09%

controls:0.18%

cases:2.85%

controls:0.53%

1019

10362

1033

10394

—

999

10052

885

8953

meloxicam; oral, parenteral, rectal
M01AC06 [21603965]

1.1e+00

1.5e+00

2.2e+00

—

1.3e+00

1.1e+00

cases:11.32%

controls:4.05%

cases:5.18%

controls:1.15%

cases:0.96%

controls:0.11%

—

cases:0.58%

controls:0.16%

cases:4.95%

controls:1.37%

cases:10.87%

controls:3.91%

118

421

924

9984

120

988

10285

1032

10394

—

1035

10357

138

960

9932

352

812

8649

Right side
ZXA00 [2001311346]

6.6e-01

1.4e+00

—

1.0e+50

2.5e+00

1.6e+00

1.1e+00

cases:4.80%

controls:2.54%

cases:2.59%

controls:0.64%

—

cases:1.34%

controls:0.00%

cases:0.58%

controls:0.05%

cases:2.87%

controls:0.61%

cases:5.93%

controls:1.99%

264

992

10141

1015

10338

—

1028

10405

1035

10369

981

10009

179

857

8822

Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]

1.6e+00

1.5e+00

—

2.2e+00

2.0e+00

cases:2.69%

controls:0.57%

cases:0.86%

controls:0.19%

—

cases:1.19%

controls:0.14%

cases:4.06%

controls:0.57%

1014

10346

1033

10385

—

998

10056

874

8950

tizanidine; oral
M03BX02 [21604116]

9.6e-01

1.2e+00

1.7e+00

—

1.5e+00

8.9e-01

9.3e-01

cases:25.14%

controls:11.37%

cases:11.04%

controls:3.69%

cases:2.30%

controls:0.42%

—

cases:2.02%

controls:0.44%

cases:8.42%

controls:3.64%

cases:24.37%

controls:11.32%

262

1183

780

9222

115

384

927

10021

1018

10361

—

1020

10328

367

925

9703

222

1019

689

7982

ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]

7.5e-01

1.2e+00

1.7e+00

—

1.9e+00

1.0e+00

5.5e-01

cases:8.64%

controls:4.27%

cases:4.13%

controls:1.25%

cases:0.86%

controls:0.16%

—

cases:0.86%

controls:0.13%

cases:3.56%

controls:1.28%

cases:6.59%

controls:3.90%

444

952

9961

130

999

10275

1033

10388

—

1032

10361

129

974

9941

351

851

8650

Shoulder lesions
M75 [45557983]

1.8e+00

3.0e+00

—

2.3e+00

1.0e+00

cases:1.25%

controls:0.21%

cases:1.15%

controls:0.06%

—

cases:0.69%

controls:0.07%

cases:0.88%

controls:0.31%

1029

10383

1030

10399

—

1003

10063

903

8973

Emergency Room Visit
ER [9203]

8.6e-01

9.1e-01

1.5e+00

—

1.9e+00

1.1e+00

8.3e-01

cases:43.86%

controls:24.91%

cases:18.43%

controls:8.30%

cases:4.61%

controls:1.06%

—

cases:5.28%

controls:0.86%

cases:19.60%

controls:7.62%

cases:41.05%

controls:23.34%

457

2592

585

7813

192

864

850

9541

110

994

10295

—

986

10285

198

767

812

9303

374

2101

537

6900

Lateral epicondylitis
M77.1 [45572551]

1.7e+00

1.9e+00

—

1.0e+50

—

2.2e+00

1.2e+00

cases:1.54%

controls:0.29%

cases:0.96%

controls:0.14%

—

cases:0.58%

controls:0.00%

—

cases:1.09%

controls:0.12%

cases:2.20%

controls:0.67%

1026

10375

1032

10390

—

1036

10405

—

999

10058

891

8941

One hour or less
ZXE00 [2001311394]

6.9e-01

1.2e+00

—

2.6e+00

1.6e+00

9.8e-01

cases:8.93%

controls:4.70%

cases:3.93%

controls:1.19%

—

cases:0.86%

controls:0.07%

cases:4.65%

controls:1.01%

cases:7.79%

controls:3.09%

489

949

9916

124

1001

10281

—

1032

10367

102

963

9968

278

840

8723

Other specified intervertebral disc degeneration
M51.3 [45591865]

1.6e+00

1.7e+00

—

1.0e+50

—

2.0e+00

1.6e+00

cases:2.11%

controls:0.42%

cases:1.25%

controls:0.22%

—

cases:0.86%

controls:0.00%

—

cases:1.19%

controls:0.17%

cases:3.40%

controls:0.69%

1020

10361

1029

10382

—

1033

10405

—

998

10053

880

8939

Foot and toes X-ray examination
NH3AA [2001308267]

1.1e+00

1.9e+00

—

2.0e+00

1.9e+00

cases:1.34%

controls:0.46%

cases:0.86%

controls:0.13%

—

cases:0.79%

controls:0.11%

cases:2.74%

controls:0.42%

1028

10357

1033

10391

—

1002

10059

886

8963

Cervicalgia
M54.2 [45591867]

1.5e+00

2.2e+00

—

1.7e+00

1.3e+00

cases:1.92%

controls:0.43%

cases:1.44%

controls:0.16%

—

cases:0.89%

controls:0.17%

cases:2.09%

controls:0.57%

1022

10360

1027

10388

—

1001

10053

892

8950

nortriptyline; oral, parenteral
N06AA10 [21604697]

1.6e+00

1.8e+00

—

1.6e+00

1.7e+00

cases:2.30%

controls:0.48%

cases:1.44%

controls:0.25%

—

cases:1.29%

controls:0.27%

cases:3.62%

controls:0.66%

1018

10355

1027

10379

—

997

10043

878

8942

CBC panel - Blood by Automated count
58410-2 [40761511]

2.7e-01

3.7e-01

7.1e-01

3.5e+00

9.7e-01

5.1e-01

3.3e-01

cases:29.75%

controls:24.49%

cases:21.11%

controls:15.59%

cases:5.57%

controls:2.81%

cases:3.93%

controls:0.12%

cases:6.44%

controls:2.54%

cases:24.65%

controls:16.41%

cases:43.58%

controls:35.81%

310

2548

732

7857

220

1622

822

8783

292

984

10113

1001

10392

264

974

10110

249

1652

761

8418

397

3223

514

5778

Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]

1.0e+00

1.1e+00

—

2.1e+00

1.5e+00

8.7e-01

cases:7.29%

controls:2.76%

cases:3.45%

controls:1.15%

cases:0.77%

controls:0.27%

—

cases:1.73%

controls:0.21%

cases:4.75%

controls:1.13%

cases:7.57%

controls:3.33%

287

966

10118

120

1006

10285

1034

10377

—

1023

10352

114

962

9956

300

842

8701

Internal Medicine
11 [38004456]

9.4e-01

8.5e-01

1.4e+00

—

1.5e+00

9.6e-01

9.3e-01

cases:31.96%

controls:15.44%

cases:14.01%

controls:6.49%

cases:3.55%

controls:0.94%

—

cases:4.32%

controls:0.98%

cases:14.36%

controls:6.03%

cases:31.61%

controls:15.36%

333

1607

709

8798

146

675

896

9730

1005

10307

—

102

996

10272

145

607

865

9463

288

1383

623

7618

buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]

2.9e+00

—

3.5e+00

cases:0.86%

controls:0.05%

—

cases:1.87%

controls:0.06%

1033

10400

—

894

8996

Pain in thoracic spine
M54.6 [45606247]

1.5e+00

2.0e+00

—

1.7e+00

1.2e+00

cases:1.92%

controls:0.44%

cases:1.06%

controls:0.14%

—

cases:0.99%

controls:0.18%

cases:1.98%

controls:0.61%

1022

10359

1031

10390

—

1000

10052

893

8946

Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]

1.3e+00

1.6e+00

-1.0e+50

1.0e+50

—

1.5e+00

2.0e+00

cases:3.93%

controls:1.12%

cases:2.02%

controls:0.39%

cases:0.00%

controls:0.11%

cases:0.48%

controls:0.00%

—

cases:1.68%

controls:0.40%

cases:7.14%

controls:1.06%

117

1001

10288

1021

10364

1042

10394

1037

10405

—

993

10030

846

8906

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

2.8e-01

3.7e-01

5.3e-01

3.5e+00

8.6e-01

4.7e-01

3.7e-01

cases:29.37%

controls:23.83%

cases:23.90%

controls:17.75%

cases:5.47%

controls:3.30%

cases:4.70%

controls:0.15%

cases:7.30%

controls:3.21%

cases:26.73%

controls:18.54%

cases:46.43%

controls:37.54%

306

2479

736

7926

249

1847

793

8558

343

985

10062

993

10389

333

965

10041

270

1867

740

8203

423

3379

488

5622

ibuprofen
R02AX02 [1588667]

6.9e-01

8.4e-01

1.1e+00

—

1.9e+00

1.0e+00

7.8e-01

cases:47.22%

controls:30.92%

cases:26.39%

controls:13.39%

cases:5.66%

controls:1.90%

—

cases:9.70%

controls:1.60%

cases:28.02%

controls:12.26%

cases:50.16%

controls:31.64%

492

3217

550

7188

275

1393

767

9012

198

983

10207

—

101

166

940

10208

283

1235

727

8835

457

2848

454

6153

ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]

6.9e-01

8.4e-01

1.1e+00

—

1.9e+00

1.0e+00

7.8e-01

cases:47.22%

controls:30.92%

cases:26.39%

controls:13.39%

cases:5.66%

controls:1.90%

—

cases:9.70%

controls:1.60%

cases:28.02%

controls:12.26%

cases:50.16%

controls:31.64%

492

3217

550

7188

275

1393

767

9012

198

983

10207

—

101

166

940

10208

283

1235

727

8835

457

2848

454

6153

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

2.9e-01

3.6e-01

5.6e-01

3.5e+00

8.4e-01

4.5e-01

3.6e-01

cases:29.27%

controls:23.66%

cases:23.42%

controls:17.56%

cases:5.47%

controls:3.21%

cases:4.70%

controls:0.15%

cases:7.01%

controls:3.14%

cases:25.94%

controls:18.31%

cases:45.99%

controls:37.21%

305

2462

737

7943

244

1827

798

8578

334

985

10071

993

10389

326

968

10048

262

1844

748

8226

419

3349

492

5652

Pain general/multiple sites
A01 [2002000142]

1.6e+00

1.5e+00

—

-1.0e+50

1.7e+00

1.5e+00

cases:2.11%

controls:0.45%

cases:0.86%

controls:0.19%

—

cases:0.00%

controls:0.06%

cases:1.09%

controls:0.20%

cases:3.51%

controls:0.79%

1020

10358

1033

10385

—

1041

10368

999

10050

879

8930

Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]

5.6e-01

6.5e-01

1.7e+00

—

1.9e+00

1.1e+00

9.0e-01

cases:5.57%

controls:3.26%

cases:2.98%

controls:1.58%

cases:1.25%

controls:0.23%

—

cases:1.15%

controls:0.17%

cases:4.36%

controls:1.49%

cases:10.65%

controls:4.61%

339

984

10066

164

1011

10241

1029

10381

—

1029

10356

150

966

9920

415

814

8586

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

3.6e-01

3.8e-01

7.8e-01

2.8e+00

8.4e-01

5.4e-01

3.7e-01

cases:24.09%

controls:18.09%

cases:19.87%

controls:14.51%

cases:7.01%

controls:3.35%

cases:3.55%

controls:0.22%

cases:6.82%

controls:3.07%

cases:23.27%

controls:14.98%

cases:36.88%

controls:28.69%

251

1882

791

8523

207

1510

835

8895

349

969

10056

1005

10382

318

970

10056

235

1508

775

8562

336

2582

575

6419

Bursitis of shoulder
M75.5 [45606321]

2.3e+00

—

1.0e+50

—

3.7e+00

cases:0.77%

controls:0.08%

—

cases:1.82%

controls:0.00%

cases:94.15%

controls:0.00%

cases:15.75%

controls:0.00%

—

cases:5.16%

controls:0.13%

1034

10397

—

1023

10405

981

10405

164

877

10374

—

864

8989

orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]

1.1e+00

1.3e+00

—

1.6e+00

1.1e+00

cases:15.16%

controls:5.54%

cases:4.99%

controls:1.67%

cases:0.67%

controls:0.19%

—

cases:1.06%

controls:0.22%

cases:5.25%

controls:1.74%

cases:13.61%

controls:5.20%

158

576

884

9829

174

990

10231

1035

10385

—

1030

10351

175

957

9895

124

468

787

8533

orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]

1.1e+00

1.3e+00

—

1.6e+00

1.1e+00

cases:15.16%

controls:5.54%

cases:4.99%

controls:1.67%

cases:0.67%

controls:0.19%

—

cases:1.06%

controls:0.22%

cases:5.25%

controls:1.74%

cases:13.61%

controls:5.20%

158

576

884

9829

174

990

10231

1035

10385

—

1030

10351

175

957

9895

124

468

787

8533

Infiltration anesthesia
WX110 [2001310767]

3.5e-01

5.4e-01

1.1e+00

2.7e+00

-2.5e-01

6.8e-01

6.3e-01

cases:20.35%

controls:15.22%

cases:9.79%

controls:5.92%

cases:2.30%

controls:0.79%

cases:0.86%

controls:0.06%

cases:0.67%

controls:0.86%

cases:11.09%

controls:5.95%

cases:29.42%

controls:18.18%

212

1584

830

8821

102

616

940

9789

1018

10323

1033

10399

1034

10285

112

599

898

9471

268

1636

643

7365

Trochanteric bursitis
M70.6 [45606304]

1.7e+00

1.4e+00

—

1.0e+50

—

1.6e+00

1.4e+00

cases:3.45%

controls:0.67%

cases:1.15%

controls:0.30%

—

cases:0.48%

controls:0.00%

—

cases:1.49%

controls:0.31%

cases:3.62%

controls:0.92%

1006

10335

1030

10374

—

1037

10405

—

995

10039

878

8918

Myalgia
M79.1 [45587062]

1.5e+00

1.7e+00

—

1.8e+00

1.0e+00

cases:3.74%

controls:0.90%

cases:1.25%

controls:0.24%

—

cases:1.19%

controls:0.19%

cases:3.29%

controls:1.20%

1003

10311

1029

10380

—

998

10051

108

881

8893

Knee X-ray examination without contrast
NG1AA [2001308049]

1.1e+00

1.6e+00

—

1.9e+00

1.4e+00

cases:2.11%

controls:0.69%

cases:1.06%

controls:0.22%

—

cases:1.09%

controls:0.17%

cases:3.51%

controls:0.89%

1020

10333

1031

10382

—

999

10053

879

8921

Occupational therapy
R4120 [2001310234]

8.5e-01

2.2e+00

—

1.7e+00

1.9e+00

cases:0.96%

controls:0.41%

cases:1.25%

controls:0.13%

—

cases:0.79%

controls:0.15%

cases:2.85%

controls:0.43%

1032

10362

1029

10391

—

1002

10055

885

8962

Other psoriatic arthropathies
M07.3*L40.5 [2000503010]

1.7e+00

1.5e+00

—

2.1e+00

cases:1.06%

controls:0.20%

cases:0.58%

controls:0.13%

—

cases:0.79%

controls:0.10%

cases:1.54%

controls:0.20%

1031

10384

1036

10391

—

1002

10060

897

8983

diclofenac
D11AX18 [21602355]

5.4e-01

1.2e+00

—

2.3e+00

1.3e+00

9.1e-01

cases:2.69%

controls:1.59%

cases:2.02%

controls:0.59%

—

cases:0.77%

controls:0.08%

cases:2.18%

controls:0.60%

cases:5.27%

controls:2.20%

165

1014

10240

1021

10344

—

1033

10366

988

10010

198

863

8803

diclofenac; ointment
M02AA15 [21604051]

5.4e-01

1.2e+00

—

2.3e+00

1.3e+00

9.1e-01

cases:2.69%

controls:1.59%

cases:2.02%

controls:0.59%

—

cases:0.77%

controls:0.08%

cases:2.18%

controls:0.60%

cases:5.27%

controls:2.20%

165

1014

10240

1021

10344

—

1033

10366

988

10010

198

863

8803

Emergency Medicine
93 [38004510]

5.4e-01

7.8e-01

1.4e+00

—

1.4e+00

8.5e-01

6.8e-01

cases:14.49%

controls:9.00%

cases:9.50%

controls:4.60%

cases:2.69%

controls:0.65%

—

cases:2.79%

controls:0.68%

cases:10.59%

controls:4.82%

cases:25.80%

controls:14.99%

151

936

891

9469

479

943

9926

1014

10337

—

1012

10303

107

485

903

9585

235

1349

676

7652

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

3.1e-01

3.8e-01

6.8e-01

3.0e+00

7.8e-01

4.9e-01

2.2e-01

cases:27.45%

controls:21.80%

cases:22.36%

controls:16.39%

cases:6.72%

controls:3.53%

cases:3.84%

controls:0.19%

cases:6.82%

controls:3.26%

cases:25.64%

controls:17.39%

cases:40.29%

controls:35.20%

286

2268

756

8137

233

1705

809

8700

367

972

10038

1002

10385

338

970

10036

259

1751

751

8319

367

3168

544

5833

Hand/finger symptom/complaint
L12 [2002000636]

1.2e+00

1.5e+00

1.9e+00

—

1.7e+00

1.2e+00

cases:3.26%

controls:0.98%

cases:1.54%

controls:0.34%

cases:0.58%

controls:0.09%

—

cases:1.78%

controls:0.32%

cases:5.27%

controls:1.70%

102

1008

10303

1026

10370

1036

10396

—

992

10038

153

863

8848

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

2.6e-01

3.5e-01

5.5e-01

3.0e+00

7.5e-01

4.4e-01

3.0e-01

cases:31.48%

controls:26.19%

cases:26.97%

controls:20.61%

cases:7.29%

controls:4.32%

cases:4.80%

controls:0.25%

cases:8.36%

controls:4.13%

cases:30.50%

controls:22.08%

cases:49.18%

controls:41.86%

328

2725

714

7680

281

2144

761

8261

450

966

9955

992

10379

428

954

9946

308

2223

702

7847

448

3768

463

5233

Arthrosis, unspecified
M19.9 [45543488]

1.7e+00

—

2.0e+00

1.9e+00

cases:1.06%

controls:0.19%

—

cases:0.59%

controls:0.08%

cases:1.76%

controls:0.27%

1031

10385

—

1004

10062

895

8977

Exposure to other specified factors
X58 [45756411]

1.3e+00

1.5e+00

—

1.0e+50

—

1.8e+00

1.0e+00

cases:3.07%

controls:0.87%

cases:1.25%

controls:0.28%

—

cases:0.67%

controls:0.00%

—

cases:1.88%

controls:0.31%

cases:3.29%

controls:1.22%

1010

10314

1029

10376

—

1035

10405

—

991

10039

110

881

8891

Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]

1.2e+00

1.1e+00

—

1.0e+50

—

2.5e+00

2.0e+00

cases:1.54%

controls:0.49%

cases:0.86%

controls:0.29%

—

cases:0.67%

controls:0.00%

—

cases:2.08%

controls:0.18%

cases:3.29%

controls:0.48%

1026

10354

1033

10375

—

1035

10405

—

989

10052

881

8958

Case Management Agency
251B00000X [38004193]

2.1e-01

3.0e-01

7.0e-01

3.5e+00

7.4e-01

3.8e-01

2.4e-01

cases:59.60%

controls:54.53%

cases:54.89%

controls:47.49%

cases:30.33%

controls:17.71%

cases:27.06%

controls:1.16%

cases:31.51%

controls:17.98%

cases:58.51%

controls:49.10%

cases:73.55%

controls:68.61%

621

5674

421

4731

572

4941

470

5464

316

1843

726

8562

282

121

760

10284

328

1865

713

8509

591

4944

419

5126

670

6176

241

2825

Care involving use of other rehabilitation procedures
Z50.8 [45556842]

1.6e+00

1.7e+00

—

2.2e+00

8.9e-01

cases:2.02%

controls:0.40%

cases:1.25%

controls:0.22%

—

cases:0.79%

controls:0.09%

cases:1.43%

controls:0.59%

1021

10363

1029

10382

—

1002

10061

898

8948

Musculoskeletal sympt/complt other
L29 [2002000648]

1.2e+00

1.6e+00

—

1.8e+00

1.0e+00

cases:1.63%

controls:0.51%

cases:1.25%

controls:0.26%

—

cases:1.29%

controls:0.22%

cases:2.20%

controls:0.81%

1025

10352

1029

10378

—

997

10048

891

8928

Outpatient Hospital
22 [8756]

7.6e-01

9.9e-01

1.9e-01

—

1.7e+00

1.2e+00

9.2e-01

cases:33.78%

controls:19.30%

cases:12.57%

controls:5.07%

cases:0.96%

controls:0.80%

—

cases:2.69%

controls:0.52%

cases:13.56%

controls:4.48%

cases:29.75%

controls:14.40%

352

2008

690

8397

131

528

911

9877

1032

10322

—

1013

10320

137

451

873

9619

271

1296

640

7705

leflunomide; oral
L04AK01 [955035]

1.4e+00

2.0e+00

—

1.6e+00

1.8e+00

cases:0.77%

controls:0.19%

cases:0.86%

controls:0.12%

—

cases:0.79%

controls:0.16%

cases:1.10%

controls:0.18%

1034

10385

1033

10393

—

1002

10054

901

8985

Bacteria identified in Isolate by Culture
43409-2 [3042936]

4.1e-01

6.3e-01

1.6e+00

—

2.8e+00

1.5e+00

1.1e+00

cases:2.30%

controls:1.54%

cases:1.15%

controls:0.62%

cases:0.58%

controls:0.12%

—

cases:1.15%

controls:0.07%

cases:2.38%

controls:0.52%

cases:5.38%

controls:1.94%

160

1018

10245

1030

10341

1036

10393

—

1029

10367

986

10018

175

862

8826

Sleep apnoea
G47.3 [45562094]

7.7e-01

1.1e+00

1.4e+00

—

1.2e+00

9.6e-01

cases:5.95%

controls:2.84%

cases:4.80%

controls:1.63%

cases:1.34%

controls:0.33%

—

cases:0.96%

controls:0.28%

cases:5.45%

controls:1.78%

cases:10.21%

controls:4.17%

296

980

10109

170

992

10235

1028

10371

—

1031

10345

179

955

9891

375

818

8626

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

2.0e-01

3.2e-01

5.3e-01

2.8e+00

8.0e-01

5.1e-01

4.1e-01

cases:20.92%

controls:17.85%

cases:18.81%

controls:14.40%

cases:5.18%

controls:3.10%

cases:3.17%

controls:0.19%

cases:6.15%

controls:2.86%

cases:22.57%

controls:14.93%

cases:38.64%

controls:29.53%

218

1857

824

8548

196

1498

846

8907

323

988

10082

1009

10385

297

977

10077

228

1503

782

8567

352

2658

559

6343

Spinal stenosis
M48.0 [45557888]

1.2e+00

1.4e+00

—

1.0e+50

—

1.3e+00

1.5e+00

cases:2.98%

controls:0.95%

cases:1.73%

controls:0.41%

—

cases:0.48%

controls:0.00%

—

cases:1.58%

controls:0.44%

cases:4.50%

controls:1.08%

1011

10306

1024

10362

—

1037

10405

—

994

10026

870

8904

Fall on same level from slipping, tripping and stumbling
W01 [45756243]

7.3e-01

1.2e+00

1.6e+00

—

1.8e+00

9.9e-01

6.1e-01

cases:5.28%

controls:2.60%

cases:2.98%

controls:0.91%

cases:0.48%

controls:0.10%

—

cases:0.77%

controls:0.13%

cases:2.87%

controls:1.08%

cases:6.59%

controls:3.69%

271

987

10134

1011

10310

1037

10395

—

1033

10361

109

981

9961

332

851

8669

Thorax X-ray examination
GD1AA [2001303617]

7.4e-01

7.6e-01

8.7e-01

1.0e+50

1.9e+00

1.0e+00

9.5e-01

cases:10.84%

controls:5.48%

cases:4.41%

controls:2.10%

cases:0.48%

controls:0.20%

cases:0.67%

controls:0.00%

cases:1.25%

controls:0.19%

cases:4.95%

controls:1.88%

cases:13.72%

controls:5.80%

113

570

929

9835

219

996

10186

1037

10384

1035

10405

1028

10354

189

960

9881

125

522

786

8479

diclofenac, combinations; oral
M01AB55 [21603959]

1.5e+00

2.5e+00

—

1.3e+00

cases:1.15%

controls:0.26%

cases:0.96%

controls:0.08%

—

cases:1.21%

controls:0.33%

1030

10378

1032

10397

—

900

8971

prednisolone
A07EA01 [21600653]

8.7e-01

9.0e-01

6.4e-01

—

1.2e+00

1.1e+00

cases:17.75%

controls:8.29%

cases:7.97%

controls:3.40%

cases:0.96%

controls:0.51%

—

cases:1.73%

controls:0.54%

cases:10.30%

controls:3.25%

cases:22.06%

controls:8.45%

185

863

857

9542

354

959

10051

1032

10352

—

1023

10318

104

327

906

9743

201

761

710

8240

prednisolone; oral, parenteral
H02AB06 [21602734]

8.7e-01

9.1e-01

6.4e-01

—

1.2e+00

1.1e+00

cases:17.66%

controls:8.23%

cases:7.97%

controls:3.37%

cases:0.96%

controls:0.51%

—

cases:1.73%

controls:0.54%

cases:10.20%

controls:3.24%

cases:21.73%

controls:8.40%

184

856

858

9549

351

959

10054

1032

10352

—

1023

10318

103

326

907

9744

198

756

713

8245

Bacteria identified in Blood by Culture
600-7 [3023368]

4.0e-01

3.2e-01

1.5e+00

—

2.0e+00

9.2e-01

7.9e-01

cases:4.03%

controls:2.73%

cases:1.92%

controls:1.40%

cases:0.86%

controls:0.19%

—

cases:1.15%

controls:0.15%

cases:2.48%

controls:1.00%

cases:8.45%

controls:4.01%

284

1000

10121

146

1022

10259

1033

10385

—

1029

10358

101

985

9969

361

834

8640

Left side
ZXA05 [2001311347]

9.6e-01

1.1e+00

—

1.0e+50

—

1.9e+00

1.2e+00

cases:5.76%

controls:2.29%

cases:1.73%

controls:0.58%

—

cases:1.06%

controls:0.00%

—

cases:3.07%

controls:0.46%

cases:5.60%

controls:1.74%

238

982

10167

1024

10345

—

1031

10405

—

979

10024

157

860

8844

Lumbago with sciatica
M54.4 [45553205]

1.3e+00

—

1.2e+00

1.4e+00

cases:4.89%

controls:1.39%

cases:1.34%

controls:0.37%

—

cases:1.58%

controls:0.51%

cases:7.24%

controls:1.84%

145

991

10260

1028

10367

—

994

10019

166

845

8835

pantoprazole; oral, parenteral
A02BC02 [21600097]

7.1e-01

8.1e-01

7.3e-01

1.8e+00

9.6e-01

9.9e-01

9.7e-01

cases:22.74%

controls:12.70%

cases:14.78%

controls:7.13%

cases:2.98%

controls:1.46%

cases:0.58%

controls:0.10%

cases:4.13%

controls:1.62%

cases:17.03%

controls:7.07%

cases:33.15%

controls:15.89%

237

1321

805

9084

154

742

888

9663

152

1011

10253

1036

10395

168

998

10206

172

712

838

9358

302

1430

609

7571

Laceration/cut
S18 [2002000983]

5.0e-01

7.2e-01

—

1.8e+00

1.2e+00

9.7e-01

cases:7.68%

controls:4.79%

cases:3.84%

controls:1.90%

—

cases:1.54%

controls:0.26%

cases:5.64%

controls:1.83%

cases:15.26%

controls:6.37%

498

962

9907

198

1002

10207

—

1025

10347

184

953

9886

139

573

772

8428

Persistent somatoform pain disorder
F45.4 [45605498]

2.5e+00

—

1.0e+50

2.7e+00

cases:0.58%

controls:0.05%

—

cases:0.59%

controls:0.00%

cases:1.10%

controls:0.08%

1036

10400

—

1004

10070

901

8994

General anesthesia, balanced
WX408 [2001310808]

5.8e-01

6.0e-01

-1.0e+50

—

2.3e+00

1.2e+00

1.0e+00

cases:4.99%

controls:2.84%

cases:1.73%

controls:0.95%

cases:0.00%

controls:0.09%

—

cases:0.77%

controls:0.08%

cases:1.58%

controls:0.50%

cases:4.72%

controls:1.71%

296

990

10109

1024

10306

1042

10396

—

1033

10366

994

10020

154

868

8847

MCH [Entitic mass]
28539-5 [3035941]

1.9e-01

3.1e-01

6.3e-01

3.0e+00

7.3e-01

4.2e-01

1.7e-01

cases:33.30%

controls:29.31%

cases:29.46%

controls:23.44%

cases:9.21%

controls:5.12%

cases:5.37%

controls:0.28%

cases:9.32%

controls:4.73%

cases:33.56%

controls:24.88%

cases:50.60%

controls:46.26%

347

3050

695

7355

307

2439

735

7966

533

946

9872

986

10376

491

944

9883

339

2505

671

7565

461

4164

450

4837

Synovial cyst of popliteal space [Baker]
M71.2 [45596669]

2.5e+00

—

2.6e+00

cases:1.06%

controls:0.09%

—

cases:0.88%

controls:0.07%

1031

10396

—

903

8995

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

1.9e-01

3.0e-01

6.3e-01

3.0e+00

7.3e-01

4.2e-01

1.7e-01

cases:33.40%

controls:29.35%

cases:29.37%

controls:23.51%

cases:9.21%

controls:5.14%

cases:5.37%

controls:0.28%

cases:9.32%

controls:4.71%

cases:33.56%

controls:24.96%

cases:50.60%

controls:46.32%

348

3054

694

7351

306

2446

736

7959

535

946

9870

986

10376

489

944

9885

339

2513

671

7557

461

4169

450

4832

Platelets [#/volume] in Blood
26515-7 [3007461]

1.9e-01

3.1e-01

6.3e-01

3.0e+00

7.2e-01

4.2e-01

1.8e-01

cases:33.40%

controls:29.27%

cases:29.37%

controls:23.41%

cases:9.21%

controls:5.14%

cases:5.37%

controls:0.28%

cases:9.32%

controls:4.76%

cases:33.56%

controls:24.91%

cases:50.60%

controls:46.16%

348

3046

694

7359

306

2436

736

7969

535

946

9870

986

10376

494

944

9880

339

2508

671

7562

461

4155

450

4846

Leukocytes [#/volume] in Blood
26464-8 [3010813]

2.0e-01

3.0e-01

6.2e-01

3.0e+00

7.3e-01

4.2e-01

1.7e-01

cases:33.59%

controls:29.36%

cases:29.46%

controls:23.58%

cases:9.21%

controls:5.16%

cases:5.37%

controls:0.28%

cases:9.41%

controls:4.79%

cases:33.66%

controls:24.98%

cases:50.60%

controls:46.35%

350

3055

692

7350

307

2453

735

7952

537

946

9868

986

10376

497

943

9877

340

2515

670

7555

461

4172

450

4829

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

1.9e-01

3.1e-01

6.3e-01

3.0e+00

7.2e-01

4.2e-01

1.7e-01

cases:33.49%

controls:29.35%

cases:29.46%

controls:23.53%

cases:9.21%

controls:5.14%

cases:5.37%

controls:0.28%

cases:9.32%

controls:4.77%

cases:33.56%

controls:24.98%

cases:50.60%

controls:46.33%

349

3054

693

7351

307

2448

735

7957

535

946

9870

986

10376

495

944

9879

339

2515

671

7555

461

4170

450

4831

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

1.9e-01

3.1e-01

6.3e-01

3.0e+00

7.1e-01

4.2e-01

1.8e-01

cases:33.59%

controls:29.41%

cases:29.56%

controls:23.58%

cases:9.21%

controls:5.14%

cases:5.37%

controls:0.28%

cases:9.32%

controls:4.79%

cases:33.66%

controls:25.07%

cases:50.82%

controls:46.37%

350

3060

692

7345

308

2454

734

7951

535

946

9870

986

10376

497

944

9877

340

2525

670

7545

463

4174

448

4827

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

1.9e-01

3.1e-01

6.3e-01

3.0e+00

7.2e-01

4.2e-01

1.8e-01

cases:33.49%

controls:29.35%

cases:29.46%

controls:23.53%

cases:9.21%

controls:5.15%

cases:5.37%

controls:0.28%

cases:9.32%

controls:4.78%

cases:33.56%

controls:24.98%

cases:50.71%

controls:46.32%

349

3054

693

7351

307

2448

735

7957

536

946

9869

986

10376

496

944

9878

339

2515

671

7555

462

4169

449

4832

Office Visit
OMOP4822458 [581477]

8.1e-01

8.6e-01

8.0e-01

—

1.4e+00

1.1e+00

8.0e-01

cases:12.38%

controls:5.92%

cases:4.13%

controls:1.79%

cases:0.58%

controls:0.26%

—

cases:1.25%

controls:0.30%

cases:3.96%

controls:1.37%

cases:10.87%

controls:5.21%

129

616

913

9789

186

999

10219

1036

10378

—

1028

10343

138

970

9932

469

812

8532

Exposure to unspecified factor
X59 [45756412]

9.5e-01

1.5e+00

—

2.0e+00

1.4e+00

1.1e+00

cases:3.74%

controls:1.48%

cases:1.63%

controls:0.38%

—

cases:0.48%

controls:0.07%

cases:1.39%

controls:0.34%

cases:5.05%

controls:1.67%

154

1003

10251

1025

10365

—

1036

10367

996

10036

150

865

8851

Other shoulder lesions
M75.8 [45572543]

1.3e+00

2.7e+00

—

2.3e+00

cases:0.58%

controls:0.15%

cases:0.96%

controls:0.07%

—

cases:1.21%

controls:0.12%

1036

10389

1032

10398

—

900

8990

Basophils [#/volume] in Blood
26444-0 [3006315]

4.9e-01

5.0e-01

1.1e+00

—

1.3e+00

7.4e-01

7.7e-01

cases:11.80%

controls:7.61%

cases:7.39%

controls:4.60%

cases:2.69%

controls:0.92%

—

cases:2.69%

controls:0.71%

cases:8.71%

controls:4.35%

cases:21.08%

controls:10.99%

123

792

919

9613

479

965

9926

1014

10309

—

1013

10300

438

922

9632

192

989

719

8012

Monocytes [#/volume] in Blood
26484-6 [3001604]

4.8e-01

5.1e-01

1.1e+00

—

1.3e+00

7.4e-01

7.7e-01

cases:11.71%

controls:7.58%

cases:7.39%

controls:4.59%

cases:2.69%

controls:0.92%

—

cases:2.69%

controls:0.71%

cases:8.61%

controls:4.31%

cases:21.08%

controls:10.98%

122

789

920

9616

478

965

9927

1014

10309

—

1013

10300

434

923

9636

192

988

719

8013

Inpatient Hospital
21 [8717]

6.9e-01

7.6e-01

3.7e-01

—

1.7e+00

9.9e-01

8.2e-01

cases:39.25%

controls:24.56%

cases:14.78%

controls:7.53%

cases:1.73%

controls:1.20%

—

cases:4.42%

controls:0.86%

cases:16.53%

controls:6.86%

cases:34.91%

controls:19.15%

409

2555

633

7850

154

783

888

9622

125

1024

10280

—

995

10285

167

691

843

9379

318

1724

593

7277

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

3.0e-01

3.8e-01

6.5e-01

2.6e+00

9.4e-01

7.4e-01

5.9e-01

cases:13.53%

controls:10.40%

cases:7.58%

controls:5.32%

cases:1.44%

controls:0.76%

cases:0.67%

controls:0.05%

cases:1.92%

controls:0.76%

cases:9.70%

controls:4.87%

cases:23.49%

controls:14.50%

141

1082

901

9323

554

963

9851

1027

10326

1035

10400

1021

10295

490

912

9580

214

1305

697

7696

pramipexole; oral
N04BC05 [21604477]

1.2e+00

1.1e+00

1.2e+00

—

1.5e+00

1.4e+00

1.2e+00

cases:2.02%

controls:0.62%

cases:1.34%

controls:0.46%

cases:0.48%

controls:0.14%

—

cases:0.48%

controls:0.11%

cases:1.58%

controls:0.40%

cases:2.41%

controls:0.74%

1021

10341

1028

10357

1037

10390

—

1036

10363

994

10030

889

8934

nimesulide; oral
M01AX17 [21604007]

1.3e+00

1.9e+00

—

1.6e+00

7.0e-01

cases:4.22%

controls:1.19%

cases:2.11%

controls:0.31%

—

cases:1.29%

controls:0.26%

cases:1.54%

controls:0.77%

124

998

10281

1020

10373

—

997

10044

897

8932

Differential panel - Synovial fluid
29582-4 [3021788]

—

1.0e+50

—

2.6e+00

2.2e+00

—

cases:0.67%

controls:0.00%

—

cases:0.69%

controls:0.05%

cases:1.10%

controls:0.12%

—

1035

10405

—

1003

10065

901

8990

Trigger finger
M65.3 [45538828]

2.4e+00

—

2.4e+00

cases:1.06%

controls:0.10%

—

cases:0.88%

controls:0.08%

1031

10395

—

903

8994

Inpatient Visit
IP [9201]

5.1e-01

6.8e-01

—

2.0e+00

7.6e-01

8.3e-01

cases:8.64%

controls:5.37%

cases:3.93%

controls:2.04%

—

cases:1.25%

controls:0.16%

cases:3.76%

controls:1.79%

cases:12.07%

controls:5.64%

559

952

9846

212

1001

10193

—

1028

10357

180

972

9890

110

508

801

8493

INR in Blood by Coagulation assay
34714-6 [3032080]

4.2e-01

3.9e-01

5.9e-01

3.1e+00

7.5e-01

6.5e-01

6.6e-01

cases:9.02%

controls:6.09%

cases:5.37%

controls:3.70%

cases:2.21%

controls:1.24%

cases:1.44%

controls:0.07%

cases:2.31%

controls:1.10%

cases:6.73%

controls:3.61%

cases:15.26%

controls:8.51%

634

948

9771

385

986

10020

129

1019

10276

1027

10398

114

1017

10260

364

942

9706

139

766

772

8235

Primary gonarthrosis, bilateral
M17.0 [45562648]

7.9e-01

1.2e+00

1.3e+00

—

1.5e+00

1.3e+00

cases:2.59%

controls:1.19%

cases:1.92%

controls:0.57%

cases:0.48%

controls:0.12%

—

cases:2.28%

controls:0.53%

cases:5.49%

controls:1.56%

124

1015

10281

1022

10346

1037

10392

—

987

10017

140

861

8861

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]

7.2e-01

9.0e-01

—

2.3e+00

8.3e-01

8.8e-01

cases:4.51%

controls:2.24%

cases:1.92%

controls:0.79%

—

cases:0.58%

controls:0.06%

cases:1.78%

controls:0.78%

cases:8.12%

controls:3.54%

233

995

10172

1022

10323

—

1035

10368

992

9991

319

837

8682

Eosinophils [#/volume] in Blood
26449-9 [3013115]

4.8e-01

4.9e-01

1.1e+00

—

1.3e+00

7.2e-01

8.0e-01

cases:12.28%

controls:7.96%

cases:7.58%

controls:4.77%

cases:2.78%

controls:0.99%

—

cases:2.69%

controls:0.78%

cases:8.81%

controls:4.51%

cases:22.17%

controls:11.39%

128

828

914

9577

496

963

9909

103

1013

10302

—

1013

10293

454

921

9616

202

1025

709

7976

Observation for suspected disease or condition, unspecified
Z03.9 [45552062]

1.0e+00

1.2e+00

—

1.6e+00

9.9e-01

cases:4.89%

controls:1.82%

cases:1.54%

controls:0.49%

—

cases:2.57%

controls:0.52%

cases:5.38%

controls:2.07%

189

991

10216

1026

10354

—

984

10018

186

862

8815

Essential (primary) hypertension
I10 [45591453]

3.7e-01

3.4e-01

6.5e-01

3.5e+00

2.0e-01

4.6e-01

4.2e-01

cases:16.51%

controls:12.01%

cases:8.93%

controls:6.51%

cases:2.02%

controls:1.07%

cases:1.63%

controls:0.05%

cases:1.06%

controls:0.87%

cases:10.00%

controls:6.55%

cases:23.49%

controls:16.79%

172

1250

870

9155

677

949

9728

111

1021

10294

1025

10400

1030

10284

101

660

909

9410

214

1511

697

7490

Normoblasts [#/volume] in Blood
715-3 [3021589]

3.9e-01

3.3e-01

5.6e-01

2.4e+00

8.5e-01

5.0e-01

6.1e-01

cases:9.40%

controls:6.58%

cases:7.01%

controls:5.14%

cases:2.21%

controls:1.28%

cases:0.86%

controls:0.08%

cases:2.50%

controls:1.08%

cases:8.12%

controls:5.08%

cases:17.67%

controls:10.47%

685

944

9720

535

969

9870

133

1019

10272

1033

10397

112

1015

10262

512

928

9558

161

942

750

8059

X-ray examination of the lungs in one projection
GD1PA [2001303645]

4.2e-01

2.1e+00

—

1.7e+00

1.0e+00

cases:0.86%

controls:0.57%

cases:0.67%

controls:0.09%

—

cases:0.89%

controls:0.17%

cases:1.98%

controls:0.71%

1033

10346

1035

10396

—

1001

10053

893

8937

Wrist X-ray examination
ND1AA [2001307576]

1.1e+00

2.3e+00

—

1.3e+00

cases:1.25%

controls:0.41%

cases:0.77%

controls:0.08%

—

cases:2.20%

controls:0.59%

1029

10362

1034

10397

—

891

8948

Other primary gonarthrosis
M17.1 [45596493]

1.1e+00

8.9e-01

—

2.1e+00

1.5e+00

1.3e+00

cases:4.99%

controls:1.80%

cases:2.02%

controls:0.84%

—

cases:0.48%

controls:0.06%

cases:3.17%

controls:0.73%

cases:7.90%

controls:2.27%

187

990

10218

1021

10318

—

1036

10368

978

9996

204

839

8797

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

4.4e-01

4.8e-01

1.0e+00

—

1.3e+00

7.1e-01

7.6e-01

cases:11.80%

controls:7.92%

cases:7.49%

controls:4.77%

cases:2.69%

controls:0.97%

—

cases:2.69%

controls:0.74%

cases:8.91%

controls:4.59%

cases:21.73%

controls:11.47%

123

824

919

9581

496

964

9909

101

1014

10304

—

1013

10297

462

920

9608

198

1032

713

7969

Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]

5.1e-01

6.7e-01

1.0e+00

1.0e+50

1.1e+00

8.4e-01

6.1e-01

cases:19.29%

controls:12.60%

cases:11.61%

controls:6.30%

cases:2.59%

controls:0.96%

cases:0.67%

controls:0.00%

cases:2.11%

controls:0.72%

cases:13.66%

controls:6.43%

cases:29.20%

controls:18.36%

201

1311

841

9094

121

656

921

9749

100

1015

10305

1035

10405

1019

10299

138

647

872

9423

266

1653

645

7348

Asthma, unspecified
J45.9 [45562456]

1.2e+00

1.4e+00

9.2e-01

—

1.2e+00

9.7e-01

cases:6.05%

controls:1.93%

cases:3.55%

controls:0.92%

cases:0.58%

controls:0.23%

—

cases:2.87%

controls:0.92%

cases:7.14%

controls:2.82%

201

979

10204

1005

10309

1036

10381

—

981

9977

254

846

8747

Brachial plexus disorders
G54.0 [45586302]

2.6e+00

—

1.0e+50

—

2.1e+00

cases:1.34%

controls:0.11%

—

cases:0.77%

controls:0.00%

cases:0.67%

controls:0.00%

—

cases:1.10%

controls:0.13%

1028

10394

—

1034

10405

1034

10374

—

901

8989

Treatment plan or consultation
WZC00 [2001310885]

3.9e-01

9.3e-01

1.6e+00

—

9.7e-01

1.2e+00

9.0e-01

cases:6.14%

controls:4.24%

cases:4.03%

controls:1.62%

cases:1.15%

controls:0.23%

—

cases:0.48%

controls:0.18%

cases:4.36%

controls:1.33%

cases:10.10%

controls:4.36%

441

978

9964

169

1000

10236

1030

10381

—

1036

10355

134

966

9936

392

819

8609

Ultrasound examination of lower leg veins
PH2AE [2001309451]

1.7e+00

1.3e+00

—

1.7e+00

1.2e+00

cases:3.26%

controls:0.61%

cases:0.58%

controls:0.16%

—

cases:0.89%

controls:0.16%

cases:2.63%

controls:0.79%

1008

10342

1036

10388

—

1001

10054

887

8930

Telehealth
OMOP5556618 [722455]

4.0e-01

6.8e-01

1.1e+00

—

1.1e+00

7.8e-01

5.1e-01

cases:25.24%

controls:18.39%

cases:13.92%

controls:7.56%

cases:3.84%

controls:1.25%

—

cases:3.07%

controls:1.04%

cases:13.86%

controls:6.84%

cases:26.02%

controls:17.41%

263

1913

779

8492

145

787

897

9618

130

1002

10275

—

108

1009

10266

140

689

870

9381

237

1567

674

7434

Other internal derangements of knee
M23.8 [45548371]

2.1e+00

2.5e+00

—

-1.0e+50

—

cases:0.86%

controls:0.11%

cases:0.58%

controls:0.05%

—

cases:0.00%

controls:0.05%

—

1033

10394

1036

10400

—

1010

10065

—

Low back pain
M54.5 [45553207]

1.0e+00

1.1e+00

1.4e+00

1.0e+50

1.3e+00

1.6e+00

8.9e-01

cases:9.21%

controls:3.58%

cases:3.07%

controls:1.02%

cases:0.48%

controls:0.12%

cases:0.58%

controls:0.00%

cases:0.58%

controls:0.15%

cases:5.74%

controls:1.25%

cases:11.31%

controls:4.99%

373

946

10032

106

1010

10299

1037

10393

1036

10405

1035

10358

126

952

9944

103

449

808

8552

methylprednisolone; oral, parenteral
H02AB04 [21602732]

8.8e-01

1.2e+00

—

1.3e+00

1.1e+00

cases:3.45%

controls:1.46%

cases:1.73%

controls:0.51%

—

cases:1.49%

controls:0.40%

cases:4.06%

controls:1.38%

152

1006

10253

1024

10352

—

995

10030

124

874

8877

Pain localized to other parts of lower abdomen
R10.3 [45534426]

1.1e+00

1.2e+00

—

1.3e+00

9.6e-01

cases:6.05%

controls:2.19%

cases:2.40%

controls:0.76%

—

cases:2.28%

controls:0.62%

cases:5.60%

controls:2.21%

228

979

10177

1017

10326

—

987

10008

199

860

8802

Medical doctor
Z2221 [2001311556]

6.6e-01

8.5e-01

—

1.9e+00

1.1e+00

6.0e-01

cases:7.29%

controls:3.89%

cases:2.69%

controls:1.16%

—

cases:0.67%

controls:0.11%

cases:2.67%

controls:0.87%

cases:3.84%

controls:2.16%

405

966

10000

121

1014

10284

—

1034

10363

983

9982

194

876

8807

piroxicam; ointment
M02AA07 [21604043]

1.0e+00

1.4e+00

1.3e+00

—

1.1e+00

8.9e-01

cases:6.91%

controls:2.57%

cases:3.26%

controls:0.81%

cases:0.48%

controls:0.12%

—

cases:2.48%

controls:0.82%

cases:6.15%

controls:2.61%

267

970

10138

1008

10321

1037

10392

—

985

9987

235

855

8766

naproxcinod
M01AE18 [40254094]

7.8e-01

1.0e+00

9.2e-01

1.0e+50

1.3e+00

8.0e-01

5.6e-01

cases:15.36%

controls:7.67%

cases:7.20%

controls:2.71%

cases:0.67%

controls:0.27%

cases:0.67%

controls:0.00%

cases:1.25%

controls:0.35%

cases:5.74%

controls:2.66%

cases:12.18%

controls:7.35%

160

798

882

9607

282

967

10123

1035

10377

1035

10405

1028

10338

268

952

9802

111

662

800

8339

naproxen; oral, rectal
M01AE02 [21603968]

7.8e-01

1.0e+00

9.2e-01

1.0e+50

1.3e+00

8.0e-01

5.6e-01

cases:15.36%

controls:7.67%

cases:7.20%

controls:2.71%

cases:0.67%

controls:0.27%

cases:0.67%

controls:0.00%

cases:1.25%

controls:0.35%

cases:5.74%

controls:2.66%

cases:12.18%

controls:7.35%

160

798

882

9607

282

967

10123

1035

10377

1035

10405

1028

10338

268

952

9802

111

662

800

8339

Other cervical disc degeneration
M50.3 [45582167]

1.7e+00

—

1.0e+50

—

2.7e+00

cases:0.77%

controls:0.13%

—

cases:0.58%

controls:0.00%

—

cases:0.99%

controls:0.07%

1034

10391

—

1036

10405

—

902

8995

Calcific tendinitis of shoulder
M75.3 [45567648]

2.3e+00

—

1.0e+50

—

2.1e+00

cases:0.67%

controls:0.07%

—

cases:1.25%

controls:0.00%

cases:0.58%

controls:0.00%

—

cases:0.66%

controls:0.08%

1035

10398

—

1029

10405

1035

10374

—

905

8994

Release of median nerve
ACC51 [2001300642]

1.1e+00

1.5e+00

—

1.9e+00

1.4e+00

cases:1.63%

controls:0.54%

cases:0.77%

controls:0.17%

—

cases:0.79%

controls:0.12%

cases:2.20%

controls:0.54%

1025

10349

1034

10387

—

1002

10058

891

8952

Neurology
13 [38004458]

7.9e-01

5.6e-01

1.1e+00

—

7.1e-01

1.0e+00

9.3e-01

cases:14.78%

controls:7.28%

cases:5.57%

controls:3.27%

cases:1.54%

controls:0.52%

—

cases:0.96%

controls:0.47%

cases:7.82%

controls:2.94%

cases:16.90%

controls:7.45%

154

757

888

9648

340

984

10065

1026

10351

—

1031

10325

296

931

9774

154

671

757

8330

Crystals [Presence] in Synovial fluid by Light microscopy
38458-6 [3050238]

8.2e-01

1.8e+00

—

1.0e+50

—

2.8e+00

1.6e+00

cases:0.48%

controls:0.21%

cases:0.48%

controls:0.08%

—

cases:1.15%

controls:0.00%

—

cases:0.99%

controls:0.06%

cases:1.54%

controls:0.32%

1037

10383

1037

10397

—

1030

10405

—

1000

10064

897

8972

Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]

6.9e-01

—

2.6e+00

1.8e+00

cases:0.48%

controls:0.24%

—

cases:0.89%

controls:0.07%

cases:1.76%

controls:0.29%

1037

10380

—

1001

10063

895

8975

Removal of sutures
SPAT1153 [2001700254]

3.6e-01

6.3e-01

—

2.5e+00

1.2e+00

7.4e-01

cases:4.80%

controls:3.41%

cases:1.82%

controls:0.98%

—

cases:1.34%

controls:0.12%

cases:3.37%

controls:1.08%

cases:7.46%

controls:3.70%

355

992

10050

102

1023

10303

—

1027

10362

109

976

9961

333

843

8668

Post-traumatic arthrosis of other joints
M19.1 [45596496]

2.6e+00

—

1.8e+00

cases:0.86%

controls:0.07%

—

cases:0.99%

controls:0.17%

1033

10398

—

902

8986

More than one and less than three hours
ZXE10 [2001311401]

5.6e-01

1.2e+00

1.3e+00

—

1.9e+00

1.6e+00

9.8e-01

cases:7.58%

controls:4.47%

cases:3.45%

controls:1.02%

cases:0.48%

controls:0.12%

—

cases:0.58%

controls:0.09%

cases:3.96%

controls:0.86%

cases:7.24%

controls:2.84%

465

963

9940

106

1006

10299

1037

10392

—

1035

10365

970

9983

256

845

8745

Abdominal pain localized other
D06 [2002000305]

1.1e+00

—

1.7e+00

1.5e+00

cases:2.11%

controls:0.70%

cases:0.48%

controls:0.15%

—

cases:0.89%

controls:0.16%

cases:2.85%

controls:0.66%

1020

10332

1037

10389

—

1001

10054

885

8942

Medial epicondylitis
M77.0 [45557989]

2.2e+00

—

1.0e+50

—

2.1e+00

cases:0.67%

controls:0.08%

—

cases:0.48%

controls:0.00%

—

cases:1.32%

controls:0.16%

1035

10397

—

1037

10405

—

899

8987

Other synovitis and tenosynovitis
M65.8 [45582208]

2.3e+00

—

2.0e+00

cases:0.58%

controls:0.06%

—

cases:0.66%

controls:0.09%

1036

10399

—

905

8993

Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]

9.2e-01

1.3e+00

—

2.6e+00

1.7e+00

cases:1.54%

controls:0.62%

cases:0.48%

controls:0.12%

—

cases:1.29%

controls:0.10%

cases:2.74%

controls:0.50%

1026

10341

1037

10392

—

997

10060

886

8956

Pain, unspecified
R52.9 [45544151]

1.3e+00

1.9e+00

—

1.4e+00

1.1e+00

cases:2.40%

controls:0.66%

cases:1.15%

controls:0.17%

—

cases:0.59%

controls:0.15%

cases:2.20%

controls:0.76%

1017

10336

1030

10387

—

1004

10055

891

8933

Chest pain, unspecified
R07.4 [45558450]

9.5e-01

1.2e+00

—

1.9e+00

9.6e-01

1.2e+00

cases:6.33%

controls:2.56%

cases:2.40%

controls:0.75%

—

cases:0.58%

controls:0.09%

cases:2.67%

controls:1.04%

cases:9.00%

controls:2.93%

266

976

10139

1017

10327

—

1035

10365

105

983

9965

264

829

8737

Seropositive rheumatoid arthritis, unspecified
M05.9 [45553050]

1.5e+00

2.3e+00

—

2.0e+00

cases:0.48%

controls:0.11%

cases:0.58%

controls:0.06%

—

cases:1.10%

controls:0.16%

1037

10394

1036

10399

—

901

8987

Laboratory Visit
OMOP4822461 [32036]

1.4e-01

2.7e-01

5.1e-01

2.6e+00

5.4e-01

3.1e-01

1.1e-01

cases:35.99%

controls:32.93%

cases:36.28%

controls:30.24%

cases:14.40%

controls:9.15%

cases:7.10%

controls:0.55%

cases:14.02%

controls:8.68%

cases:39.50%

controls:32.49%

cases:54.01%

controls:51.22%

375

3426

667

6979

378

3146

664

7259

150

952

892

9453

968

10348

146

900

895

9474

399

3272

611

6798

492

4610

419

4391

Emergency care or similar visit
WYA10 [2001310872]

1.0e+00

1.1e+00

—

1.7e+00

1.5e+00

cases:1.54%

controls:0.57%

cases:0.48%

controls:0.16%

—

cases:0.79%

controls:0.14%

cases:1.87%

controls:0.43%

1026

10346

1037

10388

—

1002

10056

894

8962

rofecoxib; oral
M01AH02 [21603993]

1.7e+00

1.3e+00

—

2.5e+00

7.5e-01

cases:2.50%

controls:0.45%

cases:0.58%

controls:0.16%

—

cases:1.19%

controls:0.10%

cases:1.10%

controls:0.52%

1016

10358

1036

10388

—

998

10060

901

8954

piroxicam; oral, parenteral, rectal
M01AC01 [21603961]

9.2e-01

1.4e+00

1.1e+00

—

2.0e+00

1.0e+00

8.4e-01

cases:7.29%

controls:3.03%

cases:3.65%

controls:0.92%

cases:0.48%

controls:0.15%

—

cases:0.48%

controls:0.07%

cases:2.57%

controls:0.92%

cases:6.48%

controls:2.91%

315

966

10090

1004

10309

1037

10389

—

1036

10367

984

9977

262

852

8739

Shoulder extensive X-ray examination without contrast
NB1BA [2001307228]

—

1.0e+50

—

2.6e+00

1.6e+00

—

cases:0.77%

controls:0.00%

—

cases:0.69%

controls:0.05%

cases:0.99%

controls:0.21%

—

1034

10405

—

1003

10065

902

8982

cefalexin; oral
J01DB01 [21602870]

7.3e-01

6.7e-01

1.9e-01

—

1.4e+00

6.1e-01

7.1e-01

cases:39.06%

controls:23.54%

cases:13.72%

controls:7.54%

cases:1.15%

controls:0.95%

—

cases:3.55%

controls:0.88%

cases:12.48%

controls:7.19%

cases:38.09%

controls:23.20%

407

2449

635

7956

143

785

899

9620

1030

10306

—

1004

10283

126

724

884

9346

347

2088

564

6913

Leukocytes [#/volume] in Synovial fluid
26469-7 [3000475]

1.1e+00

—

1.0e+50

—

2.3e+00

1.8e+00

cases:0.48%

controls:0.16%

—

cases:0.96%

controls:0.00%

—

cases:0.69%

controls:0.07%

cases:1.76%

controls:0.29%

1037

10388

—

1032

10405

—

1003

10063

895

8975

Anterior fusion of cervical spine without fixation
NAG40 [2001307112]

1.9e+00

—

2.2e+00

cases:0.77%

controls:0.12%

—

cases:1.10%

controls:0.12%

1034

10393

—

901

8990

budesonide; inhalant
R03BA02 [21603285]

7.6e-01

7.2e-01

4.8e-01

—

1.0e+00

8.5e-01

7.6e-01

cases:8.93%

controls:4.38%

cases:5.37%

controls:2.70%

cases:1.06%

controls:0.65%

—

cases:1.63%

controls:0.60%

cases:6.14%

controls:2.72%

cases:9.55%

controls:4.71%

456

949

9949

281

986

10124

1031

10337

—

1024

10312

274

948

9796

424

824

8577

Other specified arthrosis
M19.8 [45548327]

—

2.0e+00

—

1.0e+50

—

2.5e+00

1.6e+00

—

cases:0.48%

controls:0.07%

—

cases:0.58%

controls:0.00%

—

cases:0.59%

controls:0.05%

cases:1.21%

controls:0.24%

—

1037

10398

—

1036

10405

—

1004

10065

900

8979

Other and unspecified abdominal pain
R10.4 [45568113]

1.2e+00

1.0e+00

—

9.5e-01

8.8e-01

cases:11.13%

controls:3.58%

cases:3.07%

controls:1.11%

—

cases:3.07%

controls:1.21%

cases:9.99%

controls:4.41%

116

372

926

10033

116

1010

10289

—

122

979

9948

397

820

8604

Presence of coronary angioplasty implant and graft
Z95.5 [45542496]

1.8e+00

2.3e+00

—

5.0e-01

cases:1.06%

controls:0.18%

cases:0.77%

controls:0.08%

—

cases:0.55%

controls:0.33%

1031

10386

1034

10397

—

906

8971

formoterol; inhalant
R03AC13 [21603267]

1.4e+00

1.5e+00

—

1.1e+00

1.2e+00

cases:1.54%

controls:0.38%

cases:1.15%

controls:0.27%

—

cases:0.89%

controls:0.29%

cases:1.43%

controls:0.43%

1026

10365

1030

10377

—

1001

10041

898

8962

Moderate depressive episode without somatic syndrome
F32.10 [2000501980]

1.0e+00

1.6e+00

—

1.4e+00

9.7e-01

cases:1.92%

controls:0.68%

cases:1.06%

controls:0.22%

—

cases:0.99%

controls:0.24%

cases:1.65%

controls:0.63%

1022

10334

1031

10382

—

1000

10046

896

8944

Supplier / Service Provider
OMOP5117446 [33004]

-9.4e-01

-8.5e-01

—

2.6e+00

3.2e+00

cases:12.38%

controls:26.54%

cases:3.84%

controls:8.57%

—

cases:5.15%

controls:0.41%

cases:15.92%

controls:0.78%

129

2762

913

7643

892

1002

9513

—

958

10029

145

766

8931

Headache
R51.80 [2000503603]

1.3e+00

4.2e-01

—

1.3e+00

cases:3.93%

controls:1.10%

cases:0.67%

controls:0.44%

—

cases:1.19%

controls:0.32%

cases:4.72%

controls:1.28%

114

1001

10291

1035

10359

—

998

10038

115

868

8886

montelukast; oral
R03DC03 [21603356]

9.4e-01

8.7e-01

9.7e-01

—

1.0e+00

1.1e+00

1.0e+00

cases:6.05%

controls:2.46%

cases:3.36%

controls:1.44%

cases:0.96%

controls:0.37%

—

cases:1.15%

controls:0.42%

cases:4.16%

controls:1.43%

cases:7.03%

controls:2.60%

256

979

10149

150

1007

10255

1032

10367

—

1029

10330

144

968

9926

234

847

8767

ENMG
XA402 [2001300405]

2.0e+00

—

1.9e+00

cases:0.96%

controls:0.13%

—

cases:0.77%

controls:0.11%

1032

10391

—

904

8991

Nonallergic asthma
J45.1 [45557625]

1.4e+00

9.5e-01

—

1.3e+00

1.2e+00

cases:2.02%

controls:0.53%

cases:0.77%

controls:0.30%

—

cases:1.29%

controls:0.35%

cases:2.31%

controls:0.68%

1021

10350

1034

10374

—

997

10035

890

8940

Internal derangement of knee, unspecified
M23.9 [45567507]

1.2e+00

1.6e+00

—

1.1e+00

cases:1.34%

controls:0.40%

cases:0.77%

controls:0.15%

—

cases:1.87%

controls:0.64%

1028

10363

1034

10389

—

894

8943

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

3.7e-01

5.5e-01

—

1.0e+50

1.9e+00

8.9e-01

1.1e+00

cases:3.36%

controls:2.35%

cases:1.73%

controls:1.00%

—

cases:0.67%

controls:0.00%

cases:0.67%

controls:0.10%

cases:2.77%

controls:1.16%

cases:8.89%

controls:3.27%

245

1007

10160

104

1024

10301

—

1035

10405

1034

10364

117

982

9953

294

830

8707

Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]

8.3e-01

1.2e+00

—

1.1e+00

8.2e-01

cases:3.45%

controls:1.54%

cases:1.73%

controls:0.55%

—

cases:1.88%

controls:0.65%

cases:4.28%

controls:1.93%

160

1006

10245

1024

10348

—

991

10005

174

872

8827

misoprostol; oral, vaginal
G02AD06 [21602443]

1.5e+00

2.4e+00

—

1.2e+00

cases:1.25%

controls:0.29%

cases:0.96%

controls:0.09%

—

cases:1.21%

controls:0.37%

1029

10375

1032

10396

—

900

8968

misoprostol; oral
A02BB01 [21600093]

1.5e+00

2.4e+00

—

1.2e+00

cases:1.25%

controls:0.29%

cases:0.96%

controls:0.09%

—

cases:1.21%

controls:0.37%

1029

10375

1032

10396

—

900

8968

Polyarthrosis, unspecified
M15.9 [45543481]

1.4e+00

—

1.0e+50

—

2.1e+00

1.8e+00

cases:0.96%

controls:0.25%

—

cases:0.48%

controls:0.00%

—

cases:0.99%

controls:0.12%

cases:2.09%

controls:0.37%

1032

10379

—

1037

10405

—

1000

10058

892

8968

Other chronic pain
R52.2 [45568139]

1.9e+00

—

2.1e+00

1.9e+00

cases:0.77%

controls:0.12%

—

cases:0.50%

controls:0.06%

cases:0.77%

controls:0.11%

1034

10393

—

1005

10064

904

8991

Arthritis, unspecified
M13.9 [45567463]

6.1e-01

1.2e+00

—

1.0e+50

—

2.2e+00

1.6e+00

cases:0.86%

controls:0.47%

cases:0.67%

controls:0.21%

—

cases:0.96%

controls:0.00%

—

cases:2.48%

controls:0.27%

cases:2.85%

controls:0.60%

1033

10356

1035

10383

—

1032

10405

—

985

10043

885

8947

Dorsalgia, unspecified
M54.9 [45538791]

9.9e-01

1.8e+00

—

1.0e+00

cases:2.50%

controls:0.94%

cases:1.06%

controls:0.18%

—

cases:0.59%

controls:0.22%

cases:3.07%

controls:1.11%

1016

10307

1031

10386

—

1004

10048

100

883

8901

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

4.0e-01

4.2e-01

7.1e-01

1.8e+00

8.2e-01

7.1e-01

7.3e-01

cases:13.24%

controls:9.26%

cases:8.64%

controls:5.84%

cases:3.07%

controls:1.53%

cases:0.48%

controls:0.08%

cases:2.88%

controls:1.29%

cases:10.50%

controls:5.45%

cases:22.94%

controls:12.60%

138

964

904

9441

608

952

9797

159

1010

10246

1037

10397

134

1011

10240

106

549

904

9521

209

1134

702

7867

General psychiatric examination, not elsewhere classified
Z00.4 [45605094]

1.0e+00

—

-1.0e+50

—

1.7e+00

1.1e+00

cases:1.82%

controls:0.65%

—

cases:0.00%

controls:0.06%

—

cases:0.79%

controls:0.15%

cases:2.31%

controls:0.80%

1023

10337

—

1042

10399

—

1002

10055

890

8929

Rehabilitation Hospital
283X00000X [38004285]

1.4e+00

—

1.0e+50

—

2.3e+00

9.5e-01

cases:1.25%

controls:0.30%

—

cases:0.86%

controls:0.00%

—

cases:0.59%

controls:0.06%

cases:0.77%

controls:0.30%

1029

10374

—

1033

10405

—

1004

10064

904

8974

HLA-B27 [Presence]
4821-5 [3008898]

2.2e-01

—

2.3e+00

1.4e+00

cases:0.58%

controls:0.46%

—

cases:0.89%

controls:0.09%

cases:1.98%

controls:0.48%

1036

10357

—

1001

10061

893

8958

Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]

8.4e-01

—

2.2e+00

1.6e+00

cases:0.58%

controls:0.25%

—

cases:0.69%

controls:0.08%

cases:1.32%

controls:0.28%

1036

10379

—

1003

10062

899

8976

hydroxychloroquine; oral
P01BA02 [21604889]

8.6e-01

6.6e-01

—

1.2e+00

1.3e+00

1.6e+00

cases:2.40%

controls:1.03%

cases:1.54%

controls:0.80%

—

cases:0.48%

controls:0.14%

cases:3.07%

controls:0.87%

cases:4.72%

controls:1.03%

107

1017

10298

1026

10322

—

1036

10359

979

9982

868

8908

epinephrine
S01EA01 [21603673]

9.9e-01

1.2e+00

—

1.3e+00

1.4e+00

cases:1.92%

controls:0.72%

cases:0.86%

controls:0.25%

—

cases:1.19%

controls:0.34%

cases:3.40%

controls:0.83%

1022

10330

1033

10379

—

998

10036

880

8926

epinephrine; parenteral
C01CA24 [21600303]

9.9e-01

1.2e+00

—

1.3e+00

1.4e+00

cases:1.92%

controls:0.72%

cases:0.86%

controls:0.25%

—

cases:1.19%

controls:0.34%

cases:3.40%

controls:0.83%

1022

10330

1033

10379

—

998

10036

880

8926

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

2.0e-01

2.6e-01

2.3e-01

2.1e+00

6.0e-01

3.9e-01

2.7e-01

cases:28.89%

controls:24.87%

cases:22.65%

controls:18.40%

cases:4.32%

controls:3.45%

cases:1.06%

controls:0.12%

cases:5.38%

controls:3.04%

cases:26.04%

controls:19.18%

cases:47.09%

controls:40.41%

301

2588

741

7817

236

1915

806

8490

359

997

10046

1031

10392

315

985

10059

263

1931

747

8139

429

3637

482

5364

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

4.7e-01

4.6e-01

8.0e-01

—

1.2e+00

7.0e-01

7.5e-01

cases:11.23%

controls:7.31%

cases:6.72%

controls:4.33%

cases:2.02%

controls:0.91%

—

cases:2.31%

controls:0.67%

cases:7.92%

controls:4.10%

cases:18.66%

controls:9.81%

117

761

925

9644

451

972

9954

1021

10310

—

1017

10304

413

930

9657

170

883

741

8118

Gonarthrosis, unspecified
M17.9 [45606128]

1.1e+00

1.2e+00

—

1.3e+00

1.2e+00

cases:1.92%

controls:0.65%

cases:0.86%

controls:0.26%

—

cases:1.29%

controls:0.35%

cases:4.39%

controls:1.34%

1022

10337

1033

10378

—

997

10035

121

871

8880

Obesity due to excess calories
E66.01 [2000501501]

1.2e+00

8.0e-01

—

1.4e+00

9.9e-01

cases:2.02%

controls:0.63%

cases:0.96%

controls:0.43%

—

cases:1.49%

controls:0.36%

cases:2.96%

controls:1.12%

1021

10339

1032

10360

—

995

10034

101

884

8900

lansoprazole; oral
A02BC03 [21600098]

8.5e-01

8.7e-01

4.3e-01

—

8.5e-01

1.0e+00

8.5e-01

cases:8.35%

controls:3.76%

cases:4.22%

controls:1.82%

cases:0.58%

controls:0.37%

—

cases:0.96%

controls:0.41%

cases:4.75%

controls:1.77%

cases:8.89%

controls:4.02%

391

955

10014

189

998

10216

1036

10366

—

1031

10331

178

962

9892

362

830

8639

Monocytes/Leukocytes in Blood
26485-3 [3019069]

4.5e-01

8.0e-01

—

1.2e+00

7.1e-01

7.4e-01

cases:11.04%

controls:7.34%

cases:6.62%

controls:4.32%

cases:2.02%

controls:0.91%

—

cases:2.31%

controls:0.68%

cases:7.92%

controls:4.07%

cases:18.66%

controls:9.88%

115

764

927

9641

449

973

9956

1021

10310

—

1017

10303

410

930

9660

170

889

741

8112

salbutamol; inhalant
R03AC02 [21603256]

7.1e-01

6.9e-01

8.4e-01

—

1.7e-01

5.7e-01

7.3e-01

cases:20.15%

controls:11.00%

cases:10.27%

controls:5.44%

cases:2.11%

controls:0.92%

—

cases:1.15%

controls:0.97%

cases:9.41%

controls:5.54%

cases:24.26%

controls:13.32%

210

1145

832

9260

107

566

935

9839

1020

10309

—

101

1029

10273

558

915

9512

221

1199

690

7802

Basophils/Leukocytes in Blood
30180-4 [3022096]

4.8e-01

4.6e-01

8.1e-01

—

1.2e+00

7.0e-01

7.5e-01

cases:11.23%

controls:7.28%

cases:6.72%

controls:4.34%

cases:2.02%

controls:0.90%

—

cases:2.21%

controls:0.70%

cases:7.92%

controls:4.11%

cases:18.66%

controls:9.79%

117

757

925

9648

452

972

9953

1021

10311

—

1018

10301

414

930

9656

170

881

741

8120

Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]

1.7e+00

—

1.9e+00

1.1e+00

cases:0.86%

controls:0.16%

—

cases:0.69%

controls:0.11%

cases:1.10%

controls:0.36%

1033

10388

—

1003

10059

901

8969

Pulmonary Disease
29 [38004472]

7.7e-01

8.6e-01

8.8e-01

—

5.3e-01

9.8e-01

8.8e-01

cases:12.38%

controls:6.12%

cases:7.10%

controls:3.13%

cases:1.73%

controls:0.72%

—

cases:0.96%

controls:0.57%

cases:7.62%

controls:3.00%

cases:15.81%

controls:7.23%

129

637

913

9768

326

968

10079

1024

10330

—

1031

10315

302

933

9768

144

651

767

8350

salmeterol and fluticasone
R03AK06 [21603280]

9.2e-01

8.7e-01

1.3e+00

—

3.8e-02

9.3e-01

7.5e-01

cases:4.61%

controls:1.89%

cases:3.17%

controls:1.35%

cases:0.96%

controls:0.27%

—

cases:0.48%

controls:0.46%

cases:3.47%

controls:1.40%

cases:4.72%

controls:2.29%

197

994

10208

140

1009

10265

1032

10377

—

1036

10326

141

975

9929

206

868

8795

Severe depressive episode without psychotic symptoms
F32.2 [45557202]

1.0e+00

1.3e+00

—

1.9e+00

1.6e+00

cases:1.34%

controls:0.50%

cases:0.67%

controls:0.18%

—

cases:0.89%

controls:0.14%

cases:2.09%

controls:0.44%

1028

10353

1035

10386

—

1001

10056

892

8961

Pelvis X-ray examination
NE1AA [2001307792]

1.7e+00

—

1.7e+00

cases:1.73%

controls:0.32%

—

cases:1.65%

controls:0.31%

1024

10372

—

896

8973

Ankle X-ray examination without contrast
NH1AA [2001308235]

9.0e-01

—

2.0e+00

1.4e+00

cases:1.15%

controls:0.47%

—

cases:0.79%

controls:0.11%

cases:1.87%

controls:0.47%

1030

10356

—

1002

10059

894

8959

Plastic And Reconstructive Surgery
24 [38004467]

6.8e-01

1.0e+00

1.3e+00

—

9.2e-01

7.8e-01

cases:3.84%

controls:1.98%

cases:2.11%

controls:0.79%

cases:0.58%

controls:0.15%

—

cases:1.68%

controls:0.68%

cases:5.82%

controls:2.77%

206

1002

10199

1020

10323

1036

10389

—

993

10002

249

858

8752

Sedation and analgesia
WX002 [2001310758]

6.7e-01

1.5e+00

-1.0e+50

—

6.7e-01

1.2e+00

cases:3.26%

controls:1.70%

cases:1.63%

controls:0.37%

cases:0.00%

controls:0.05%

—

cases:0.79%

controls:0.41%

cases:4.94%

controls:1.53%

177

1008

10228

1025

10366

1042

10400

—

1002

10029

138

866

8863

Specific gravity of Urine by Refractometry
5810-7 [3019150]

5.2e-01

3.6e-01

1.5e+00

—

5.4e-01

8.1e-01

5.2e-01

cases:5.37%

controls:3.26%

cases:2.69%

controls:1.88%

cases:1.15%

controls:0.26%

—

cases:0.48%

controls:0.28%

cases:4.36%

controls:1.99%

cases:10.32%

controls:6.38%

339

986

10066

196

1014

10209

1030

10378

—

1036

10345

200

966

9870

574

817

8427

Limited function/disability (L)
L28 [2002000647]

7.8e-01

1.3e+00

1.6e+00

—

1.2e+00

8.7e-01

cases:2.11%

controls:0.98%

cases:1.82%

controls:0.51%

cases:0.48%

controls:0.10%

—

cases:1.98%

controls:0.62%

cases:4.50%

controls:1.93%

102

1020

10303

1023

10352

1037

10395

—

990

10008

174

870

8827

methotrexate
L01BA01 [21601423]

8.0e-01

6.6e-01

7.4e-01

—

8.5e-01

1.1e+00

1.5e+00

cases:3.17%

controls:1.44%

cases:2.30%

controls:1.20%

cases:0.86%

controls:0.41%

—

cases:1.06%

controls:0.45%

cases:3.27%

controls:1.16%

cases:6.59%

controls:1.62%

150

1009

10255

125

1018

10280

1033

10362

—

1030

10327

117

977

9953

146

851

8855

methotrexate; oral, parenteral
L04AX03 [21603929]

8.0e-01

6.6e-01

7.4e-01

—

8.5e-01

1.1e+00

1.5e+00

cases:3.17%

controls:1.44%

cases:2.30%

controls:1.20%

cases:0.86%

controls:0.41%

—

cases:1.06%

controls:0.45%

cases:3.27%

controls:1.16%

cases:6.59%

controls:1.62%

150

1009

10255

125

1018

10280

1033

10362

—

1030

10327

117

977

9953

146

851

8855

Hand and fingers X-ray examination
ND2AA [2001307607]

8.9e-01

1.8e+00

—

1.4e+00

1.5e+00

cases:1.54%

controls:0.63%

cases:0.67%

controls:0.12%

—

cases:0.69%

controls:0.17%

cases:3.18%

controls:0.70%

1026

10339

1035

10393

—

1003

10053

882

8938

esomeprazole; oral, parenteral
A02BC05 [21600100]

7.0e-01

8.3e-01

7.1e-01

—

4.7e-01

8.5e-01

9.1e-01

cases:11.61%

controls:6.15%

cases:6.81%

controls:3.10%

cases:1.34%

controls:0.66%

—

cases:1.06%

controls:0.67%

cases:7.43%

controls:3.31%

cases:15.81%

controls:7.03%

121

640

921

9765

323

971

10082

1028

10336

—

1030

10305

333

935

9737

144

633

767

8368

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

3.5e-01

4.4e-01

7.1e-01

—

1.6e+00

7.1e-01

6.2e-01

cases:11.13%

controls:8.08%

cases:6.14%

controls:4.05%

cases:1.25%

controls:0.62%

—

cases:1.92%

controls:0.40%

cases:7.52%

controls:3.86%

cases:20.64%

controls:12.22%

116

841

926

9564

421

978

9984

1029

10341

—

1021

10333

389

934

9681

188

1100

723

7901

Seronegative rheumatoid arthritis
M06.0 [45577103]

1.7e+00

1.4e+00

—

1.8e+00

1.6e+00

cases:1.06%

controls:0.20%

cases:0.48%

controls:0.12%

—

cases:0.59%

controls:0.10%

cases:1.10%

controls:0.22%

1031

10384

1037

10393

—

1004

10060

901

8981

Rheumatism, unspecified
M79.0 [45567658]

3.3e+00

—

1.0e+50

—

cases:1.25%

controls:0.05%

—

cases:0.58%

controls:0.00%

—

1029

10400

—

1036

10405

—

Nonorganic insomnia
F51.0 [45552492]

8.0e-01

2.2e-01

2.5e+00

—

1.8e+00

9.0e-01

3.9e-01

cases:2.50%

controls:1.13%

cases:0.77%

controls:0.62%

cases:0.67%

controls:0.06%

—

cases:0.48%

controls:0.08%

cases:1.39%

controls:0.57%

cases:3.29%

controls:2.26%

118

1016

10287

1034

10341

1035

10399

—

1036

10366

996

10013

203

881

8798

Neurosurgery
14 [38004459]

7.7e-01

1.3e+00

—

1.5e+00

8.1e-01

1.2e+00

cases:4.13%

controls:1.95%

cases:2.88%

controls:0.81%

—

cases:0.58%

controls:0.13%

cases:1.68%

controls:0.75%

cases:5.38%

controls:1.69%

203

999

10202

1012

10321

—

1035

10361

993

9994

152

862

8849

Atherosclerotic heart disease
I25.1 [45596196]

5.2e-01

8.0e-01

1.2e+00

—

1.8e+00

5.0e-01

6.1e-01

cases:4.22%

controls:2.56%

cases:2.98%

controls:1.36%

cases:0.86%

controls:0.27%

—

cases:0.96%

controls:0.15%

cases:2.48%

controls:1.52%

cases:6.48%

controls:3.63%

266

998

10139

141

1011

10264

1033

10377

—

1031

10358

153

985

9917

327

852

8674

Acute bronchitis, unspecified
J20.9 [45562445]

9.6e-01

1.4e+00

-1.0e+50

—

8.4e-01

8.9e-01

cases:4.32%

controls:1.69%

cases:1.54%

controls:0.39%

cases:0.00%

controls:0.08%

—

cases:0.89%

controls:0.39%

cases:4.94%

controls:2.09%

176

997

10229

1026

10364

1042

10397

—

1001

10031

188

866

8813

Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]

8.6e-01

1.3e+00

—

-1.0e+50

1.1e+00

6.3e-01

cases:2.98%

controls:1.28%

cases:1.63%

controls:0.46%

—

cases:0.00%

controls:0.06%

cases:1.68%

controls:0.58%

cases:3.29%

controls:1.79%

133

1011

10272

1025

10357

—

1041

10368

993

10012

161

881

8840

Otolaryngology
4 [38004449]

9.0e-01

6.6e-01

5.1e-01

—

1.0e+00

8.1e-01

8.2e-01

cases:17.85%

controls:8.08%

cases:5.57%

controls:2.96%

cases:0.86%

controls:0.52%

—

cases:1.25%

controls:0.46%

cases:6.14%

controls:2.84%

cases:16.90%

controls:8.19%

186

841

856

9564

308

984

10097

1033

10351

—

1028

10326

286

948

9784

154

737

757

8264

Angiography of heart and/or coronary arteries
FN1AC [2001302996]

4.0e-01

1.3e+00

—

1.1e+00

8.8e-01

cases:2.88%

controls:1.94%

cases:1.82%

controls:0.53%

—

cases:1.58%

controls:0.56%

cases:4.72%

controls:2.01%

202

1012

10203

1023

10350

—

994

10014

181

868

8820

Knee symptom/complaint
L15 [2002000639]

9.0e-01

1.1e+00

—

7.0e-01

1.1e+00

cases:4.32%

controls:1.80%

cases:2.02%

controls:0.67%

—

cases:1.49%

controls:0.74%

cases:7.79%

controls:2.72%

187

997

10218

1021

10335

—

995

9995

245

840

8756

Other specified counselling
Z71.8 [45581061]

7.3e-01

6.7e-01

—

1.4e+00

9.3e-01

7.6e-01

cases:5.18%

controls:2.56%

cases:2.98%

controls:1.54%

—

cases:0.58%

controls:0.14%

cases:3.86%

controls:1.56%

cases:10.43%

controls:5.15%

266

988

10139

160

1011

10245

—

1035

10359

157

971

9913

464

816

8537

CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]

5.6e-01

5.7e-01

8.3e-01

—

1.8e+00

6.9e-01

4.0e-01

cases:5.37%

controls:3.15%

cases:2.88%

controls:1.65%

cases:0.77%

controls:0.34%

—

cases:1.15%

controls:0.18%

cases:3.27%

controls:1.66%

cases:6.92%

controls:4.77%

328

986

10077

172

1012

10233

1034

10370

—

1029

10355

167

977

9903

429

848

8572

Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]

6.2e-01

1.8e+00

—

1.7e+00

1.4e+00

cases:0.96%

controls:0.52%

cases:0.58%

controls:0.10%

—

cases:0.89%

controls:0.17%

cases:1.87%

controls:0.47%

1032

10351

1036

10395

—

1001

10053

894

8959

Day surgery
ZXD20 [2001311388]

8.5e-01

—

1.0e+50

—

2.2e+00

8.0e-01

cases:2.30%

controls:1.00%

—

cases:0.48%

controls:0.00%

—

cases:1.09%

controls:0.12%

cases:1.65%

controls:0.74%

104

1018

10301

—

1037

10405

—

999

10058

896

8934

ranitidine; oral, parenteral
A02BA02 [21600083]

8.9e-01

7.2e-01

—

1.1e+00

1.0e+00

cases:3.45%

controls:1.44%

cases:1.06%

controls:0.52%

—

cases:1.29%

controls:0.42%

cases:2.85%

controls:1.03%

150

1006

10255

1031

10351

—

997

10028

885

8908

ranitidine bismuth citrate; oral
A02BA07 [21600088]

8.9e-01

7.2e-01

—

1.1e+00

1.0e+00

cases:3.45%

controls:1.44%

cases:1.06%

controls:0.52%

—

cases:1.29%

controls:0.42%

cases:2.85%

controls:1.03%

150

1006

10255

1031

10351

—

997

10028

885

8908

Acute maxillary sinusitis
J01.0 [45601112]

9.6e-01

1.1e+00

—

4.1e-01

1.0e+00

cases:6.14%

controls:2.45%

cases:2.59%

controls:0.90%

—

cases:1.58%

controls:1.05%

cases:8.34%

controls:3.13%

255

978

10150

1015

10311

—

106

994

9964

282

835

8719

Emergency Room and Inpatient Visit
ERIP [262]

1.8e-01

5.0e-01

9.2e-01

—

1.7e+00

8.4e-01

5.0e-01

cases:3.74%

controls:3.14%

cases:2.88%

controls:1.76%

cases:0.67%

controls:0.27%

—

cases:1.06%

controls:0.19%

cases:3.86%

controls:1.71%

cases:9.66%

controls:6.08%

327

1003

10078

183

1012

10222

1035

10377

—

1030

10354

172

971

9898

547

823

8454

Wrist symptom/complaint
L11 [2002000635]

8.8e-01

1.9e+00

—

9.7e-01

1.1e+00

cases:1.15%

controls:0.48%

cases:0.77%

controls:0.12%

—

cases:0.50%

controls:0.19%

cases:2.52%

controls:0.87%

1030

10355

1034

10393

—

1005

10051

888

8923

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

4.2e-01

4.1e-01

7.7e-01

—

1.2e+00

6.9e-01

7.1e-01

cases:11.13%

controls:7.58%

cases:6.62%

controls:4.48%

cases:2.02%

controls:0.94%

—

cases:2.31%

controls:0.73%

cases:8.22%

controls:4.30%

cases:19.10%

controls:10.38%

116

789

926

9616

466

973

9939

1021

10307

—

1017

10298

433

927

9637

174

934

737

8067

SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]

7.5e-01

2.0e+00

—

1.4e+00

9.6e-01

cases:0.67%

controls:0.32%

cases:0.86%

controls:0.12%

—

cases:0.69%

controls:0.17%

cases:1.76%

controls:0.68%

1035

10372

1033

10393

—

1003

10053

895

8940

Lumbar spine X-ray examination without contrast
NA3AA [2001307026]

1.4e+00

—

1.2e+00

1.5e+00

cases:2.21%

controls:0.54%

cases:0.58%

controls:0.14%

—

cases:0.69%

controls:0.22%

cases:2.96%

controls:0.67%

1019

10349

1036

10390

—

1003

10048

884

8941

Interscalenous plexus blockade
WX200 [2001310777]

—

1.0e+50

—

1.0e+50

2.9e+00

—

cases:0.77%

controls:0.00%

—

cases:1.92%

controls:0.00%

cases:0.58%

controls:0.00%

cases:1.49%

controls:0.00%

cases:1.21%

controls:0.07%

—

1034

10405

—

1022

10405

1035

10374

995

10070

900

8995

Ganglion
M67.4 [45582222]

1.6e+00

—

1.3e+00

cases:0.86%

controls:0.18%

—

cases:1.43%

controls:0.38%

1033

10386

—

898

8967

Cardiology
6 [38004451]

6.0e-01

7.4e-01

7.8e-01

—

4.8e-01

7.7e-01

cases:11.61%

controls:6.71%

cases:6.72%

controls:3.33%

cases:1.25%

controls:0.58%

—

cases:0.58%

controls:0.36%

cases:6.24%

controls:3.00%

cases:15.37%

controls:7.73%

121

698

921

9707

346

972

10059

1029

10345

—

1035

10337

302

947

9768

140

696

771

8305

Neutrophils/Leukocytes in Blood
26511-6 [3018010]

4.5e-01

4.3e-01

7.6e-01

—

1.0e+00

6.8e-01

7.1e-01

cases:11.04%

controls:7.31%

cases:6.53%

controls:4.34%

cases:1.92%

controls:0.90%

—

cases:2.02%

controls:0.72%

cases:7.92%

controls:4.19%

cases:18.66%

controls:10.11%

115

761

927

9644

452

974

9953

1022

10311

—

1020

10299

422

930

9648

170

910

741

8091

doxycycline; oral, parenteral
J01AA02 [21602800]

6.5e-01

8.1e-01

9.2e-01

—

-1.7e-01

6.7e-01

7.4e-01

cases:28.31%

controls:17.16%

cases:9.98%

controls:4.69%

cases:0.86%

controls:0.35%

—

cases:0.48%

controls:0.57%

cases:8.32%

controls:4.44%

cases:25.91%

controls:14.29%

295

1785

747

8620

104

488

938

9917

1033

10369

—

1036

10315

447

926

9623

236

1286

675

7715

tiotropium bromide; inhalant
R03BB04 [21603296]

9.6e-01

9.3e-01

8.5e-01

—

1.4e+00

8.0e-01

9.7e-01

cases:2.59%

controls:1.01%

cases:2.11%

controls:0.85%

cases:0.67%

controls:0.29%

—

cases:0.86%

controls:0.21%

cases:1.98%

controls:0.90%

cases:3.73%

controls:1.44%

105

1015

10300

1020

10317

1035

10375

—

1032

10352

990

9979

130

877

8871

Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]

4.3e-01

3.9e-01

1.5e+00

—

8.0e-01

5.6e-01

cases:4.22%

controls:2.80%

cases:2.50%

controls:1.71%

cases:1.06%

controls:0.24%

—

cases:3.86%

controls:1.78%

cases:9.66%

controls:5.73%

291

998

10114

178

1016

10227

1031

10380

—

179

971

9891

516

823

8485

prednisone; oral
H02AB07 [21602735]

9.2e-01

1.1e+00

—

9.6e-01

8.3e-01

cases:2.88%

controls:1.16%

cases:1.25%

controls:0.42%

—

cases:1.19%

controls:0.46%

cases:2.31%

controls:1.02%

121

1012

10284

1029

10361

—

998

10024

890

8909

prednisone
A07EA03 [21600655]

9.2e-01

1.1e+00

—

9.6e-01

8.3e-01

cases:2.88%

controls:1.16%

cases:1.25%

controls:0.42%

—

cases:1.19%

controls:0.46%

cases:2.31%

controls:1.02%

121

1012

10284

1029

10361

—

998

10024

890

8909

Pain localized to upper abdomen
R10.1 [45568111]

9.2e-01

9.0e-01

—

9.2e-01

9.8e-01

cases:3.74%

controls:1.53%

cases:1.06%

controls:0.43%

—

cases:1.68%

controls:0.68%

cases:4.61%

controls:1.78%

159

1003

10246

1031

10360

—

993

10002

160

869

8841

naproxen and esomeprazole; oral
M01AE52 [40254096]

7.4e-01

1.4e+00

—

-1.3e-01

6.8e-01

cases:2.78%

controls:1.35%

cases:1.34%

controls:0.34%

—

cases:0.50%

controls:0.57%

cases:3.29%

controls:1.69%

140

1013

10265

1028

10370

—

1005

10013

152

881

8849

Spondylosis, unspecified
M47.9 [45557887]

2.8e+00

—

cases:0.96%

controls:0.06%

—

1032

10399

—

Bloodpressure measurement
XF600 [2001303376]

—

1.5e+00

—

1.3e+00

—

cases:0.86%

controls:0.19%

—

cases:1.65%

controls:0.47%

—

1033

10385

—

896

8959

Fibromyalgia
M79.7 [45553272]

1.9e+00

—

2.8e+00

cases:0.58%

controls:0.09%

—

cases:2.09%

controls:0.13%

1036

10396

—

892

8989

Hand and fingers extensive X-ray examination
ND2BA [2001307610]

—

2.8e+00

—

cases:0.88%

controls:0.06%

—

903

8996

zopiclone; oral
N05CF01 [21604654]

6.1e-01

7.1e-01

6.8e-01

—

7.2e-01

6.8e-01

7.7e-01

cases:10.08%

controls:5.75%

cases:5.95%

controls:3.02%

cases:1.73%

controls:0.88%

—

cases:1.54%

controls:0.75%

cases:6.14%

controls:3.21%

cases:12.18%

controls:6.04%

105

598

937

9807

314

980

10091

1024

10313

—

1025

10296

323

948

9747

111

544

800

8457

fluconazole; oral, parenteral
J02AC01 [21603080]

6.2e-01

6.4e-01

6.9e-01

—

1.3e+00

7.4e-01

7.7e-01

cases:10.56%

controls:5.99%

cases:3.36%

controls:1.81%

cases:0.48%

controls:0.24%

—

cases:0.67%

controls:0.19%

cases:3.96%

controls:1.93%

cases:9.88%

controls:4.84%

110

623

932

9782

188

1007

10217

1037

10380

—

1034

10354

194

970

9876

436

821

8565

sulfasalazine; oral, rectal
A07EC01 [21600663]

7.3e-01

7.9e-01

6.9e-01

—

8.5e-01

1.3e+00

1.4e+00

cases:2.21%

controls:1.08%

cases:1.63%

controls:0.75%

cases:0.48%

controls:0.24%

—

cases:0.67%

controls:0.29%

cases:2.87%

controls:0.78%

cases:4.61%

controls:1.13%

112

1019

10293

1025

10327

1037

10380

—

1034

10344

981

9991

102

869

8899

Differential panel, method unspecified - Blood
69738-3 [42870588]

3.0e-01

4.3e-01

9.4e-01

—

1.4e+00

6.1e-01

7.9e-01

cases:6.43%

controls:4.84%

cases:4.32%

controls:2.84%

cases:1.54%

controls:0.61%

—

cases:1.73%

controls:0.45%

cases:5.05%

controls:2.82%

cases:12.29%

controls:5.95%

504

975

9901

296

997

10109

1026

10342

—

1023

10327

284

959

9786

112

536

799

8465

Other chest pain
R07.3 [45597166]

6.8e-01

1.5e+00

—

1.7e+00

1.0e+00

cases:1.25%

controls:0.63%

cases:0.58%

controls:0.12%

—

cases:0.79%

controls:0.14%

cases:1.76%

controls:0.66%

1029

10339

1036

10392

—

1002

10056

895

8942

Intravenous general anesthesia
WX404 [2001310807]

4.2e-01

9.1e-01

1.4e+00

—

1.7e+00

9.7e-01

cases:3.36%

controls:2.23%

cases:1.34%

controls:0.55%

cases:0.48%

controls:0.12%

—

cases:2.67%

controls:0.48%

cases:3.40%

controls:1.32%

232

1007

10173

1028

10348

1037

10393

—

983

10022

119

880

8882

C reactive protein [Mass/volume] in Body fluid
16503-5 [3035320]

—

-1.0e+50

—

-1.0e+50

2.7e+00

—

cases:0.00%

controls:0.05%

—

cases:0.00%

controls:0.05%

cases:0.99%

controls:0.07%

—

1042

10400

—

1010

10065

902

8995

azithromycin; oral, parenteral
J01FA10 [21602978]

6.5e-01

7.3e-01

—

7.5e-01

5.5e-01

cases:14.20%

controls:7.98%

cases:3.93%

controls:1.93%

—

cases:3.76%

controls:1.81%

cases:10.87%

controls:6.54%

148

830

894

9575

201

1001

10204

—

182

972

9888

589

812

8412

duloxetine; oral
N06AX21 [21604749]

1.2e+00

8.9e-01

—

7.4e-01

1.4e+00

cases:3.26%

controls:1.00%

cases:1.44%

controls:0.60%

—

cases:1.29%

controls:0.62%

cases:5.60%

controls:1.39%

104

1008

10301

1027

10343

—

997

10008

125

860

8876

Skin, Repair/fix-suture/cast/prosth device
S54 [2002001018]

—

2.6e+00

—

cases:0.69%

controls:0.05%

—

1003

10065

—

cetirizine; oral
R06AE07 [21603497]

7.2e-01

5.8e-01

7.0e-01

—

3.1e-01

6.2e-01

7.3e-01

cases:13.53%

controls:7.08%

cases:5.57%

controls:3.21%

cases:0.86%

controls:0.43%

—

cases:0.86%

controls:0.64%

cases:5.45%

controls:3.02%

cases:13.50%

controls:7.01%

141

737

901

9668

334

984

10071

1033

10360

—

1032

10308

304

955

9766

123

631

788

8370

golimumab; parenteral
L04AB06 [21603913]

—

2.6e+00

—

cases:0.77%

controls:0.06%

—

904

8996

Other rehabilitation service
R5599 [2001310270]

1.5e+00

—

1.0e+50

—

2.6e+00

cases:0.48%

controls:0.11%

—

cases:0.67%

controls:0.00%

—

cases:1.21%

controls:0.09%

1037

10394

—

1035

10405

—

900

8993

Leg/thigh symptom/complaint
L14 [2002000638]

1.3e+00

—

1.3e+00

cases:1.63%

controls:0.46%

—

cases:1.87%

controls:0.50%

1025

10357

—

894

8956

mirtazapine; oral
N06AX11 [21604740]

5.4e-01

5.8e-01

7.1e-01

—

6.1e-01

5.9e-01

8.8e-01

cases:7.58%

controls:4.55%

cases:4.22%

controls:2.41%

cases:1.25%

controls:0.62%

—

cases:1.15%

controls:0.63%

cases:4.75%

controls:2.68%

cases:13.17%

controls:5.90%

473

963

9932

251

998

10154

1029

10341

—

1029

10309

270

962

9800

120

531

791

8470

Bicipital tendinitis
M75.2 [45557984]

2.6e+00

—

1.0e+50

—

cases:0.77%

controls:0.06%

—

cases:1.06%

controls:0.00%

—

1034

10399

—

1031

10405

—

Haematemesis
K92.0 [45605964]

—

-1.0e+50

—

2.6e+00

—

cases:0.00%

controls:0.10%

—

cases:0.88%

controls:0.07%

—

1042

10395

—

903

8995

Teaching
WZC30 [2001310891]

4.3e-01

5.5e-01

-1.0e+50

—

1.7e+00

8.6e-01

cases:1.92%

controls:1.26%

cases:0.86%

controls:0.50%

cases:0.00%

controls:0.09%

—

cases:1.68%

controls:0.31%

cases:3.73%

controls:1.61%

131

1022

10274

1033

10353

1042

10396

—

993

10039

145

877

8856

Fall on same level involving ice and snow
W00 [45756242]

4.8e-01

1.6e+00

—

1.3e+00

1.0e+00

cases:1.34%

controls:0.84%

cases:0.86%

controls:0.18%

—

cases:0.79%

controls:0.21%

cases:2.52%

controls:0.93%

1028

10318

1033

10386

—

1002

10049

888

8917

clindamycin; oral, parenteral
J01FF01 [21602985]

7.1e-01

3.6e-01

—

1.0e+00

8.6e-01

cases:5.28%

controls:2.67%

cases:1.25%

controls:0.87%

—

cases:1.68%

controls:0.63%

cases:5.93%

controls:2.60%

278

987

10127

1029

10314

—

993

10007

234

857

8767

Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]

8.7e-01

—

9.7e-01

1.7e+00

cases:2.69%

controls:1.14%

—

cases:0.99%

controls:0.38%

cases:3.73%

controls:0.71%

119

1014

10286

—

1000

10032

877

8937

FEV1 --post bronchodilation
20155-8 [3023550]

8.7e-01

—

9.7e-01

1.7e+00

cases:2.69%

controls:1.14%

—

cases:0.99%

controls:0.38%

cases:3.73%

controls:0.71%

119

1014

10286

—

1000

10032

877

8937

FEV1 percent change
69983-5 [42868472]

8.7e-01

—

9.7e-01

1.7e+00

cases:2.69%

controls:1.14%

—

cases:0.99%

controls:0.38%

cases:3.73%

controls:0.71%

119

1014

10286

—

1000

10032

877

8937

FVC percent change Respiratory system
69982-7 [42868471]

8.7e-01

—

9.7e-01

1.7e+00

cases:2.69%

controls:1.14%

—

cases:0.99%

controls:0.38%

cases:3.73%

controls:0.71%

119

1014

10286

—

1000

10032

877

8937

FEV1/FVC --post bronchodilation
69970-2 [42868459]

8.7e-01

—

9.7e-01

1.7e+00

cases:2.69%

controls:1.14%

—

cases:0.99%

controls:0.38%

cases:3.73%

controls:0.71%

119

1014

10286

—

1000

10032

877

8937

Other obesity
E66.8 [45533036]

1.3e+00

—

1.2e+00

1.3e+00

cases:1.44%

controls:0.41%

—

cases:0.79%

controls:0.23%

cases:2.09%

controls:0.58%

1027

10362

—

1002

10047

892

8949

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

9.3e-01

4.0e-01

-1.0e+50

—

9.3e-01

7.0e-01

cases:6.43%

controls:2.64%

cases:1.34%

controls:0.90%

cases:0.00%

controls:0.06%

—

cases:2.48%

controls:0.99%

cases:6.15%

controls:3.16%

275

975

10130

1028

10311

1042

10399

—

100

985

9970

284

855

8717

Fracture of tooth, open
S02.51 [45755762]

1.0e+00

1.2e+00

—

1.5e+00

3.7e-01

cases:2.50%

controls:0.91%

cases:0.67%

controls:0.20%

—

cases:1.09%

controls:0.24%

cases:1.32%

controls:0.91%

1016

10310

1035

10384

—

999

10046

899

8919

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

336

1480

2.87

51.13

1.5

1.2

34.03

31.59

iu/ml

0.11

114

470

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

310

1355

2.83

47.37

1.5

1.2

12.37

14.53

u/ml

0.23

128

530

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

853

6484

2.68

34.98

5.9

3.9

12.56

12.10

mm/h

0.41

829

6038

(3042936) Bacteria identified in Isolate by Culture

242

1145

2.45

29.84

2.1

2.0

—

(3037522) Nuclear Ab [Titer] in Serum

238

1142

2.40

28.30

1.4

1.3

334.48

500.86

titre

1.01

232

(3013115) Eosinophils [#/volume] in Blood

655

4670

2.07

27.73

7.1

6.3

0.21

0.19

e9/l

3.34

602

4076

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

434

2677

2.06

27.39

3.0

2.5

54.71

65.51

u/l

2.63

405

2502

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

864

6882

2.44

27.28

8.9

8.1

75.61

79.34

u/l

2.09

840

6545

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

322

1793

2.15

26.53

1.9

1.6

0.92

1.17

mg/l

1.40

258

1374

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

412

2517

2.05

26.48

2.3

2.0

174.93

227.04

u/l

0.67

395

2385

(3013650) Neutrophils [#/volume] in Blood by Automated count

698

5148

2.06

26.23

8.9

10.0

4.19

4.07

e9/l

0.72

631

4492

(3001604) Monocytes [#/volume] in Blood

633

4527

2.00

25.71

6.9

6.1

0.59

0.58

e9/l

1.08

564

3898

(3006315) Basophils [#/volume] in Blood

633

4532

2.00

25.56

6.8

6.1

0.04

e9/l

0.05

565

3895

(3019198) Lymphocytes [#/volume] in Blood

641

4621

1.99

25.24

7.1

6.1

1.98

1.94

e9/l

0.21

586

4067

(3000475) Leukocytes [#/volume] in Synovial fluid

183

4.09

24.89

1.6

11684.10

13402.10

e6/l

0.10

125

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

195

3.95

24.37

1.4

—

(3032080) INR in Blood by Coagulation assay

557

3867

1.94

24.04

15.4

13.1

1.22

1.23

inr

0.14

481

3182

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

258

1365

2.18

23.88

1.9

—

(3019150) Specific gravity of Urine by Refractometry

331

1940

2.03

23.27

5.1

3.8

1.02

1.80

kg/l

0.50

230

1284

(3026493) Urate [Moles/volume] in Serum or Plasma

366

2223

1.99

23.26

2.5

2.7

328.89

341.18

umol/l

1.73

337

1983

(3037467) Urinalysis macro (dipstick) panel - Urine

760

5942

2.01

22.18

5.6

4.1

—

1.51

—

(3021601) Nitrite [Presence] in Urine by Test strip

620

4542

1.89

21.86

4.9

3.5

0.00

estimate

0.50

121

939

(3035350) Ketones [Presence] in Urine by Test strip

625

4595

1.89

21.74

4.9

3.6

0.00

1.48

estimate

0.50

121

950

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

635

4695

1.89

21.67

6.0

6.9

10.27

11.61

umol/l

3.49

612

4495

(3009261) Glucose [Presence] in Urine by Test strip

628

4636

1.88

21.44

5.0

3.6

0.00

0.01

estimate

0.93

116

894

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

202

1013

2.23

21.12

1.9

1.7

—

(3019069) Monocytes/Leukocytes in Blood

576

4183

1.84

20.24

7.0

6.3

8.88

8.85

0.08

552

3936

(3006504) Eosinophils/Leukocytes in Blood

575

4174

1.83

20.23

6.9

6.2

2.90

2.80

0.51

550

3929

(3022096) Basophils/Leukocytes in Blood

574

4168

1.83

20.14

7.0

6.3

0.68

0.69

0.18

549

3908

(3018010) Neutrophils/Leukocytes in Blood

578

4212

1.83

19.98

7.0

6.1

56.58

57.28

0.73

557

4043

(3002030) Lymphocytes/Leukocytes in Blood

584

4305

1.80

19.08

7.0

6.2

27.78

27.92

0.12

561

4098

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

591

4385

1.80

18.76

6.8

7.2

1.21

mmol/l

0.03

532

3796

(3031040) Bacteria [#/volume] in Urine by Automated count

714

5610

1.85

18.70

6.1

4.1

2577.86

2853.67

e6/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

668

5150

1.82

18.53

5.6

4.9

6.79

6.65

mmol/l

1.03

654

4864

(3023368) Bacteria identified in Blood by Culture

360

2322

1.84

18.13

4.3

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

447

3081

1.79

18.01

2.7

3.2

29.82

32.79

u/l

1.51

421

2938

(3024561) Albumin [Mass/volume] in Serum or Plasma

542

3951

1.77

17.99

4.1

5.0

36.01

35.83

g/l

0.34

517

3730

(40758558) Short blood count panel - Blood

410

2761

1.80

17.83

6.7

6.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

487

3450

1.77

17.79

4.9

3.5

0.05

0.03

estimate

0.28

774

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

186

969

2.12

17.42

2.0

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

408

2758

1.78

17.42

3.8

3.0

17.45

90.26

e6/l

2.31

337

2072

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

534

3915

1.74

17.03

6.2

6.5

1.21

mmol/l

0.23

505

3623

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

453

3175

1.75

16.93

4.9

3.4

33.36

37.63

ng/l

0.15

323

2134

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

336

2160

1.82

16.87

2.5

2.2

2.61

2.86

mg/l

1.40

307

1856

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

985

8804

2.92

16.79

21.8

14.0

22.21

24.60

mg/l

1.78

872

7087

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

308

1945

1.83

16.30

1.4

1.3

1.18

1.68

u/ml

0.52

530

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

271

1658

1.86

15.82

4.6

3.5

365.77

555.85

ng/l

0.33

204

1269

(3018095) Leukocytes [#/volume] in Urine

449

3196

1.71

15.47

4.6

3.6

44.98

86.81

e6/l

2.88

353

2205

(42870588) Differential panel, method unspecified - Blood

420

2939

1.72

15.38

6.7

6.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

543

4075

1.69

15.28

2.9

2.7

—

estimate

—

(3000850) Epithelial cells [#/volume] in Urine

293

1856

1.80

15.19

2.9

2.4

5.31

6.21

e6/l

0.56

281

1678

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

431

3062

1.69

14.76

3.9

3.0

—

(3015736) pH of Urine

490

3613

1.67

14.48

4.3

3.2

6.33

6.20

1.71

300

2065

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

511

3814

1.66

14.37

2.4

2.0

95.06

95.54

pmol/l

0.09

285

1991

(3030467) Casts [#/volume] in Urine by Automated count

350

2370

1.72

14.20

3.5

2.9

0.40

0.49

e6/l

0.24

277

1708

(3026008) Bacteria identified in Urine by Culture

369

2544

1.69

13.96

3.6

2.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

318

2.64

13.82

1.3

1.2

2.53

2.33

u/ml

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

354

2422

1.70

13.73

3.4

3.1

1169.57

1275.45

ng/l

0.21

310

2056

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

819

7003

1.77

12.98

5.3

4.3

14.81

14.74

pmol/l

0.33

775

6445

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

238

1479

1.79

12.89

1.7

1.5

—

(3021788) Differential panel - Synovial fluid

134

3.46

12.85

1.8

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

231

1424

1.80

12.85

2.5

12.76

13.43

umol/l

0.71

223

1338

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

528

4057

1.61

12.61

2.6

2.4

77.01

77.82

nmol/l

0.26

496

3689

(3045414) Leukocytes [Presence] in Urine

141

747

2.03

12.42

2.5

2.1

0.04

0.02

estimate

0.19

160

(3006571) Granulocytes/Leukocytes in Synovial fluid

4.45

12.21

1.6

1.7

58.24

52.47

0.29

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

234

1469

1.76

12.17

3.1

2.7

1.06

1.09

e6/l

0.05

142

756

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

115

575

2.12

11.81

3.1

3.5

4.38

4.56

pmol/l

1.27

106

516

(3023103) Potassium [Moles/volume] in Serum or Plasma

995

9172

2.62

11.60

23.6

16.7

3.97

3.96

mmol/l

0.36

990

8959

(3010144) Erythrocytes [#/volume] in Synovial fluid

4.59

11.47

1.3

1.4

141030.47

182613.54

e6/l

0.08

(3029937) Albumin [Presence] in Urine by Test strip

345

2437

1.62

11.38

5.6

3.7

0.00

estimate

0.99

111

882

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

116

595

2.07

11.13

1.6

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

163

945

1.86

10.95

1.9

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

532

4196

1.54

10.66

3.5

2.9

122.88

128.48

ug/l

0.17

507

3929

(3021960) Folate [Moles/volume] in Serum or Plasma

336

2392

1.60

10.59

1.7

21.25

20.79

nmol/l

0.20

300

2029

(3048689) Calprotectin [Mass/mass] in Stool

177

1066

1.79

10.48

2.1

2.5

87.76

135.17

ug/g

3.16

146

857

(3003329) Lymphocytes/Leukocytes in Synovial fluid

4.97

10.29

1.8

1.6

23.75

32.41

0.52

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

169

1012

1.80

10.19

2.1

2.6

5.33

8.14

umol/l

2.43

152

899

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

388

2.24

10.08

2.6

2.3

—

(40761511) CBC panel - Blood by Automated count

993

9220

2.42

10.04

17.7

12.7

—

(3008898) HLA-B27 [Presence]

261

2.50

10.03

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

658

5481

1.54

9.95

3.2

2.9

—

(3014051) Protein [Presence] in Urine by Test strip

346

2512

1.56

9.88

3.2

2.8

0.00

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

146

844

1.85

9.86

2.7

2.2

38.70

45.73

u/l

0.30

122

718

(3000570) Elastase.pancreatic [Mass/mass] in Stool

244

2.50

9.44

1.3

1.5

256.87

286.04

ug/g

0.47

152

(3018418) pH of Serum or Plasma

358

2641

1.54

9.43

3.9

4.0

7.40

0.51

267

1863

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

270

2.42

9.34

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

210

2.60

9.26

1.3

1.2

3.51

11.51

u/ml

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

205

1330

1.67

9.23

2.5

2.4

2.36

2.33

g/l

0.40

193

1233

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

916

8312

1.80

9.21

6.6

5.1

1.87

1.91

mu/l

0.22

882

7700

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

118

651

1.92

9.19

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

318

2.29

9.11

2.3

1.8

9.18

8.62

iu/ml

0.05

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

237

2.49

9.02

1.4

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

496

2.03

9.02

1.4

1.3

56.33

44.96

au/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

102

539

1.99

9.00

2.8

2.4

30.53

17.64

au/ml

0.52

(3022621) pH of Urine by Test strip

118

657

1.90

8.94

2.7

2.5

6.12

6.06

0.27

446

(3020630) Protein [Mass/volume] in Serum or Plasma

117

651

1.90

8.88

3.3

66.22

67.03

g/l

0.55

110

604

(3027945) Reticulocytes/Erythrocytes in Blood

157

957

1.75

8.85

1.9

2.8

1.72

1.82

0.80

140

857

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

190

1222

1.68

8.81

2.5

22.05

23.00

0.41

183

1147

(3030981) Hyaline casts [#/volume] in Urine by Automated count

120

675

1.88

8.81

3.0

2.2

0.41

0.66

e6/l

0.68

114

643

(3023520) Reticulocytes [#/volume] in Blood

127

729

1.84

8.75

1.8

3.1

68.15

69.08

e9/l

0.11

533

(3036481) Cortisol [Moles/volume] in Serum or Plasma

137

806

1.80

8.71

3.0

2.3

349.87

389.08

nmol/l

1.42

129

753

(3021589) Normoblasts [#/volume] in Blood

503

4030

1.48

8.69

11.9

10.7

0.00

e9/l

1.50

413

3320

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

720

6197

1.51

8.67

3.6

3.1

46.42

48.19

u/l

0.32

682

5843

(3024263) Appearance of Synovial fluid

4.82

8.61

1.9

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

929

8503

1.80

8.55

7.5

5.9

40.34

38.94

mmol/mol

4.62

895

7976

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1009

9512

2.56

8.47

14.9

11.4

26.41

26.20

u/l

0.17

994

9253

(3007164) IgA [Mass/volume] in Serum or Plasma

250

1737

1.58

8.45

1.6

1.5

2.38

2.44

g/l

0.16

163

1106

(3012544) pH of Venous blood

144

872

1.75

8.29

2.9

3.5

7.38

0.36

487

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

407

2.07

8.22

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

217

2.47

8.19

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

211

2.49

8.18

1.2

2.36

2.59

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

320

2.20

8.15

3.1

2.3

3.90

3.91

g/l

0.01

297

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

320

2.20

8.15

3.1

2.3

7.40

7.47

g/l

0.12

297

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

320

2.20

8.15

3.1

2.3

4.17

4.26

g/l

0.41

297

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

479

1.99

8.13

1.9

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

940

8663

1.81

8.05

19.0

13.8

82.05

81.64

ml/min/173m2

0.26

894

8009

(3019309) Folate [Moles/volume] in Red Blood Cells

198

1321

1.61

7.90

1.7

1193.27

1172.42

nmol/l

0.12

165

1000

(3003327) Ova and parasites identified in Stool by Light microscopy

299

2.21

7.82

1.7

1.6

—

(3003396) Base excess in Arterial blood by calculation

159

1007

1.68

7.77

6.1

9.0

1.18

0.99

mmol/l

0.31

137

834

(3017732) Neutrophils [#/volume] in Blood

171

1107

1.65

7.68

3.8

3.3

4.17

4.91

e9/l

0.76

157

978

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

843

7579

1.57

7.66

23.4

17.7

13.72

13.59

1.98

836

7470

(4024509) Urine culture

367

2.06

7.41

2.5

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

307

2.16

7.34

3.3

2.3

2.81

3.02

g/l

0.88

284

(3019977) pH of Arterial blood

157

1009

1.65

7.24

6.2

9.1

7.41

7.42

0.32

550

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

200

1367

1.57

7.16

3.5

2.8

4.26

2.83

e6/l

0.75

109

654

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

966

9030

1.87

7.14

5.8

4.9

4.69

4.72

mmol/l

0.43

937

8469

(3044640) Blood type and Crossmatch panel - Blood

366

2840

1.44

7.06

2.6

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

962

8986

1.84

7.06

5.6

4.8

1.47

1.49

mmol/l

0.70

929

8370

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

279

2.18

7.02

1.6

1.5

0.13

0.09

iu/ml

0.19

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

266

2.21

7.00

3.0

2.2

10.16

10.65

g/l

0.30

240

(3005322) IgE [Units/volume] in Serum or Plasma

100

571

1.83

7.00

1.5

1.2

117.99

209.33

u/ml

1.12

523

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

106

620

1.79

6.86

2.7

3.0

123.28

199.12

ng/l

2.03

564

(3015377) Calcium [Moles/volume] in Serum or Plasma

396

3131

1.43

6.84

2.7

3.8

2.35

2.36

mmol/l

1.01

372

2883

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

974

9150

1.89

6.77

6.6

5.5

2.74

2.77

mmol/l

0.48

934

8550

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

163

2.51

6.66

1.3

1.2

1.04

1.86

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

213

2.31

6.65

1.3

1.1

4.94

2.88

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

286

2.13

6.61

3.7

2.3

0.40

1.79

g/l

2.73

243

(3000330) Specific gravity of Urine by Test strip

406

1.94

6.53

3.7

3.2

1.02

ratio

0.05

381

(3002032) Base excess in Venous blood by calculation

132

837

1.66

6.40

2.8

3.4

2.22

1.82

mmol/l

0.59

114

719

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

934

8693

1.67

6.39

5.7

4.8

6.08

5.89

mmol/l

2.75

897

8005

(40768804) Tissue Pathology biopsy report

445

3624

1.40

6.36

2.0

2.1

—

(40768797) Stomach Pathology biopsy report

172

1166

1.57

6.34

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

384

3053

1.41

6.31

3.5

3.3

7.41

7.64

mmol/l

0.52

340

2619

(3047007) Chlamydophila sp Ab [Presence] in Serum

126

2.67

6.27

1.4

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

111

677

1.72

6.22

3.3

2.9

10.37

10.74

g/l

0.40

105

622

(3041096) Erythrocytes [Presence] in Urine by Automated

327

2535

1.42

6.18

3.8

3.0

0.03

0.01

estimate

0.24

731

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

158

2.46

6.09

1.7

1.5

—

(3019060) Gas panel - Arterial blood

484

1.82

6.02

4.0

5.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

370

2943

1.40

5.99

4.2

4.0

7.25

7.94

mg/mmol

0.09

243

1815

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

837

7631

1.48

5.97

25.8

18.0

331.80

332.26

g/l

0.80

837

7580

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

383

1.92

5.95

1.8

2.2

38.06

39.83

u/l

0.34

343

(3012095) Magnesium [Moles/volume] in Serum or Plasma

207

1483

1.49

5.89

2.8

3.5

0.81

0.82

mmol/l

0.33

195

1408

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

921

8576

1.60

5.88

4.8

4.1

1.35

1.29

mmol/l

2.10

885

7941

(3033658) Prothrombin time (PT) actual/Normal

295

2266

1.42

5.81

4.5

3.7

92.38

91.22

0.34

287

2221

(3026782) Osmolality of Urine

219

1594

1.47

5.75

3.4

2.7

529.48

526.24

mosm/kgh2o

0.08

207

1391

(3004616) Nuclear Ab [Presence] in Serum

3.01

5.71

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

244

1819

1.44

5.65

1.7

63235725.34

22302127.23

pmol/l

0.42

204

1538

(3012516) Albumin [Mass/volume] in Urine

362

2892

1.38

5.64

3.5

3.4

54.84

46.93

mg/l

0.11

229

1813

(3004588) Protein electrophoresis panel - Serum or Plasma

543

1.74

5.52

3.8

2.8

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

107

668

1.67

5.51

3.1

2.6

69.71

65.08

ml/min/173m2

0.61

278

(3013139) Helicobacter pylori Ag [Presence] in Stool

561

1.72

5.43

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.78

5.39

1.2

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

310

1.96

5.36

1.7

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

108

681

1.65

5.35

2.5

2.2

6.49

7.69

ug/l

0.37

100

605

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

243

2.07

5.22

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

230

2.09

5.19

3.6

2.1

0.02

0.00

g/l

0.49

193

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

230

2.09

5.19

2.2

1.7

1.20

1.24

g/l

0.41

214

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

431

1.80

5.18

2.8

3.4

48.25

49.22

0.11

420

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

273

2107

1.40

5.15

2.5

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

101

635

1.65

5.07

1.2

253.48

141.19

u/ml

0.79

242

(3026361) Erythrocytes [#/volume] in Blood

1019

9827

2.25

4.96

31.3

21.5

4.45

4.50

e12/l

2.31

1013

9586

(3010813) Leukocytes [#/volume] in Blood

1019

9828

2.25

4.94

31.4

21.6

6.89

6.66

e9/l

1.15

1012

9586

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.70

4.94

1.2

1.5

—

(3000494) Fungus identified in Specimen by Culture

151

1050

1.51

4.93

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.78

4.80

1.1

—

(3007461) Platelets [#/volume] in Blood

1018

9823

2.19

4.78

31.4

21.6

256.17

253.66

e9/l

0.58

1013

9616

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

462

3908

1.33

4.74

2.1

1.9

1.36

1.35

mmol/l

0.07

399

3304

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

145

1017

1.49

4.54

3.5

4.8

240.78

246.21

u/l

0.16

140

974

(3000991) Gas panel - Venous blood

113

752

1.56

4.51

6.7

9.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

569

1.64

4.44

7.6

10.8

1.40

1.30

0.40

563

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.85

4.40

1.9

1.1

3.15

1.04

u/ml

0.49

(3024522) Salmonella sp identified in Specimen by Organism specific culture

100

2.54

4.40

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

101

2.51

4.32

1.3

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

260

2048

1.36

4.24

5.3

4.8

—

(36660697) Celiac disease serology panel - Serum

102

674

1.57

4.20

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

122

2.33

4.13

1.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

280

1.86

4.12

1.6

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

549

1.62

4.10

7.8

11.2

0.62

0.65

0.37

543

(3028026) IgM [Mass/volume] in Serum or Plasma

550

1.61

4.07

1.8

1.33

1.61

g/l

0.45

506

(3025941) Bacteria identified in Stool by Culture

433

1.69

4.04

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.46

3.99

1.3

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

404

1.70

3.97

1.0

1.1

—

95.60

titre

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

219

1.96

3.96

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.48

3.90

1.2

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

279

1.83

3.86

2.1

2.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

107

2.37

3.85

1.8

1.3

0.19

0.35

nmol/l

0.46

(3045683) HLA typing for celiac disease panel - Blood or Tissue

3.09

3.81

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

3.72

3.80

1.2

1.1

—

(40768443) Skin Pathology biopsy report

372

1.71

3.76

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

255

1.84

3.64

4.5

3.7

1.51

3.86

ratio

0.89

140

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

526

1.59

3.62

7.4

11.4

24.40

24.46

mmol/l

0.08

516

(3033099) Centromere Ab [Titer] in Serum

7.82

3.56

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

221

1.89

3.54

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

148

1094

1.41

3.52

1.7

1.8

1.52

1.44

0.62

128

956

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.90

3.49

1.0

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

100

2.33

3.45

1.5

18.54

37.17

ng/l

0.91

100

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.11

3.40

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.34

3.35

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.94

3.31

1.1

1.2

—

(3036489) Thrombin time

324

1.70

3.30

2.7

1.8

19.65

20.41

0.86

289

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

109

2.23

3.27

1.9

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

221

1.84

3.23

1.2

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

157

2.00

3.22

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

157

2.00

3.22

1.5

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.88

3.20

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

297

1.72

3.18

2.1

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

215

1.85

3.17

3.9

3.1

0.95

2.64

index

2.38

126

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

224

1.82

3.10

1.7

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

3.05

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

301

1.69

3.04

1.7

17.55

12.84

u/ml

0.22

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

227

1.79

2.98

1.7

2.5

10.22

12.00

mg/l

1.03

217

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.87

2.98

1.1

1.4

91.70

95.12

nmol/24h

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

134

2.04

2.98

1.9

1.3

—

0.53

nmol/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

221

1783

1.30

2.98

2.6

3.1

2.44

2.45

mmol/l

1.48

197

1614

(3045424) Erythrocytes [Presence] in Urine

374

1.61

2.95

2.5

2.2

0.00

2.18

estimate

0.50

115

(21494755) Public health laboratory ask at order entry panel

948

0.64

2.94

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

135

2.03

2.92

1.1

—

1.37

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.85

2.92

1.2

1.4

—

(3025130) Human papilloma virus identified in Specimen

143

1.98

2.87

1.8

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

393

1.59

2.87

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.42

2.81

1.0

1.1

37.89

17.94

u/ml

—

(3018405) Lactate [Moles/volume] in Arterial blood

262

1.71

2.80

4.3

3.2

1.21

1.35

mmol/l

0.60

257

(3021440) Promyelocytes/Leukocytes in Blood

107

779

1.42

2.80

5.3

4.9

0.07

0.12

0.42

213

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

120

892

1.39

2.78

1.5

1.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

2.22

2.75

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

151

1171

1.34

2.69

4.2

5.7

1.05

1.04

mmol/l

0.35

145

1082

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2.35

2.66

6.1

5.5

59.25

51.01

u/ml

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.17

2.65

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.17

2.65

1.3

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.36

2.60

2.5

2.6

—

(3049717) Cytology report of Urine Cyto stain

300

1.63

2.57

1.8

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.24

2.55

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

143

1.91

2.52

1.1

15.50

16.19

au/ml

—

(3025159) Blasts/Leukocytes in Blood

107

794

1.39

2.52

6.6

5.2

0.00

0.54

0.75

199

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.99

2.49

1.1

2.9

20.48

14.79

ug/l

0.80

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.69

2.45

1.2

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.57

2.45

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.57

2.45

1.3

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.36

2.39

1.1

4.78

11.65

iu/ml

—

(1616796) Gas panel - Central venous blood

168

1.81

2.38

1.8

3.3

—

(3017181) Myelocytes/Leukocytes in Blood

109

824

1.36

2.31

5.3

4.8

0.71

1.06

0.90

255

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

407

1.50

2.29

1.1

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

127

985

1.33

2.28

1.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.87

2.21

1.3

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.43

2.20

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

108

822

1.35

2.20

2.1

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.52

2.19

1.3

1.1

—

(3009343) pH of Capillary blood

529

1.43

2.18

3.8

3.7

7.42

0.03

445

(3034426) Prothrombin time (PT)

3.35

2.18

1.1

1.4

28.13

28.33

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

227

1.65

2.17

1.4

1.3

9.12

9.47

u/l

0.08

182

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.18

2.15

1.7

1.3

9573.25

44588.18

e6/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

127

994

1.32

2.14

1.3

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

738

1.36

2.14

2.0

1.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.79

2.14

3.5

2.6

43.14

41.07

g/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

374

1.50

2.10

1.5

1.7

1.96

1.56

g/l

1.91

330

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.22

2.09

1.0

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

124

1.87

2.08

1.1

1.2

2.00

3.37

u/ml

1.13

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

162

1.75

2.03

2.0

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.42

2.03

1.3

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

461

1.44

2.02

1.3

1.4

31.53

28.69

iu/l

0.28

400

(46235355) HIV 1 and 2 tests - Meaningful Use set

182

1504

1.25

2.01

1.6

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

147

0.34

2.01

1.2

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.52

2.01

1.5

1.3

—

62.86

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

1.84

1.99

1.4

2.0

0.41

0.94

g/l

2.44

102

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

186

1.69

1.99

2.1

2.3

89.69

89.20

ug/min

0.00

109

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

125

988

1.30

1.98

3.7

4.7

6.13

21.68

ug/l

1.13

105

799

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

282

0.49

1.96

1.2

1.5

1594.68

1003.98

mu/l

—

231

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.37

1.95

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

4.56

1.94

2.4

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.56

1.94

1.2

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.07

1.91

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

182

1.67

1.86

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

101

782

1.32

1.86

5.1

4.6

0.50

0.76

1.03

235

(3011648) Oxygen content in Venous blood

2.04

1.86

1.4

1.5

11.24

10.86

0.17

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

4.18

1.82

1.2

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.14

1.82

1.8

3.2

364.07

910.09

2.42

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.06

1.80

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

167

0.42

1.79

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

152

0.39

1.77

1.2

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.35

1.75

1.2

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

693

1.33

1.74

2.9

2.3

13.48

13.31

nmol/l

0.07

634

(3027456) Digoxin [Moles/volume] in Serum or Plasma

155

1.69

1.73

2.6

3.3

0.78

0.81

nmol/l

0.15

130

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.15

1.72

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

2.31

1.71

1.3

1.1

—

(3016750) Collection duration of Urine

2.31

1.71

1.8

2.1

531.60

501.44

min

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

235

1.55

1.70

2.7

1.9

162.20

5384.13

u/l

1.52

(3003181) Sodium [Moles/volume] in Urine

149

1.69

1.68

1.2

1.3

79.15

56.35

mmol/l

1.09

120

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

188

1.61

1.67

2.1

1.3

61.20

447.40

e6/l

0.81

144

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

155

1286

1.24

1.67

1.4

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

343

1.45

1.67

2.1

2.0

0.90

1.58

ug/l

0.77

302

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.11

1.66

1.8

1.3

76.38

80.77

umol/l

0.71

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

127

1.75

1.65

1.1

1.2

1.13

4.67

u/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

279

2460

1.18

1.61

5.8

5.1

6.40

2.75

ug/l

0.41

259

2217

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.01

1.58

1.2

1.1

52.93

51.93

iu/ml

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

458

1.38

1.58

3.8

3.6

1.92

1.94

mmol/l

0.02

344

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.04

1.54

1.3

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

241

1.51

1.54

1.2

1.3

—

(3012565) Volume of 24 hour Urine

0.00

1.53

0.0

3.1

—

1887.57

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

114

926

1.26

1.49

8.8

6.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

139

1.67

1.49

1.1

1.0

0.29

2.50

u/ml

2.15

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

124

1.71

1.48

1.6

3.2

31.43

32.60

0.68

124

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

125

1.69

1.44

1.1

1.62

2.47

eliau/ml

—

(3045788) Cell count panel - Pleural fluid

1.93

1.44

1.6

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

188

1.56

1.44

2.0

1.3

7.68

28.47

e6/l

0.58

137

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.13

1.44

1.0

1.1

1.20

1.17

mmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

200

0.50

1.43

1.4

—

(3022145) Colonoscopy Study observation

128

1060

1.24

1.42

1.2

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

141

1.65

1.42

1.2

1.3

—

(4268621) Lupus anticoagulant assay

1.83

1.42

2.2

2.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.26

1.40

1.1

111.10

222.42

iu/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

222

1.50

1.40

2.6

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

198

0.50

1.39

2.9

4.2

20.50

39.21

u/ml

—

193

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

183

1.54

1.35

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

2.15

1.34

1.0

1.1

23.56

9.57

mm/h

—

(3004775) Volume in Urine collected for unspecified duration

1.98

1.33

1.9

2.3

797.00

641.88

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

259

1.44

1.31

2.5

2.6

0.31

0.36

iu/ml

0.42

133

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.10

1.30

2.0

1.2

32.56

33.36

umol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

253

1.44

1.25

1.1

—

(3023419) Bacteria identified in Sputum by Culture

115

1.66

1.25

3.5

2.4

—

(3022313) Gas panel - Capillary blood

364

1.36

1.25

4.8

3.9

—

(3022689) Creatine [Moles/volume] in Urine

2.41

1.24

1.0

1.7

10.63

7.20

mmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

461

1.32

1.23

1.8

2.0

—

(40768793) Breast Pathology biopsy report

264

0.60

1.23

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

101

1.69

1.20

1.6

1.4

36.48

33.39

g/l

0.44

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

678

1.26

1.20

2.8

3.6

72.62

84.77

ng/l

0.97

593

(3024139) IgG subclass 3 [Mass/volume] in Serum

1.84

1.19

1.5

1.4

0.44

0.36

g/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1.84

1.19

1.5

1.4

2.79

2.94

g/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1.84

1.19

1.5

1.4

5.76

7.34

g/l

—

(4146454) Self-monitoring of blood glucose

1.75

1.19

2.4

2.5

—

(4034850) Laboratory test

265

1.41

1.18

7.1

8.5

—

(3000012) Reticulocyte production index

133

1.59

1.18

1.7

2.9

0.86

0.92

0.14

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.01

1.16

1.6

1.9

65.60

130.23

ng/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

681

1.25

1.16

1.2

1.5

—

(4062490) Immunoglobulin typing, IgG

1.82

1.15

1.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

364

0.68

1.11

2.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

1.97

1.11

3.3

2.7

36.40

42.93

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

260

1.40

1.11

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

390

1.32

1.10

1.6

0.29

0.34

mg/l

0.37

188

(3008037) Lactate [Moles/volume] in Venous blood

210

1.44

1.09

2.5

2.7

1.43

1.61

mmol/l

1.00

202

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.39

1.09

2.8

1.7

8.46

8.55

ug/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

261

1.39

1.09

1.9

2.1

3.42

4.74

iu/l

—

118

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.87

1.07

2.1

2.0

—

(3027008) Opiates [Presence] in Urine

296

1.37

1.07

2.4

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

297

1.36

1.05

2.4

2.0

—

(3016879) Cocaine [Presence] in Urine

272

1.37

1.04

2.5

2.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.28

1.03

1.6

3.8

0.77

1.03

ug/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.28

1.03

1.8

2.0

5.22

10.50

mg/l

—

(3028300) Cannabinoids [Presence] in Urine

299

1.35

1.02

2.4

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.70

1.01

3.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

220

1975

1.14

1.00

5.2

4.2

20.44

21.23

0.36

107

897

(1761482) Bacteria [#/volume] in Urine by Culture

206

1.42

0.99

4.1

3.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.18

0.98

1.0

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

1.53

0.97

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

141

1.50

0.95

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

356

1.31

0.94

3.0

3.8

16.25

967.71

u/ml

1.27

314

(3002079) Sodium [Moles/time] in 24 hour Urine

1.90

0.94

1.6

1.4

137.86

193.43

mmol/24h

—

(3019225) pH of Specimen

784

1.20

0.93

4.8

4.3

7.36

7.35

0.27

569

(3027944) Amphetamines [Presence] in Urine

296

1.33

0.92

2.4

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

110

1.55

0.91

3.6

2.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.91

0.88

6.0

3.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.62

0.88

1.9

1.4

—

(3004451) EKG impression Narrative

1.87

0.87

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

1.60

0.84

4.1

3.1

11.75

12.52

index

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

399

0.74

0.84

1.1

1.2

1.59

1.56

g/l

0.21

399

(3048929) Epstein Barr virus Ab [Presence] in Serum

266

1.33

0.83

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.74

0.82

1.6

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.71

0.80

1.3

1.7

—

(4195642) Thrombophilia screening test

122

1.48

0.80

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

106

1.52

0.79

1.0

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

199

1.37

0.78

3.5

2.9

59.62

56.93

0.46

199

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

2.1

—

2.16

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

269

1.31

0.78

5.3

4.1

24.65

25.09

mmol/l

0.59

249

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.63

0.78

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

191

1.37

0.77

3.2

3.6

30.06

2050.40

u/ml

0.88

178

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

1.00

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

168

1512

1.13

0.76

1.6

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.70

0.76

1.0

—

(4281824) Cell count and differential, peritoneal fluid

133

0.60

0.73

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.85

0.73

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.00

0.72

1.0

—

(40768800) Prostate Pathology biopsy report

158

0.63

0.71

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.71

0.70

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

1.86

0.68

2.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.86

0.68

1.0

3.47

4.77

u/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.67

0.68

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

170

1.36

0.68

2.0

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

170

1.36

0.68

1.3

1.1

0.16

2.80

u/ml

2.06

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

119

1.44

0.67

1.4

1.3

26.17

30.25

u/l

—

103

(3011288) Drugs identified in Urine by Screen method Nominal

197

1.33

0.66

1.8

2.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.79

0.66

2.2

2.4

54.20

51.94

umol/l

—

(4211845) Urine protein measurement

1.73

0.64

2.0

1.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

102

0.59

0.62

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

543

0.82

0.62

1.5

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.59

0.62

1.8

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.60

0.61

1.0

—

(1002224) Polysomnography panel

491

1.19

0.61

1.1

—

(3012441) Differential panel - Pleural fluid

1.48

0.60

1.5

1.3

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.60

0.0

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

122

1.40

0.60

1.5

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

381

1.22

0.60

1.8

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

148

1.36

0.60

1.1

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

131

1.38

0.59

1.2

1.0

0.74

2.85

u/ml

1.91

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1.51

0.58

1.6

1.1

44.85

41.54

mg/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

149

1.35

0.58

1.2

1.0

3.98

6.33

u/ml

0.35

(3029634) Reagin Ab [Titer] in Serum by VDRL

116

0.60

0.57

1.1

2.5

—

9.40

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.57

0.56

1.2

1.6

60.82

49.40

ug/l

—

(3038515) Glucose [Moles/volume] in Venous blood

169

1.31

0.53

3.0

2.8

6.91

7.37

mmol/l

0.60

163

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.41

0.51

1.8

1.3

1.73

1.15

promille

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.42

0.50

1.5

2.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.50

0.49

1.0

1.1

115.70

116.07

pmol/l

—

(40768806) Pleura Pathology biopsy report

1.43

0.49

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

108

0.65

0.48

1.1

2.1

—

2512.00

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

108

0.65

0.48

1.7

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

182

1.27

0.46

1.1

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.43

0.46

1.1

3.2

2986.14

1454.35

u/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.43

0.46

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

715

0.87

0.46

1.5

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1.37

0.44

1.4

1.1

285.13

271.64

mg/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

104

1.35

0.43

1.1

1.0

0.05

0.09

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

285

1.20

0.43

1.3

135.79

240.41

miu/ml

—

142

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.65

0.42

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

1.57

0.42

1.2

2.1

0.00

estimate

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.41

0.0

3.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

834

0.89

0.41

1.8

3.47

3.55

mmol/l

0.23

607

(3020876) Protein [Mass/time] in 24 hour Urine

114

1.32

0.41

2.2

2.5

1.59

1.07

g/24h

—

(3051651) Icteric interference index of Serum or Plasma

1.34

0.40

5.8

3.4

0.50

0.88

index

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.0

—

1.41

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

4.6

—

67.33

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

105

1144

0.91

0.40

2.1

3.63

3.48

ratio

0.49

923

(3037756) Immunofixation for Serum or Plasma

205

1.22

0.39

2.2

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

196

1.23

0.39

1.1

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.38

0.38

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.39

0.38

1.2

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

179

1.23

0.37

1.1

1.4

—

(44806420) Estimation of glomerular filtration rate

112

0.71

0.37

2.5

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1044

0.91

0.36

5.7

4.7

32.28

31.90

0.13

684

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

226

1.20

0.36

1.2

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.64

0.35

1.0

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.40

0.35

1.2

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.40

0.35

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

172

1.23

0.34

1.2

290.31

270.14

u/ml

0.10

102

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.35

0.34

2.5

4.6

—

(3025577) Chromium [Mass/volume] in Blood

1.34

0.33

3.3

2.6

3.43

2.21

ug/l

—

(3045142) Bone marrow Pathology biopsy report

133

0.75

0.33

1.0

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.35

0.32

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.28

0.32

1.0

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

1.28

0.32

1.5

1.1

0.62

0.52

ratio

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

146

1.24

0.32

1.2

1.0

0.37

1.22

u/ml

—

(44790048) Parainfluenza type 2 nucleic acid detection

119

1.26

0.32

1.3

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

119

1.26

0.32

1.3

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

119

1.26

0.32

1.3

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

119

1.26

0.32

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

211

1.19

0.31

1.1

1.4

—

(3037121) Protein [Mass/volume] in Urine

286

1.16

0.31

2.9

3.9

344.38

230.41

mg/l

0.30

133

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.73

0.31

1.9

2.4

—

22.61

—

(3002256) Pathology report gross observation

130

1221

1.07

0.30

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

120

1.25

0.30

1.1

0.38

5.27

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

1.25

0.29

3.1

1.2

151.00

144.05

nmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

157

1489

1.06

0.28

3.6

3.0

0.73

ug/l

0.00

111

913

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

113

1.24

0.26

1.2

1.7

—

(3023410) Appearance of Cerebral spinal fluid

1.27

0.26

3.1

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.28

0.26

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.25

0.25

2.1

3.2

—

(3003694) ABO and Rh group [Type] in Blood

274

2648

1.05

0.25

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

889

1.08

0.25

3.7

3.3

—

(3042631) Mycobacterium sp identified in Specimen

123

1.22

0.25

3.2

2.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.22

0.25

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

1.20

0.25

1.0

1.1

333.89

278.62

mg/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.20

0.25

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.27

0.24

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.32

0.23

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

238

1.14

0.22

1.3

1.6

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.21

0.0

3.3

—

11.82

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

49.13

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

75.45

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

134

0.82

0.20

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

1.25

0.20

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.24

0.18

1.0

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

688

1.07

0.18

3.4

3.6

1.22

1.23

mmol/l

1.13

591

(3002523) Influenza virus A Ag [Presence] in Specimen

195

0.87

0.17

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.76

0.17

1.0

1.5

—

(3006270) Folate [Moles/volume] in Blood

0.76

0.17

1.0

1.2

387.40

414.31

nmol/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

194

0.87

0.16

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.18

0.16

1.1

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

389

0.92

0.15

1.6

1.8

3.61

5.72

mg/l

0.60

277

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

1.11

0.11

1.3

1.9

—

(3005570) Glucose [Moles/volume] in Urine

1.16

0.11

2.2

2.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

260

1.08

0.11

1.2

1.1

—

(4035726) Immunohistochemistry procedure

859

1.04

0.11

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.09

0.09

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

1.15

0.09

2.2

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.08

0.07

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

1.07

0.07

1.3

2.2

47.36

36.94

—

(3021901) Oxygen saturation in Capillary blood

186

1.08

0.07

1.9

2.8

90.95

89.62

0.54

181

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

1.3

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

1.2

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.11

0.06

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

148

1.08

0.06

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

182

0.93

0.05

2.1

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

0.92

0.05

1.7

2.8

—

3385.25

—

(3039443) Prostate specific Ag panel - Serum or Plasma

149

1.07

0.05

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

386

3885

0.99

0.04

3.2

3.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

180

1.06

0.04

1.2

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

302

1.03

0.02

1.4

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

111

0.99

0.00

1.4

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

119

1.01

0.00

1.4

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

117

1.03

0.00

1.2

1.6

—

(40761536) Microorganisms panel - Urine sediment

693

1.00

0.00

4.8

3.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

145

1.03

0.00

1.1

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.98

0.00

1.0

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.0

8.3

—

0.20

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.00

-0.00

1.2

1.9

—

1130639.80

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

0.57

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3017569) Oxygen content in Arterial blood

1.02

-0.00

1.6

3.1

16.10

16.30

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

0.00

-0.00

0.0

1.4

—

0.71

—

(40768441) Liver Pathology biopsy report

0.92

-0.00

1.0

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.00

-0.00

1.6

1.0

815.80

1497.78

miu/ml

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

1.0

1.7

—

(3017704) Immunofixation for Urine

0.91

-0.00

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

1.0

1.7

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.87

-0.00

1.0

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

264.80

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

1.0

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

7.0

—

2.58

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

442.17

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.98

-0.00

8.8

3.6

34.07

55.61

u/ml

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(44813793) Dust mix specific IgE antibody measurement

1.00

-0.00

1.1

1.0

—

(21494434) Karyotype in Bone marrow

1.00

-0.00

1.0

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

5.4

—

105.20

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.88

-0.00

1.4

137.24

164.77

pmol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SHOULDERBURSITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SHOULDERBURSITIS	1.197 [1.02, 1.41]	0.031
Birth year	0.995 [0.99, 1.0]	0.291

During the follow-up period (1.1.1998 — 31.12.2019), 318 out of 2869 females with M13_SHOULDERBURSITIS died.

Males

Parameter	HR [95% CI]	p-value
M13_SHOULDERBURSITIS	1.059 [0.89, 1.26]	0.509
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 268 out of 2156 males with M13_SHOULDERBURSITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SHOULDERBURSITIS.

N-year risk	Females	Males
1	0.093%	0.233%
5	0.725%	1.275%
10	1.765%	3.121%
15	3.525%	5.873%
20	6.049%	9.934%

Relationships between endpoints

↥

Index endpoint: M13_SHOULDERBURSITIS – Bursitis of shoulder

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bursitis of shoulder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints